,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
1963,GO:0042446,0.00839646729219275,0.999310027233382,5,7,hormone biosynthetic process,BP,CYP11A1;HSD3B2;HSD17B3;DHCR7;HSD17B11
1120,GO:0016229,0.0123714962679987,0.999514920982079,3,4,steroid dehydrogenase activity,MF,HSD3B2;HSD17B3;HSD17B11
1721,GO:0033764,0.0123714962679987,0.999514920982079,3,4,steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,HSD3B2;HSD17B3;HSD17B11
969,GO:0010817,0.0123755139453329,0.99863931298752,5,8,regulation of hormone levels,BP,CYP11A1;HSD3B2;HSD17B3;DHCR7;HSD17B11
1962,GO:0042445,0.0123755139453329,0.99863931298752,5,8,hormone metabolic process,BP,CYP11A1;HSD3B2;HSD17B3;DHCR7;HSD17B11
727,GO:0008209,0.0252065598464598,0.998677909001427,3,4,androgen metabolic process,BP,HSD3B2;HSD17B3;HSD17B11
1157,GO:0016614,0.0275059714741887,0.995473081729772,5,10,oxidoreductase activity, acting on CH-OH group of donors,MF,HSD3B2;HSD17B3;AOX1;HSD17B11;BDH2
1554,GO:0031965,0.0306440940890733,1,2,2,nuclear membrane,CC,DHCR7;IFI27
9,GO:0000122,0.0324038128849691,1,1,1,negative regulation of transcription from RNA polymerase II promoter,BP,IFI27
49,GO:0001085,0.0324038128849691,1,1,1,RNA polymerase II transcription factor binding,MF,IFI27
51,GO:0001102,0.0324038128849691,1,1,1,RNA polymerase II activating transcription factor binding,MF,IFI27
353,GO:0005521,0.0324038128849691,1,1,1,lamin binding,MF,IFI27
372,GO:0005637,0.0324038128849691,1,1,1,nuclear inner membrane,CC,IFI27
514,GO:0006611,0.0324038128849691,1,1,1,protein export from nucleus,BP,IFI27
711,GO:0008134,0.0324038128849691,1,1,1,transcription factor binding,MF,IFI27
1717,GO:0033613,0.0324038128849691,1,1,1,activating transcription factor binding,MF,IFI27
2309,GO:0045892,0.0324038128849691,1,1,1,negative regulation of transcription, DNA-templated,BP,IFI27
2402,GO:0046825,0.0324038128849691,1,1,1,regulation of protein export from nucleus,BP,IFI27
2641,GO:0051168,0.0324038128849691,1,1,1,nuclear export,BP,IFI27
3378,GO:1903507,0.0324038128849691,1,1,1,negative regulation of nucleic acid-templated transcription,BP,IFI27
1797,GO:0034754,0.032697729043159,0.995873502513031,4,7,cellular hormone metabolic process,BP,CYP11A1;HSD3B2;HSD17B3;HSD17B11
1159,GO:0016616,0.0332720938773852,0.995346486394243,4,8,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,HSD3B2;HSD17B3;HSD17B11;BDH2
786,GO:0009058,0.0609277536109363,0.976713585542507,16,59,biosynthetic process,BP,ACSF2;PNP;HEXB;MRI1;CYP11A1;HSD3B2;TICAM1;ACCS;HSD17B3;PDK4;RBMS3;DHCR7;HSD17B11;BDH2;IFI27;RNASEL
427,GO:0006026,0.0698103218409031,1,2,2,aminoglycan catabolic process,BP,HEXB;IDUA
428,GO:0006027,0.0698103218409031,1,2,2,glycosaminoglycan catabolic process,BP,HEXB;IDUA
1410,GO:0030204,0.0698103218409031,1,2,2,chondroitin sulfate metabolic process,BP,HEXB;IDUA
1412,GO:0030207,0.0698103218409031,1,2,2,chondroitin sulfate catabolic process,BP,HEXB;IDUA
2534,GO:0050654,0.0698103218409031,1,2,2,chondroitin sulfate proteoglycan metabolic process,BP,HEXB;IDUA
3381,GO:1903510,0.0698103218409031,1,2,2,mucopolysaccharide metabolic process,BP,HEXB;IDUA
926,GO:0010557,0.0704506392051715,0.988246360794531,4,7,positive regulation of macromolecule biosynthetic process,BP,HEXB;TICAM1;RBMS3;RNASEL
540,GO:0006694,0.0731675927743487,0.982923807953083,5,11,steroid biosynthetic process,BP,CYP11A1;HSD3B2;HSD17B3;DHCR7;HSD17B11
1190,GO:0016787,0.0738190255155449,0.976767521336597,7,21,hydrolase activity,MF,HEXB;CMBL;CASP4;PON2;RNASEL;IDUA;ASAH2
371,GO:0005635,0.0775433295519898,0.993533371421092,2,4,nuclear envelope,CC,DHCR7;IFI27
390,GO:0005773,0.0825851999025646,0.982979658145105,4,9,vacuole,CC,HEXB;TICAM1;PON2;IDUA
2646,GO:0051173,0.0845528253886902,0.983427668087226,4,8,positive regulation of nitrogen compound metabolic process,BP,HEXB;TICAM1;RBMS3;RNASEL
615,GO:0006955,0.0848053089436295,0.974752891336719,6,17,immune response,BP,PNP;HEXB;TICAM1;CASP4;IFI27;RNASEL
544,GO:0006702,0.0883528272006384,0.994223296516233,2,3,androgen biosynthetic process,BP,HSD3B2;HSD17B3
2046,GO:0043094,0.0884149109780598,1,2,2,cellular metabolic compound salvage,BP,PNP;MRI1
1444,GO:0030539,0.0906715621210475,1,1,1,male genitalia development,BP,HSD17B3
2434,GO:0047035,0.0906715621210475,1,1,1,testosterone dehydrogenase (NAD+) activity,MF,HSD17B3
2435,GO:0047045,0.0906715621210475,1,1,1,testosterone 17-beta-dehydrogenase (NADP+) activity,MF,HSD17B3
3258,GO:1901576,0.0980192256529935,0.958533683660824,15,57,organic substance biosynthetic process,BP,ACSF2;PNP;HEXB;MRI1;CYP11A1;HSD3B2;TICAM1;HSD17B3;PDK4;RBMS3;DHCR7;HSD17B11;BDH2;IFI27;RNASEL
27,GO:0000323,0.0985340523224573,0.982977440796373,3,7,lytic vacuole,CC,HEXB;PON2;IDUA
385,GO:0005764,0.0985340523224573,0.982977440796373,3,7,lysosome,CC,HEXB;PON2;IDUA
3249,GO:1901362,0.0993939816272123,0.960691598912921,10,33,organic cyclic compound biosynthetic process,BP,PNP;HEXB;CYP11A1;HSD3B2;TICAM1;HSD17B3;DHCR7;HSD17B11;IFI27;RNASEL
1749,GO:0034340,0.101517343035228,0.9927606408962,2,3,response to type I interferon,BP,IFI27;RNASEL
2814,GO:0060337,0.101517343035228,0.9927606408962,2,3,type I interferon signaling pathway,BP,IFI27;RNASEL
2979,GO:0071357,0.101517343035228,0.9927606408962,2,3,cellular response to type I interferon,BP,IFI27;RNASEL
467,GO:0006357,0.101767513438865,0.983587820447606,3,6,regulation of transcription from RNA polymerase II promoter,BP,HEXB;IFI27;RNASEL
2155,GO:0044249,0.105196135086265,0.954881684189416,14,52,cellular biosynthetic process,BP,ACSF2;PNP;HEXB;MRI1;CYP11A1;HSD3B2;TICAM1;HSD17B3;PDK4;RBMS3;HSD17B11;BDH2;IFI27;RNASEL
3069,GO:0072593,0.114048599373725,0.983218082855091,3,5,reactive oxygen species metabolic process,BP,TICAM1;PDK4;AOX1
3266,GO:1901653,0.122803454068458,0.981255097844251,3,5,cellular response to peptide,BP,CASP4;PDK4;RNASEL
723,GO:0008202,0.123224471786621,0.963649389159992,5,13,steroid metabolic process,BP,CYP11A1;HSD3B2;HSD17B3;DHCR7;HSD17B11
2878,GO:0070059,0.125371047627214,1,1,1,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,CASP4
3065,GO:0072557,0.125371047627214,1,1,1,IPAF inflammasome complex,CC,CASP4
3132,GO:0097194,0.125371047627214,1,1,1,execution phase of apoptosis,BP,CASP4
3133,GO:0097200,0.125371047627214,1,1,1,cysteine-type endopeptidase activity involved in execution phase of apoptosis,MF,CASP4
3420,GO:1904645,0.125371047627214,1,1,1,response to beta-amyloid,BP,CASP4
3421,GO:1904646,0.125371047627214,1,1,1,cellular response to beta-amyloid,BP,CASP4
283,GO:0004553,0.130048094099344,0.989126060118639,2,3,hydrolase activity, hydrolyzing O-glycosyl compounds,MF,HEXB;IDUA
836,GO:0009311,0.130048094099344,0.989126060118639,2,3,oligosaccharide metabolic process,BP,HEXB;IDUA
1194,GO:0016798,0.130048094099344,0.989126060118639,2,3,hydrolase activity, acting on glycosyl bonds,MF,HEXB;IDUA
235,GO:0003824,0.133340869603745,0.941571774339289,18,72,catalytic activity,MF,ACSF2;PNP;HEXB;MRI1;CMBL;CYP11A1;HSD3B2;CASP4;HSD17B3;PDK4;AOX1;PON2;DHCR7;HSD17B11;BDH2;RNASEL;IDUA;ASAH2
3061,GO:0072523,0.134004078485709,0.988572530510694,2,3,purine-containing compound catabolic process,BP,PNP;AOX1
534,GO:0006672,0.134187050339212,0.988546638172094,2,3,ceramide metabolic process,BP,HEXB;ASAH2
2652,GO:0051188,0.13481283803399,0.966304870831486,4,9,cofactor biosynthetic process,BP,ACSF2;PNP;PDK4;BDH2
606,GO:0006915,0.13840991539511,0.955947726310328,5,15,apoptotic process,BP,TICAM1;CASP4;PDK4;IFI27;ASAH2
2242,GO:0045087,0.140880884135378,0.960715389380906,4,12,innate immune response,BP,TICAM1;CASP4;IFI27;RNASEL
469,GO:0006366,0.141413683674405,0.971004177605658,3,7,transcription from RNA polymerase II promoter,BP,HEXB;IFI27;RNASEL
3234,GO:1901136,0.145545940549462,0.969732540890304,3,7,carbohydrate derivative catabolic process,BP,PNP;HEXB;IDUA
2521,GO:0048806,0.145903197527424,0.994504654846429,1,2,genitalia development,BP,HSD17B3
1311,GO:0019867,0.150628048090484,0.981030314933334,2,4,outer membrane,CC,DHCR7;IFI27
1557,GO:0031968,0.150628048090484,0.981030314933334,2,4,organelle outer membrane,CC,DHCR7;IFI27
904,GO:0010008,0.155039761440235,0.985427742713652,2,3,endosome membrane,CC,SNX21;TICAM1
2194,GO:0044440,0.155039761440235,0.985427742713652,2,3,endosomal part,CC,SNX21;TICAM1
2196,GO:0044445,0.157236087171303,0.979635072277854,2,4,cytosolic part,CC,TICAM1;CASP4
613,GO:0006952,0.157362402323243,0.947561928373676,5,15,defense response,BP,TICAM1;CASP4;AOX1;IFI27;RNASEL
2771,GO:0055080,0.158463413449975,0.96826601067726,3,6,cation homeostasis,BP,HEXB;PDK4;BDH2
3177,GO:0098771,0.158463413449975,0.96826601067726,3,6,inorganic ion homeostasis,BP,HEXB;PDK4;BDH2
604,GO:0006913,0.163355692439749,0.993039899426174,1,2,nucleocytoplasmic transport,BP,IFI27
1600,GO:0032386,0.163355692439749,0.993039899426174,1,2,regulation of intracellular transport,BP,IFI27
1699,GO:0033157,0.163355692439749,0.993039899426174,1,2,regulation of intracellular protein transport,BP,IFI27
2401,GO:0046822,0.163355692439749,0.993039899426174,1,2,regulation of nucleocytoplasmic transport,BP,IFI27
2642,GO:0051169,0.163355692439749,0.993039899426174,1,2,nuclear transport,BP,IFI27
2817,GO:0060341,0.163355692439749,0.993039899426174,1,2,regulation of cellular localization,BP,IFI27
3408,GO:1903827,0.163355692439749,0.993039899426174,1,2,regulation of cellular protein localization,BP,IFI27
294,GO:0004672,0.165949658602018,0.98366324359014,2,3,protein kinase activity,MF,PDK4;RNASEL
2061,GO:0043202,0.166652297998121,0.977572430921299,2,4,lysosomal lumen,CC,HEXB;IDUA
259,GO:0004197,0.174882179110103,0.991967772534811,1,2,cysteine-type endopeptidase activity,MF,CASP4
734,GO:0008234,0.174882179110103,0.991967772534811,1,2,cysteine-type peptidase activity,MF,CASP4
2869,GO:0061702,0.174882179110103,0.991967772534811,1,2,inflammasome complex,CC,CASP4
3067,GO:0072559,0.174882179110103,0.991967772534811,1,2,NLRP3 inflammasome complex,CC,CASP4
3124,GO:0097153,0.174882179110103,0.991967772534811,1,2,cysteine-type endopeptidase activity involved in apoptotic process,MF,CASP4
3127,GO:0097169,0.174882179110103,0.991967772534811,1,2,AIM2 inflammasome complex,CC,CASP4
3143,GO:0097367,0.179024983644352,0.949541900949801,4,9,carbohydrate derivative binding,MF,ACSF2;PNP;PDK4;RNASEL
147,GO:0002376,0.182514131380647,0.92776545565599,6,22,immune system process,BP,PNP;HEXB;TICAM1;CASP4;IFI27;RNASEL
605,GO:0006914,0.185565277383385,0.980260562664227,2,3,autophagy,BP,TICAM1;WDR45
1287,GO:0019439,0.188127575156654,0.953170307323099,3,8,aromatic compound catabolic process,BP,PNP;AOX1;PON2
424,GO:0006022,0.189335581691269,0.979572481200646,2,3,aminoglycan metabolic process,BP,HEXB;IDUA
429,GO:0006029,0.189335581691269,0.979572481200646,2,3,proteoglycan metabolic process,BP,HEXB;IDUA
1409,GO:0030203,0.189335581691269,0.979572481200646,2,3,glycosaminoglycan metabolic process,BP,HEXB;IDUA
732,GO:0008219,0.19072720265075,0.930908643189987,5,16,cell death,BP,TICAM1;CASP4;PDK4;IFI27;ASAH2
1013,GO:0012501,0.19072720265075,0.930908643189987,5,16,programmed cell death,BP,TICAM1;CASP4;PDK4;IFI27;ASAH2
140,GO:0002263,0.191266960911457,0.95433882482024,3,7,cell activation involved in immune response,BP,PNP;HEXB;TICAM1
142,GO:0002275,0.191266960911457,0.95433882482024,3,7,myeloid cell activation involved in immune response,BP,PNP;HEXB;TICAM1
146,GO:0002366,0.191266960911457,0.95433882482024,3,7,leukocyte activation involved in immune response,BP,PNP;HEXB;TICAM1
249,GO:0004064,0.19186203800737,1,1,1,arylesterase activity,MF,PON2
1279,GO:0019372,0.19186203800737,1,1,1,lipoxygenase pathway,BP,PON2
2382,GO:0046573,0.19186203800737,1,1,1,lactonohydrolase activity,MF,PON2
3205,GO:0102007,0.19186203800737,1,1,1,acyl-L-homoserine-lactone lactonohydrolase activity,MF,PON2
3253,GO:1901565,0.192658473267118,0.938835953192663,4,12,organonitrogen compound catabolic process,BP,PNP;HEXB;AOX1;IDUA
2992,GO:0071417,0.193778977039789,0.956905537741192,3,6,cellular response to organonitrogen compound,BP,CASP4;PDK4;RNASEL
3277,GO:1901699,0.193778977039789,0.956905537741192,3,6,cellular response to nitrogen compound,BP,CASP4;PDK4;RNASEL
391,GO:0005775,0.194136695179601,0.967081087690667,2,5,vacuolar lumen,CC,HEXB;IDUA
2191,GO:0044437,0.194136695179601,0.967081087690667,2,5,vacuolar part,CC,HEXB;IDUA
12,GO:0000166,0.195081073484962,0.926261258696596,6,15,nucleotide binding,MF,ACSF2;PDK4;AOX1;DHCR7;BDH2;RNASEL
3241,GO:1901265,0.195081073484962,0.926261258696596,6,15,nucleoside phosphate binding,MF,ACSF2;PDK4;AOX1;DHCR7;BDH2;RNASEL
1209,GO:0016860,0.200888770120322,0.969335628103221,2,4,intramolecular oxidoreductase activity,MF,MRI1;HSD3B2
3248,GO:1901361,0.20259133814512,0.947610836739397,3,8,organic cyclic compound catabolic process,BP,PNP;AOX1;HSD17B11
715,GO:0008152,0.209930796523045,0.921910972147058,23,101,metabolic process,BP,ACSF2;PNP;HEXB;MRI1;CMBL;CYP11A1;HSD3B2;TICAM1;ACCS;CASP4;HSD17B3;PDK4;RBMS3;AOX1;PON2;DHCR7;HSD17B11;BDH2;IFI27;RNASEL;WDR45;IDUA;ASAH2
3128,GO:0097190,0.212739716424385,0.940064056095727,3,10,apoptotic signaling pathway,BP,TICAM1;CASP4;IFI27
236,GO:0003854,0.216056004245526,1,1,1,3-beta-hydroxy-delta5-steroid dehydrogenase activity,MF,HSD3B2
547,GO:0006705,0.216056004245526,1,1,1,mineralocorticoid biosynthetic process,BP,HSD3B2
730,GO:0008212,0.216056004245526,1,1,1,mineralocorticoid metabolic process,BP,HSD3B2
1474,GO:0030868,0.216056004245526,1,1,1,smooth endoplasmic reticulum membrane,CC,HSD3B2
3145,GO:0097425,0.216056004245526,1,1,1,smooth endoplasmic reticulum part,CC,HSD3B2
3276,GO:1901698,0.217247732993425,0.928837915518487,4,11,response to nitrogen compound,BP,TICAM1;CASP4;PDK4;RNASEL
2120,GO:0043603,0.217800786374877,0.92706277475959,4,12,cellular amide metabolic process,BP,HEXB;RBMS3;BDH2;ASAH2
1674,GO:0032869,0.219016048845944,0.973768136792796,2,3,cellular response to insulin stimulus,BP,PDK4;RNASEL
938,GO:0010629,0.219579150366491,0.982892008512218,1,3,negative regulation of gene expression,BP,IFI27
2166,GO:0044273,0.220111542424664,0.964201861791655,2,4,sulfur compound catabolic process,BP,HEXB;IDUA
137,GO:0002252,0.22167126149742,0.926731521029213,4,11,immune effector process,BP,PNP;HEXB;TICAM1;RNASEL
1511,GO:0031328,0.22294601115572,0.926120354098004,4,11,positive regulation of cellular biosynthetic process,BP,HEXB;TICAM1;RBMS3;RNASEL
185,GO:0002696,0.225440036177213,0.962713489014112,2,4,positive regulation of leukocyte activation,BP,PNP;TICAM1
1682,GO:0032943,0.225440036177213,0.962713489014112,2,4,mononuclear cell proliferation,BP,PNP;TICAM1
1683,GO:0032944,0.225440036177213,0.962713489014112,2,4,regulation of mononuclear cell proliferation,BP,PNP;TICAM1
1684,GO:0032946,0.225440036177213,0.962713489014112,2,4,positive regulation of mononuclear cell proliferation,BP,PNP;TICAM1
2391,GO:0046649,0.225440036177213,0.962713489014112,2,4,lymphocyte activation,BP,PNP;TICAM1
2392,GO:0046651,0.225440036177213,0.962713489014112,2,4,lymphocyte proliferation,BP,PNP;TICAM1
2540,GO:0050670,0.225440036177213,0.962713489014112,2,4,regulation of lymphocyte proliferation,BP,PNP;TICAM1
2541,GO:0050671,0.225440036177213,0.962713489014112,2,4,positive regulation of lymphocyte proliferation,BP,PNP;TICAM1
2596,GO:0050867,0.225440036177213,0.962713489014112,2,4,positive regulation of cell activation,BP,PNP;TICAM1
2670,GO:0051249,0.225440036177213,0.962713489014112,2,4,regulation of lymphocyte activation,BP,PNP;TICAM1
2671,GO:0051251,0.225440036177213,0.962713489014112,2,4,positive regulation of lymphocyte activation,BP,PNP;TICAM1
2925,GO:0070661,0.225440036177213,0.962713489014112,2,4,leukocyte proliferation,BP,PNP;TICAM1
2926,GO:0070663,0.225440036177213,0.962713489014112,2,4,regulation of leukocyte proliferation,BP,PNP;TICAM1
2927,GO:0070665,0.225440036177213,0.962713489014112,2,4,positive regulation of leukocyte proliferation,BP,PNP;TICAM1
3265,GO:1901652,0.226512891194494,0.940847943436822,3,7,response to peptide,BP,CASP4;PDK4;RNASEL
857,GO:0009615,0.228851853111747,0.961745524632454,2,4,response to virus,BP,TICAM1;RNASEL
2726,GO:0051607,0.228851853111747,0.961745524632454,2,4,defense response to virus,BP,TICAM1;RNASEL
3157,GO:0098542,0.228851853111747,0.961745524632454,2,4,defense response to other organism,BP,TICAM1;RNASEL
533,GO:0006665,0.236794023822595,0.959446844313432,2,4,sphingolipid metabolic process,BP,HEXB;ASAH2
1144,GO:0016491,0.237547385095084,0.891644050623865,7,25,oxidoreductase activity,MF,CYP11A1;HSD3B2;HSD17B3;AOX1;DHCR7;HSD17B11;BDH2
934,GO:0010604,0.237580224811514,0.905372957968879,5,17,positive regulation of macromolecule metabolic process,BP,HEXB;TICAM1;RBMS3;IFI27;RNASEL
263,GO:0004303,0.242988679048949,1,1,1,estradiol 17-beta-dehydrogenase activity,MF,HSD17B11
548,GO:0006706,0.242988679048949,1,1,1,steroid catabolic process,BP,HSD17B11
549,GO:0006710,0.242988679048949,1,1,1,androgen catabolic process,BP,HSD17B11
1964,GO:0042447,0.242988679048949,1,1,1,hormone catabolic process,BP,HSD17B11
2999,GO:0071495,0.24722148055814,0.93226916678343,3,7,cellular response to endogenous stimulus,BP,CASP4;PDK4;RNASEL
1014,GO:0012505,0.248186636974298,0.875598791534867,9,37,endomembrane system,CC,PNP;HEXB;SNX21;HSD3B2;TICAM1;CASP4;HSD17B3;DHCR7;IFI27
1162,GO:0016628,0.249024605497454,0.955782043364415,2,4,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,MF,DHCR7;BDH2
66,GO:0001573,0.249133012981463,1,1,1,ganglioside metabolic process,BP,HEXB
77,GO:0001669,0.249133012981463,1,1,1,acrosomal vesicle,CC,HEXB
285,GO:0004563,0.249133012981463,1,1,1,beta-N-acetylhexosaminidase activity,MF,HEXB
537,GO:0006689,0.249133012981463,1,1,1,ganglioside catabolic process,BP,HEXB
630,GO:0007040,0.249133012981463,1,1,1,lysosome organization,BP,HEXB
654,GO:0007272,0.249133012981463,1,1,1,ensheathment of neurons,BP,HEXB
660,GO:0007338,0.249133012981463,1,1,1,single fertilization,BP,HEXB
661,GO:0007341,0.249133012981463,1,1,1,penetration of zona pellucida,BP,HEXB
690,GO:0007619,0.249133012981463,1,1,1,courtship behavior,BP,HEXB
701,GO:0008049,0.249133012981463,1,1,1,male courtship behavior,BP,HEXB
748,GO:0008347,0.249133012981463,1,1,1,glial cell migration,BP,HEXB
751,GO:0008366,0.249133012981463,1,1,1,axon ensheathment,BP,HEXB
837,GO:0009313,0.249133012981463,1,1,1,oligosaccharide catabolic process,BP,HEXB
851,GO:0009566,0.249133012981463,1,1,1,fertilization,BP,HEXB
1086,GO:0015929,0.249133012981463,1,1,1,hexosaminidase activity,MF,HEXB
1414,GO:0030212,0.249133012981463,1,1,1,hyaluronan metabolic process,BP,HEXB
1415,GO:0030214,0.249133012981463,1,1,1,hyaluronan catabolic process,BP,HEXB
1942,GO:0042339,0.249133012981463,1,1,1,keratan sulfate metabolic process,BP,HEXB
1943,GO:0042340,0.249133012981463,1,1,1,keratan sulfate catabolic process,BP,HEXB
1981,GO:0042552,0.249133012981463,1,1,1,myelination,BP,HEXB
2122,GO:0043615,0.249133012981463,1,1,1,astrocyte cell migration,BP,HEXB
2213,GO:0044706,0.249133012981463,1,1,1,multi-multicellular organism process,BP,HEXB
2799,GO:0060179,0.249133012981463,1,1,1,male mating behavior,BP,HEXB
3080,GO:0080171,0.249133012981463,1,1,1,lytic vacuole organization,BP,HEXB
3135,GO:0097223,0.249133012981463,1,1,1,sperm part,CC,HEXB
937,GO:0010628,0.253504602974437,0.929570823295271,3,7,positive regulation of gene expression,BP,HEXB;RBMS3;RNASEL
355,GO:0005524,0.253845363374593,0.934474901078906,3,6,ATP binding,MF,ACSF2;PDK4;RNASEL
1228,GO:0017076,0.253845363374593,0.934474901078906,3,6,purine nucleotide binding,MF,ACSF2;PDK4;RNASEL
1446,GO:0030554,0.253845363374593,0.934474901078906,3,6,adenyl nucleotide binding,MF,ACSF2;PDK4;RNASEL
1623,GO:0032553,0.253845363374593,0.934474901078906,3,6,ribonucleotide binding,MF,ACSF2;PDK4;RNASEL
1624,GO:0032555,0.253845363374593,0.934474901078906,3,6,purine ribonucleotide binding,MF,ACSF2;PDK4;RNASEL
1625,GO:0032559,0.253845363374593,0.934474901078906,3,6,adenyl ribonucleotide binding,MF,ACSF2;PDK4;RNASEL
1842,GO:0035639,0.253845363374593,0.934474901078906,3,6,purine ribonucleoside triphosphate binding,MF,ACSF2;PDK4;RNASEL
524,GO:0006643,0.254781011576491,0.94791997305815,2,5,membrane lipid metabolic process,BP,HEXB;ASAH2
1866,GO:0036094,0.255689481139711,0.877521229303315,8,25,small molecule binding,MF,ACSF2;PNP;ACCS;PDK4;AOX1;DHCR7;BDH2;RNASEL
800,GO:0009100,0.257728801871147,0.946885321973433,2,5,glycoprotein metabolic process,BP,HEXB;IDUA
566,GO:0006775,0.259884473574153,1,1,1,fat-soluble vitamin metabolic process,BP,CYP11A1
756,GO:0008386,0.259884473574153,1,1,1,cholesterol monooxygenase (side-chain-cleaving) activity,MF,CYP11A1
1173,GO:0016713,0.259884473574153,1,1,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen,MF,CYP11A1
1946,GO:0042359,0.259884473574153,1,1,1,vitamin D metabolic process,BP,CYP11A1
568,GO:0006790,0.260876482419988,0.895776971256521,5,14,sulfur compound metabolic process,BP,ACSF2;HEXB;MRI1;PDK4;IDUA
1183,GO:0016757,0.263389429916827,0.944871284819952,2,5,transferase activity, transferring glycosyl groups,MF,PNP;HEXB
1095,GO:0016032,0.263420124089863,0.944860266195363,2,5,viral process,BP,TICAM1;RNASEL
2178,GO:0044403,0.263420124089863,0.944860266195363,2,5,symbiosis, encompassing mutualism through parasitism,BP,TICAM1;RNASEL
2179,GO:0044419,0.263420124089863,0.944860266195363,2,5,interspecies interaction between organisms,BP,TICAM1;RNASEL
2223,GO:0044764,0.263420124089863,0.944860266195363,2,5,multi-organism cellular process,BP,TICAM1;RNASEL
2217,GO:0044711,0.264226719416786,0.862893948658131,10,38,single-organism biosynthetic process,BP,PNP;HEXB;MRI1;CYP11A1;HSD3B2;HSD17B3;PDK4;DHCR7;HSD17B11;BDH2
802,GO:0009108,0.266051928360478,0.920364274390761,3,8,coenzyme biosynthetic process,BP,ACSF2;PNP;PDK4
1673,GO:0032868,0.267553784874049,0.949938348550046,2,4,response to insulin,BP,PDK4;RNASEL
1402,GO:0030170,0.269061277446885,1,1,1,pyridoxal phosphate binding,MF,ACCS
2900,GO:0070279,0.269061277446885,1,1,1,vitamin B6 binding,MF,ACCS
2685,GO:0051287,0.274239624474626,0.947742593275519,2,4,NAD binding,MF,AOX1;BDH2
2164,GO:0044271,0.274432997290425,0.86702579249663,7,28,cellular nitrogen compound biosynthetic process,BP,PNP;HEXB;TICAM1;RBMS3;BDH2;IFI27;RNASEL
2165,GO:0044272,0.274902681776707,0.920046543338297,3,7,sulfur compound biosynthetic process,BP,ACSF2;MRI1;PDK4
614,GO:0006954,0.276006488231132,0.915669217909177,3,8,inflammatory response,BP,TICAM1;CASP4;AOX1
3161,GO:0098588,0.277107628118028,0.883625840491321,5,16,bounding membrane of organelle,CC,SNX21;HSD3B2;TICAM1;DHCR7;IFI27
2317,GO:0045934,0.277243642955127,0.978464993408961,1,2,negative regulation of nucleobase-containing compound metabolic process,BP,IFI27
2673,GO:0051253,0.277243642955127,0.978464993408961,1,2,negative regulation of RNA metabolic process,BP,IFI27
3330,GO:1902679,0.277243642955127,0.978464993408961,1,2,negative regulation of RNA biosynthetic process,BP,IFI27
936,GO:0010608,0.278459378257612,0.939334022137957,2,5,posttranscriptional regulation of gene expression,BP,RBMS3;RNASEL
3059,GO:0072521,0.278782770413395,0.939212385259318,2,5,purine-containing compound metabolic process,BP,PNP;AOX1
1508,GO:0031325,0.27951919479349,0.878560413454489,5,20,positive regulation of cellular metabolic process,BP,HEXB;TICAM1;RBMS3;IFI27;RNASEL
2579,GO:0050801,0.28146741345628,0.913044848055458,3,8,ion homeostasis,BP,HEXB;PDK4;BDH2
1208,GO:0016853,0.284419402203831,0.937073212562512,2,5,isomerase activity,MF,MRI1;HSD3B2
141,GO:0002274,0.285370219894283,0.911148063845596,3,8,myeloid leukocyte activation,BP,PNP;HEXB;TICAM1
240,GO:0003940,0.285841989453057,1,1,1,L-iduronidase activity,MF,IDUA
419,GO:0005984,0.285841989453057,1,1,1,disaccharide metabolic process,BP,IDUA
1392,GO:0030135,0.285841989453057,1,1,1,coated vesicle,CC,IDUA
1411,GO:0030205,0.285841989453057,1,1,1,dermatan sulfate metabolic process,BP,IDUA
1413,GO:0030209,0.285841989453057,1,1,1,dermatan sulfate catabolic process,BP,IDUA
2535,GO:0050655,0.285841989453057,1,1,1,dermatan sulfate proteoglycan metabolic process,BP,IDUA
3131,GO:0097193,0.287263878889387,0.969563441001405,1,3,intrinsic apoptotic signaling pathway,BP,CASP4
563,GO:0006766,0.28980257268886,0.934996433583317,2,5,vitamin metabolic process,BP,CYP11A1;AOX1
301,GO:0004769,0.289820767978673,0.976268352267042,1,2,steroid delta-isomerase activity,MF,HSD3B2
401,GO:0005811,0.292232218922529,0.975832611969363,1,2,lipid particle,CC,HSD17B11
87,GO:0001816,0.293280673734149,0.9336369771953,2,5,cytokine production,BP,PNP;TICAM1
3463,GO:2000112,0.293669008745187,0.872444553822582,5,17,regulation of cellular macromolecule biosynthetic process,BP,HEXB;TICAM1;RBMS3;IFI27;RNASEL
1196,GO:0016810,0.296675162836049,1,1,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,ASAH2
1197,GO:0016811,0.296675162836049,1,1,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,ASAH2
1226,GO:0017040,0.296675162836049,1,1,1,ceramidase activity,MF,ASAH2
125,GO:0002054,0.297977867110299,1,1,1,nucleobase binding,MF,PNP
126,GO:0002060,0.297977867110299,1,1,1,purine nucleobase binding,MF,PNP
299,GO:0004731,0.297977867110299,1,1,1,purine-nucleoside phosphorylase activity,MF,PNP
453,GO:0006148,0.297977867110299,1,1,1,inosine catabolic process,BP,PNP
454,GO:0006152,0.297977867110299,1,1,1,purine nucleoside catabolic process,BP,PNP
557,GO:0006738,0.297977867110299,1,1,1,nicotinamide riboside catabolic process,BP,PNP
713,GO:0008144,0.297977867110299,1,1,1,drug binding,MF,PNP
809,GO:0009119,0.297977867110299,1,1,1,ribonucleoside metabolic process,BP,PNP
1185,GO:0016763,0.297977867110299,1,1,1,transferase activity, transferring pentosyl groups,MF,PNP
1636,GO:0032623,0.297977867110299,1,1,1,interleukin-2 production,BP,PNP
1767,GO:0034418,0.297977867110299,1,1,1,urate biosynthetic process,BP,PNP
1933,GO:0042278,0.297977867110299,1,1,1,purine nucleoside metabolic process,BP,PNP
1934,GO:0042301,0.297977867110299,1,1,1,phosphate ion binding,MF,PNP
1966,GO:0042454,0.297977867110299,1,1,1,ribonucleoside catabolic process,BP,PNP
2047,GO:0043101,0.297977867110299,1,1,1,purine-containing compound salvage,BP,PNP
2275,GO:0045580,0.297977867110299,1,1,1,regulation of T cell differentiation,BP,PNP
2276,GO:0045582,0.297977867110299,1,1,1,positive regulation of T cell differentiation,BP,PNP
2280,GO:0045619,0.297977867110299,1,1,1,regulation of lymphocyte differentiation,BP,PNP
2281,GO:0045621,0.297977867110299,1,1,1,positive regulation of lymphocyte differentiation,BP,PNP
2326,GO:0046102,0.297977867110299,1,1,1,inosine metabolic process,BP,PNP
2330,GO:0046128,0.297977867110299,1,1,1,purine ribonucleoside metabolic process,BP,PNP
2331,GO:0046130,0.297977867110299,1,1,1,purine ribonucleoside catabolic process,BP,PNP
2351,GO:0046415,0.297977867110299,1,1,1,urate metabolic process,BP,PNP
2373,GO:0046495,0.297977867110299,1,1,1,nicotinamide riboside metabolic process,BP,PNP
2385,GO:0046631,0.297977867110299,1,1,1,alpha-beta T cell activation,BP,PNP
2386,GO:0046632,0.297977867110299,1,1,1,alpha-beta T cell differentiation,BP,PNP
2387,GO:0046634,0.297977867110299,1,1,1,regulation of alpha-beta T cell activation,BP,PNP
2388,GO:0046635,0.297977867110299,1,1,1,positive regulation of alpha-beta T cell activation,BP,PNP
2389,GO:0046637,0.297977867110299,1,1,1,regulation of alpha-beta T cell differentiation,BP,PNP
2390,GO:0046638,0.297977867110299,1,1,1,positive regulation of alpha-beta T cell differentiation,BP,PNP
2921,GO:0070637,0.297977867110299,1,1,1,pyridine nucleoside metabolic process,BP,PNP
2922,GO:0070638,0.297977867110299,1,1,1,pyridine nucleoside catabolic process,BP,PNP
2948,GO:0070970,0.297977867110299,1,1,1,interleukin-2 secretion,BP,PNP
3064,GO:0072526,0.297977867110299,1,1,1,pyridine-containing compound catabolic process,BP,PNP
2219,GO:0044723,0.298650065111623,0.89906109305595,3,10,single-organism carbohydrate metabolic process,BP,HEXB;PDK4;IDUA
657,GO:0007281,0.299775326151146,0.974438827158141,1,2,germ cell development,BP,HEXB
659,GO:0007292,0.299775326151146,0.974438827158141,1,2,female gamete generation,BP,HEXB
1338,GO:0022412,0.299775326151146,0.974438827158141,1,2,cellular process involved in reproduction in multicellular organism,BP,HEXB
2470,GO:0048477,0.299775326151146,0.974438827158141,1,2,oogenesis,BP,HEXB
883,GO:0009891,0.301673375702547,0.882547241767139,4,12,positive regulation of biosynthetic process,BP,HEXB;TICAM1;RBMS3;RNASEL
373,GO:0005640,0.302250769618319,1,1,1,nuclear outer membrane,CC,DHCR7
874,GO:0009791,0.302250769618319,1,1,1,post-embryonic development,BP,DHCR7
893,GO:0009918,0.302250769618319,1,1,1,sterol delta7 reductase activity,MF,DHCR7
1110,GO:0016128,0.302250769618319,1,1,1,phytosteroid metabolic process,BP,DHCR7
1111,GO:0016129,0.302250769618319,1,1,1,phytosteroid biosynthetic process,BP,DHCR7
1112,GO:0016131,0.302250769618319,1,1,1,brassinosteroid metabolic process,BP,DHCR7
1113,GO:0016132,0.302250769618319,1,1,1,brassinosteroid biosynthetic process,BP,DHCR7
2437,GO:0047598,0.302250769618319,1,1,1,7-dehydrocholesterol reductase activity,MF,DHCR7
144,GO:0002281,0.302496239067324,1,1,1,macrophage activation involved in immune response,BP,TICAM1
921,GO:0010508,0.302496239067324,1,1,1,positive regulation of autophagy,BP,TICAM1
1389,GO:0030101,0.302496239067324,1,1,1,natural killer cell activation,BP,TICAM1
1475,GO:0030888,0.302496239067324,1,1,1,regulation of B cell proliferation,BP,TICAM1
1476,GO:0030890,0.302496239067324,1,1,1,positive regulation of B cell proliferation,BP,TICAM1
1539,GO:0031663,0.302496239067324,1,1,1,lipopolysaccharide-mediated signaling pathway,BP,TICAM1
1569,GO:0032092,0.302496239067324,1,1,1,positive regulation of protein binding,BP,TICAM1
1612,GO:0032481,0.302496239067324,1,1,1,positive regulation of type I interferon production,BP,TICAM1
1653,GO:0032728,0.302496239067324,1,1,1,positive regulation of interferon-beta production,BP,TICAM1
1669,GO:0032814,0.302496239067324,1,1,1,regulation of natural killer cell activation,BP,TICAM1
1670,GO:0032816,0.302496239067324,1,1,1,positive regulation of natural killer cell activation,BP,TICAM1
1736,GO:0034121,0.302496239067324,1,1,1,regulation of toll-like receptor signaling pathway,BP,TICAM1
1737,GO:0034122,0.302496239067324,1,1,1,negative regulation of toll-like receptor signaling pathway,BP,TICAM1
1738,GO:0034127,0.302496239067324,1,1,1,regulation of MyD88-independent toll-like receptor signaling pathway,BP,TICAM1
1739,GO:0034128,0.302496239067324,1,1,1,negative regulation of MyD88-independent toll-like receptor signaling pathway,BP,TICAM1
1897,GO:0042033,0.302496239067324,1,1,1,chemokine biosynthetic process,BP,TICAM1
1905,GO:0042100,0.302496239067324,1,1,1,B cell proliferation,BP,TICAM1
1909,GO:0042108,0.302496239067324,1,1,1,positive regulation of cytokine biosynthetic process,BP,TICAM1
1911,GO:0042113,0.302496239067324,1,1,1,B cell activation,BP,TICAM1
2089,GO:0043330,0.302496239067324,1,1,1,response to exogenous dsRNA,BP,TICAM1
2090,GO:0043331,0.302496239067324,1,1,1,response to dsRNA,BP,TICAM1
2240,GO:0045073,0.302496239067324,1,1,1,regulation of chemokine biosynthetic process,BP,TICAM1
2241,GO:0045080,0.302496239067324,1,1,1,positive regulation of chemokine biosynthetic process,BP,TICAM1
2265,GO:0045359,0.302496239067324,1,1,1,positive regulation of interferon-beta biosynthetic process,BP,TICAM1
2267,GO:0045429,0.302496239067324,1,1,1,positive regulation of nitric oxide biosynthetic process,BP,TICAM1
2560,GO:0050755,0.302496239067324,1,1,1,chemokine metabolic process,BP,TICAM1
2594,GO:0050864,0.302496239067324,1,1,1,regulation of B cell activation,BP,TICAM1
2598,GO:0050871,0.302496239067324,1,1,1,positive regulation of B cell activation,BP,TICAM1
2636,GO:0051099,0.302496239067324,1,1,1,positive regulation of binding,BP,TICAM1
3376,GO:1903428,0.302496239067324,1,1,1,positive regulation of reactive oxygen species biosynthetic process,BP,TICAM1
3417,GO:1904407,0.302496239067324,1,1,1,positive regulation of nitric oxide metabolic process,BP,TICAM1
230,GO:0003729,0.302752858793475,1,1,1,mRNA binding,MF,RBMS3
231,GO:0003730,0.302752858793475,1,1,1,mRNA 3'-UTR binding,MF,RBMS3
1743,GO:0034250,0.302752858793475,1,1,1,positive regulation of cellular amide metabolic process,BP,RBMS3
2292,GO:0045727,0.302752858793475,1,1,1,positive regulation of translation,BP,RBMS3
2322,GO:0045944,0.302939464599696,0.937782302383571,2,4,positive regulation of transcription from RNA polymerase II promoter,BP,HEXB;RNASEL
238,GO:0003858,0.303256753432912,1,1,1,3-hydroxybutyrate dehydrogenase activity,MF,BDH2
567,GO:0006778,0.303256753432912,1,1,1,porphyrin-containing compound metabolic process,BP,BDH2
822,GO:0009237,0.303256753432912,1,1,1,siderophore metabolic process,BP,BDH2
1270,GO:0019290,0.303256753432912,1,1,1,siderophore biosynthetic process,BP,BDH2
1694,GO:0033013,0.303256753432912,1,1,1,tetrapyrrole metabolic process,BP,BDH2
1922,GO:0042168,0.303256753432912,1,1,1,heme metabolic process,BP,BDH2
1961,GO:0042440,0.303256753432912,1,1,1,pigment metabolic process,BP,BDH2
2208,GO:0044550,0.303256753432912,1,1,1,secondary metabolite biosynthetic process,BP,BDH2
2768,GO:0055072,0.303256753432912,1,1,1,iron ion homeostasis,BP,BDH2
8,GO:0000097,0.303765867234565,1,1,1,sulfur amino acid biosynthetic process,BP,MRI1
69,GO:0001650,0.303765867234565,1,1,1,fibrillar center,CC,MRI1
793,GO:0009067,0.303765867234565,1,1,1,aspartate family amino acid biosynthetic process,BP,MRI1
799,GO:0009086,0.303765867234565,1,1,1,methionine biosynthetic process,BP,MRI1
1210,GO:0016861,0.303765867234565,1,1,1,intramolecular oxidoreductase activity, interconverting aldoses and ketoses,MF,MRI1
1288,GO:0019509,0.303765867234565,1,1,1,L-methionine salvage from methylthioadenosine,BP,MRI1
2048,GO:0043102,0.303765867234565,1,1,1,amino acid salvage,BP,MRI1
2200,GO:0044452,0.303765867234565,1,1,1,nucleolar part,CC,MRI1
2377,GO:0046523,0.303765867234565,1,1,1,S-methyl-5-thioribose-1-phosphate isomerase activity,MF,MRI1
2962,GO:0071265,0.303765867234565,1,1,1,L-methionine biosynthetic process,BP,MRI1
2963,GO:0071267,0.303765867234565,1,1,1,L-methionine salvage,BP,MRI1
360,GO:0005546,0.303922855339744,1,1,1,phosphatidylinositol-4,5-bisphosphate binding,MF,SNX21
388,GO:0005769,0.303922855339744,1,1,1,early endosome,CC,SNX21
1549,GO:0031901,0.303922855339744,1,1,1,early endosome membrane,CC,SNX21
1575,GO:0032266,0.303922855339744,1,1,1,phosphatidylinositol-3-phosphate binding,MF,SNX21
3286,GO:1901981,0.303922855339744,1,1,1,phosphatidylinositol phosphate binding,MF,SNX21
3348,GO:1902936,0.303922855339744,1,1,1,phosphatidylinositol bisphosphate binding,MF,SNX21
300,GO:0004740,0.304970561426563,1,1,1,pyruvate dehydrogenase (acetyl-transferring) kinase activity,MF,PDK4
435,GO:0006086,0.304970561426563,1,1,1,acetyl-CoA biosynthetic process from pyruvate,BP,PDK4
436,GO:0006090,0.304970561426563,1,1,1,pyruvate metabolic process,BP,PDK4
595,GO:0006885,0.304970561426563,1,1,1,regulation of pH,BP,PDK4
744,GO:0008286,0.304970561426563,1,1,1,insulin receptor signaling pathway,BP,PDK4
922,GO:0010510,0.304970561426563,1,1,1,regulation of acetyl-CoA biosynthetic process from pyruvate,BP,PDK4
1735,GO:0034103,0.304970561426563,1,1,1,regulation of tissue remodeling,BP,PDK4
2009,GO:0042762,0.304970561426563,1,1,1,regulation of sulfur metabolic process,BP,PDK4
2081,GO:0043276,0.304970561426563,1,1,1,anoikis,BP,PDK4
2248,GO:0045124,0.304970561426563,1,1,1,regulation of bone resorption,BP,PDK4
2269,GO:0045453,0.304970561426563,1,1,1,bone resorption,BP,PDK4
2404,GO:0046849,0.304970561426563,1,1,1,bone remodeling,BP,PDK4
2405,GO:0046850,0.304970561426563,1,1,1,regulation of bone remodeling,BP,PDK4
2584,GO:0050812,0.304970561426563,1,1,1,regulation of acyl-CoA biosynthetic process,BP,PDK4
2653,GO:0051193,0.304970561426563,1,1,1,regulation of cofactor metabolic process,BP,PDK4
2654,GO:0051196,0.304970561426563,1,1,1,regulation of coenzyme metabolic process,BP,PDK4
2766,GO:0055067,0.304970561426563,1,1,1,monovalent inorganic cation homeostasis,BP,PDK4
2957,GO:0071229,0.304970561426563,1,1,1,cellular response to acid chemical,BP,PDK4
2990,GO:0071398,0.304970561426563,1,1,1,cellular response to fatty acid,BP,PDK4
3473,GO:2000209,0.304970561426563,1,1,1,regulation of anoikis,BP,PDK4
3497,GO:2000811,0.304970561426563,1,1,1,negative regulation of anoikis,BP,PDK4
3247,GO:1901360,0.305116582045878,0.829744827675455,12,51,organic cyclic compound metabolic process,BP,PNP;HEXB;CYP11A1;HSD3B2;TICAM1;HSD17B3;AOX1;DHCR7;HSD17B11;BDH2;IFI27;RNASEL
281,GO:0004521,0.305503309705506,1,1,1,endoribonuclease activity,MF,RNASEL
468,GO:0006364,0.305503309705506,1,1,1,rRNA processing,BP,RNASEL
973,GO:0010827,0.305503309705506,1,1,1,regulation of glucose transport,BP,RNASEL
974,GO:0010828,0.305503309705506,1,1,1,positive regulation of glucose transport,BP,RNASEL
1132,GO:0016363,0.305503309705506,1,1,1,nuclear matrix,CC,RNASEL
1258,GO:0019058,0.305503309705506,1,1,1,viral life cycle,BP,RNASEL
1259,GO:0019079,0.305503309705506,1,1,1,viral genome replication,BP,RNASEL
1766,GO:0034399,0.305503309705506,1,1,1,nuclear periphery,CC,RNASEL
1931,GO:0042254,0.305503309705506,1,1,1,ribosome biogenesis,BP,RNASEL
2029,GO:0043021,0.305503309705506,1,1,1,ribonucleoprotein complex binding,MF,RNASEL
2136,GO:0043900,0.305503309705506,1,1,1,regulation of multi-organism process,BP,RNASEL
2137,GO:0043901,0.305503309705506,1,1,1,negative regulation of multi-organism process,BP,RNASEL
2138,GO:0043903,0.305503309705506,1,1,1,regulation of symbiosis, encompassing mutualism through parasitism,BP,RNASEL
2176,GO:0044381,0.305503309705506,1,1,1,glucose import in response to insulin stimulus,BP,RNASEL
2238,GO:0045069,0.305503309705506,1,1,1,regulation of viral genome replication,BP,RNASEL
2239,GO:0045071,0.305503309705506,1,1,1,negative regulation of viral genome replication,BP,RNASEL
2339,GO:0046324,0.305503309705506,1,1,1,regulation of glucose import,BP,RNASEL
2340,GO:0046326,0.305503309705506,1,1,1,positive regulation of glucose import,BP,RNASEL
2479,GO:0048525,0.305503309705506,1,1,1,negative regulation of viral process,BP,RNASEL
2574,GO:0050792,0.305503309705506,1,1,1,regulation of viral process,BP,RNASEL
3113,GO:0090502,0.305503309705506,1,1,1,RNA phosphodiester bond hydrolysis, endonucleolytic,BP,RNASEL
3213,GO:1900076,0.305503309705506,1,1,1,regulation of cellular response to insulin stimulus,BP,RNASEL
3214,GO:1900078,0.305503309705506,1,1,1,positive regulation of cellular response to insulin stimulus,BP,RNASEL
3409,GO:1903900,0.305503309705506,1,1,1,regulation of viral life cycle,BP,RNASEL
3410,GO:1903901,0.305503309705506,1,1,1,negative regulation of viral life cycle,BP,RNASEL
3520,GO:2001273,0.305503309705506,1,1,1,regulation of glucose import in response to insulin stimulus,BP,RNASEL
3521,GO:2001275,0.305503309705506,1,1,1,positive regulation of glucose import in response to insulin stimulus,BP,RNASEL
247,GO:0004031,0.305899774239776,1,1,1,aldehyde oxidase activity,MF,AOX1
302,GO:0004854,0.305899774239776,1,1,1,xanthine dehydrogenase activity,MF,AOX1
451,GO:0006144,0.305899774239776,1,1,1,purine nucleobase metabolic process,BP,AOX1
452,GO:0006145,0.305899774239776,1,1,1,purine nucleobase catabolic process,BP,AOX1
805,GO:0009112,0.305899774239776,1,1,1,nucleobase metabolic process,BP,AOX1
806,GO:0009115,0.305899774239776,1,1,1,xanthine catabolic process,BP,AOX1
1160,GO:0016623,0.305899774239776,1,1,1,oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor,MF,AOX1
1177,GO:0016725,0.305899774239776,1,1,1,oxidoreductase activity, acting on CH or CH2 groups,MF,AOX1
1178,GO:0016726,0.305899774239776,1,1,1,oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor,MF,AOX1
1219,GO:0016903,0.305899774239776,1,1,1,oxidoreductase activity, acting on the aldehyde or oxo group of donors,MF,AOX1
2014,GO:0042816,0.305899774239776,1,1,1,vitamin B6 metabolic process,BP,AOX1
2115,GO:0043546,0.305899774239776,1,1,1,molybdopterin cofactor binding,MF,AOX1
2327,GO:0046110,0.305899774239776,1,1,1,xanthine metabolic process,BP,AOX1
2328,GO:0046113,0.305899774239776,1,1,1,nucleobase catabolic process,BP,AOX1
2717,GO:0051537,0.305899774239776,1,1,1,2 iron, 2 sulfur cluster binding,MF,AOX1
3279,GO:1901701,0.307620400528858,0.881389615554809,4,11,cellular response to oxygen-containing compound,BP,TICAM1;CASP4;PDK4;RNASEL
3250,GO:1901363,0.30785100113227,0.833156041741732,10,36,heterocyclic compound binding,MF,ACSF2;PNP;CYP11A1;ACCS;PDK4;RBMS3;AOX1;DHCR7;BDH2;RNASEL
363,GO:0005576,0.310740251068616,0.832316117331455,9,39,extracellular region,CC,PNP;HEXB;CMBL;CASP4;AOX1;PON2;HSD17B11;BDH2;IDUA
785,GO:0009057,0.310745515392166,0.926599585448159,2,5,macromolecule catabolic process,BP,HEXB;IDUA
768,GO:0008610,0.311088432183524,0.843448818899928,7,26,lipid biosynthetic process,BP,HEXB;CYP11A1;HSD3B2;HSD17B3;PDK4;DHCR7;HSD17B11
1035,GO:0015031,0.317146130917397,0.887075579836888,3,11,protein transport,BP,PNP;SNX21;IFI27
1075,GO:0015833,0.317146130917397,0.887075579836888,3,11,peptide transport,BP,PNP;SNX21;IFI27
2015,GO:0042886,0.317146130917397,0.887075579836888,3,11,amide transport,BP,PNP;SNX21;IFI27
2250,GO:0045184,0.317146130917397,0.887075579836888,3,11,establishment of protein localization,BP,PNP;SNX21;IFI27
749,GO:0008360,0.317166770569477,0.971043943681138,1,2,regulation of cell shape,BP,HEXB
1902,GO:0042063,0.317166770569477,0.971043943681138,1,2,gliogenesis,BP,HEXB
2190,GO:0044433,0.320212816905314,0.871625548997472,4,12,cytoplasmic vesicle part,CC,PNP;HEXB;SNX21;TICAM1
2160,GO:0044262,0.320539680814868,0.931236522637841,2,4,cellular carbohydrate metabolic process,BP,PDK4;IDUA
3464,GO:2000113,0.326116238862054,0.959844740405077,1,3,negative regulation of cellular macromolecule biosynthetic process,BP,IFI27
881,GO:0009889,0.328858979632387,0.830509707338511,7,27,regulation of biosynthetic process,BP,HEXB;TICAM1;PDK4;RBMS3;DHCR7;IFI27;RNASEL
925,GO:0010556,0.330689565153251,0.847667287710728,5,18,regulation of macromolecule biosynthetic process,BP,HEXB;TICAM1;RBMS3;IFI27;RNASEL
2765,GO:0055065,0.333456390060062,0.916913886789303,2,5,metal ion homeostasis,BP,HEXB;BDH2
2035,GO:0043043,0.334288350129551,0.907098749978093,2,7,peptide biosynthetic process,BP,RBMS3;BDH2
2121,GO:0043604,0.334288350129551,0.907098749978093,2,7,amide biosynthetic process,BP,RBMS3;BDH2
706,GO:0008104,0.334736642985764,0.875328379772287,3,12,protein localization,BP,PNP;SNX21;IFI27
1262,GO:0019184,0.335718645458828,0.967134368190284,1,2,nonribosomal peptide biosynthetic process,BP,BDH2
2539,GO:0050663,0.33811300157991,0.966607470764416,1,2,cytokine secretion,BP,PNP
1827,GO:0035384,0.338947904275974,0.924024703797033,2,4,thioester biosynthetic process,BP,ACSF2;PDK4
3007,GO:0071616,0.338947904275974,0.924024703797033,2,4,acyl-CoA biosynthetic process,BP,ACSF2;PDK4
741,GO:0008283,0.339009540339051,0.872812054940564,3,12,cell proliferation,BP,PNP;TICAM1;DHCR7
1914,GO:0042127,0.339009540339051,0.872812054940564,3,12,regulation of cell proliferation,BP,PNP;TICAM1;DHCR7
397,GO:0005789,0.339981660347049,0.853045484331879,4,16,endoplasmic reticulum membrane,CC,HSD3B2;CASP4;HSD17B3;DHCR7
1923,GO:0042175,0.339981660347049,0.853045484331879,4,16,nuclear outer membrane-endoplasmic reticulum membrane network,CC,HSD3B2;CASP4;HSD17B3;DHCR7
2189,GO:0044432,0.339981660347049,0.853045484331879,4,16,endoplasmic reticulum part,CC,HSD3B2;CASP4;HSD17B3;DHCR7
2310,GO:0045893,0.341023594520248,0.913550052843212,2,5,positive regulation of transcription, DNA-templated,BP,HEXB;RNASEL
2674,GO:0051254,0.341023594520248,0.913550052843212,2,5,positive regulation of RNA metabolic process,BP,HEXB;RNASEL
3331,GO:1902680,0.341023594520248,0.913550052843212,2,5,positive regulation of RNA biosynthetic process,BP,HEXB;RNASEL
3379,GO:1903508,0.341023594520248,0.913550052843212,2,5,positive regulation of nucleic acid-templated transcription,BP,HEXB;RNASEL
1628,GO:0032602,0.342384593034186,0.965654552302404,1,2,chemokine production,BP,TICAM1
1637,GO:0032635,0.342384593034186,0.965654552302404,1,2,interleukin-6 production,BP,TICAM1
1640,GO:0032642,0.342384593034186,0.965654552302404,1,2,regulation of chemokine production,BP,TICAM1
1647,GO:0032675,0.342384593034186,0.965654552302404,1,2,regulation of interleukin-6 production,BP,TICAM1
1652,GO:0032722,0.342384593034186,0.965654552302404,1,2,positive regulation of chemokine production,BP,TICAM1
1658,GO:0032755,0.342384593034186,0.965654552302404,1,2,positive regulation of interleukin-6 production,BP,TICAM1
2873,GO:0065008,0.342951494589066,0.809635678405803,9,36,regulation of biological quality,BP,HEXB;CYP11A1;HSD3B2;HSD17B3;PDK4;DHCR7;HSD17B11;BDH2;RNASEL
2220,GO:0044724,0.345120347278363,0.965035489671409,1,2,single-organism carbohydrate catabolic process,BP,HEXB
98,GO:0001894,0.347685880091442,0.964448681695489,1,2,tissue homeostasis,BP,PDK4
2805,GO:0060249,0.347685880091442,0.964448681695489,1,2,anatomical structure homeostasis,BP,PDK4
1291,GO:0019538,0.348000402968563,0.809276803109965,8,35,protein metabolic process,BP,HEXB;TICAM1;CASP4;PDK4;RBMS3;IFI27;RNASEL;IDUA
458,GO:0006195,0.348729095570615,0.964208326963452,1,2,purine nucleotide catabolic process,BP,PNP
2055,GO:0043168,0.349424191085703,0.818625071968206,7,23,anion binding,MF,ACSF2;PNP;SNX21;ACCS;PDK4;AOX1;RNASEL
885,GO:0009893,0.350796325906245,0.831305297725025,5,21,positive regulation of metabolic process,BP,HEXB;TICAM1;RBMS3;IFI27;RNASEL
2091,GO:0043393,0.352349886557424,0.963366242071532,1,2,regulation of protein binding,BP,TICAM1
2108,GO:0043496,0.352349886557424,0.963366242071532,1,2,regulation of protein homodimerization activity,BP,TICAM1
2635,GO:0051098,0.352349886557424,0.963366242071532,1,2,regulation of binding,BP,TICAM1
2185,GO:0044428,0.352414816524679,0.829446483884497,5,22,nuclear part,CC,MRI1;AOX1;DHCR7;IFI27;RNASEL
279,GO:0004518,0.352498219033808,0.963331483206093,1,2,nuclease activity,MF,RNASEL
280,GO:0004519,0.352498219033808,0.963331483206093,1,2,endonuclease activity,MF,RNASEL
282,GO:0004540,0.352498219033808,0.963331483206093,1,2,ribonuclease activity,MF,RNASEL
1106,GO:0016072,0.352498219033808,0.963331483206093,1,2,rRNA metabolic process,BP,RNASEL
3108,GO:0090305,0.352498219033808,0.963331483206093,1,2,nucleic acid phosphodiester bond hydrolysis,BP,RNASEL
3112,GO:0090501,0.352498219033808,0.963331483206093,1,2,RNA phosphodiester bond hydrolysis,BP,RNASEL
2104,GO:0043487,0.352964365367686,0.963222116453774,1,2,regulation of RNA stability,BP,RNASEL
2105,GO:0043488,0.352964365367686,0.963222116453774,1,2,regulation of mRNA stability,BP,RNASEL
1675,GO:0032870,0.35609094932025,0.916964300277038,2,4,cellular response to hormone stimulus,BP,PDK4;RNASEL
2984,GO:0071375,0.35609094932025,0.916964300277038,2,4,cellular response to peptide hormone stimulus,BP,PDK4;RNASEL
184,GO:0002694,0.357072699364053,0.906185610408194,2,5,regulation of leukocyte activation,BP,PNP;TICAM1
2595,GO:0050865,0.357072699364053,0.906185610408194,2,5,regulation of cell activation,BP,PNP;TICAM1
536,GO:0006687,0.357732986456667,0.96209155156974,1,2,glycosphingolipid metabolic process,BP,HEXB
1280,GO:0019377,0.357732986456667,0.96209155156974,1,2,glycolipid catabolic process,BP,HEXB
1396,GO:0030149,0.357732986456667,0.96209155156974,1,2,sphingolipid catabolic process,BP,HEXB
2361,GO:0046466,0.357732986456667,0.96209155156974,1,2,membrane lipid catabolic process,BP,HEXB
2367,GO:0046479,0.357732986456667,0.96209155156974,1,2,glycosphingolipid catabolic process,BP,HEXB
2376,GO:0046514,0.357732986456667,0.96209155156974,1,2,ceramide catabolic process,BP,HEXB
379,GO:0005741,0.358887463268773,0.950362575396894,1,3,mitochondrial outer membrane,CC,IFI27
1126,GO:0016301,0.35999717147926,0.904809583221132,2,5,kinase activity,MF,PDK4;RNASEL
1188,GO:0016773,0.35999717147926,0.904809583221132,2,5,phosphotransferase activity, alcohol group as acceptor,MF,PDK4;RNASEL
1695,GO:0033036,0.361390185053654,0.837845118695562,4,17,macromolecule localization,BP,PNP;HEXB;SNX21;IFI27
3125,GO:0097159,0.361630822482918,0.792988632452633,10,37,organic cyclic compound binding,MF,ACSF2;PNP;CYP11A1;ACCS;PDK4;RBMS3;AOX1;DHCR7;BDH2;RNASEL
2966,GO:0071310,0.361756865584474,0.825457494458218,5,19,cellular response to organic substance,BP,TICAM1;CASP4;PDK4;IFI27;RNASEL
85,GO:0001775,0.361777924411391,0.866375162761874,3,9,cell activation,BP,PNP;HEXB;TICAM1
2256,GO:0045321,0.361777924411391,0.866375162761874,3,9,leukocyte activation,BP,PNP;HEXB;TICAM1
466,GO:0006355,0.362204589502645,0.841310465564864,4,14,regulation of transcription, DNA-templated,BP,HEXB;TICAM1;IFI27;RNASEL
2916,GO:0070542,0.364009214279626,0.960570606731608,1,2,response to fatty acid,BP,PDK4
742,GO:0008284,0.366532235453112,0.890818801780328,2,7,positive regulation of cell proliferation,BP,PNP;TICAM1
1926,GO:0042181,0.36653920415106,0.959946796479991,1,2,ketone biosynthetic process,BP,HSD17B3
2394,GO:0046661,0.36653920415106,0.959946796479991,1,2,male sex differentiation,BP,HSD17B3
2861,GO:0061370,0.36653920415106,0.959946796479991,1,2,testosterone biosynthetic process,BP,HSD17B3
2318,GO:0045935,0.366639519918671,0.895126418074443,2,6,positive regulation of nucleobase-containing compound metabolic process,BP,HEXB;RNASEL
1710,GO:0033489,0.36819569982596,0.959534999252506,1,2,cholesterol biosynthetic process via desmosterol,BP,DHCR7
1711,GO:0033490,0.36819569982596,0.959534999252506,1,2,cholesterol biosynthetic process via lathosterol,BP,DHCR7
2942,GO:0070887,0.369727197781312,0.808221822057183,6,24,cellular response to chemical stimulus,BP,CMBL;TICAM1;CASP4;PDK4;IFI27;RNASEL
532,GO:0006664,0.370195217315108,0.946801848794502,1,3,glycolipid metabolic process,BP,HEXB
3380,GO:1903509,0.370195217315108,0.946801848794502,1,3,liposaccharide metabolic process,BP,HEXB
1578,GO:0032270,0.373059017018411,0.851957099622804,3,12,positive regulation of cellular protein metabolic process,BP,TICAM1;RBMS3;IFI27
2668,GO:0051247,0.373059017018411,0.851957099622804,3,12,positive regulation of protein metabolic process,BP,TICAM1;RBMS3;IFI27
1161,GO:0016627,0.374595603125888,0.89778125549761,2,5,oxidoreductase activity, acting on the CH-CH group of donors,MF,DHCR7;BDH2
404,GO:0005829,0.375713677337963,0.780179450032373,10,44,cytosol,CC,PNP;MRI1;CMBL;TICAM1;CASP4;AOX1;DHCR7;HSD17B11;BDH2;RNASEL
145,GO:0002283,0.377778398441175,0.889388223732506,2,6,neutrophil activation involved in immune response,BP,PNP;HEXB
152,GO:0002444,0.377778398441175,0.889388223732506,2,6,myeloid leukocyte mediated immunity,BP,PNP;HEXB
153,GO:0002446,0.377778398441175,0.889388223732506,2,6,neutrophil mediated immunity,BP,PNP;HEXB
1563,GO:0031983,0.377778398441175,0.889388223732506,2,6,vesicle lumen,CC,PNP;HEXB
1802,GO:0034774,0.377778398441175,0.889388223732506,2,6,secretory granule lumen,CC,PNP;HEXB
1873,GO:0036230,0.377778398441175,0.889388223732506,2,6,granulocyte activation,BP,PNP;HEXB
1913,GO:0042119,0.377778398441175,0.889388223732506,2,6,neutrophil activation,BP,PNP;HEXB
2087,GO:0043299,0.377778398441175,0.889388223732506,2,6,leukocyte degranulation,BP,PNP;HEXB
2088,GO:0043312,0.377778398441175,0.889388223732506,2,6,neutrophil degranulation,BP,PNP;HEXB
2803,GO:0060205,0.377778398441175,0.889388223732506,2,6,cytoplasmic vesicle lumen,CC,PNP;HEXB
911,GO:0010243,0.379797202257571,0.852235466461249,3,10,response to organonitrogen compound,BP,CASP4;PDK4;RNASEL
1803,GO:0034976,0.381189727672856,0.956211162001991,1,2,response to endoplasmic reticulum stress,BP,CASP4
2163,GO:0044270,0.383452413628945,0.886403046815729,2,6,cellular nitrogen compound catabolic process,BP,PNP;AOX1
2399,GO:0046700,0.383452413628945,0.886403046815729,2,6,heterocycle catabolic process,BP,PNP;AOX1
2268,GO:0045444,0.386697400484665,0.941327602513416,1,3,fat cell differentiation,BP,RNASEL
1556,GO:0031967,0.388940260870142,0.806018852408963,5,19,organelle envelope,CC,CYP11A1;HSD3B2;PDK4;DHCR7;IFI27
1560,GO:0031975,0.388940260870142,0.806018852408963,5,19,envelope,CC,CYP11A1;HSD3B2;PDK4;DHCR7;IFI27
386,GO:0005766,0.394635774750876,0.938573609991284,1,3,primary lysosome,CC,HEXB
1833,GO:0035578,0.394635774750876,0.938573609991284,1,3,azurophil granule lumen,CC,HEXB
1988,GO:0042582,0.394635774750876,0.938573609991284,1,3,azurophil granule,CC,HEXB
2520,GO:0048771,0.400106331142817,0.951067168011054,1,2,tissue remodeling,BP,PDK4
1346,GO:0022613,0.400568648645969,0.950936795403368,1,2,ribonucleoprotein complex biogenesis,BP,RNASEL
212,GO:0003006,0.404520885908125,0.869884791480392,2,7,developmental process involved in reproduction,BP,HEXB;HSD17B3
3377,GO:1903506,0.404705038298321,0.810365564549542,4,15,regulation of nucleic acid-templated transcription,BP,HEXB;TICAM1;IFI27;RNASEL
546,GO:0006704,0.407464684100759,0.948965165538666,1,2,glucocorticoid biosynthetic process,BP,HSD3B2
2211,GO:0044702,0.409025060931372,0.867272987424191,2,7,single organism reproductive process,BP,HEXB;HSD17B3
2151,GO:0044238,0.409427765391911,0.76839027799845,20,92,primary metabolic process,BP,ACSF2;PNP;HEXB;MRI1;CYP11A1;HSD3B2;TICAM1;CASP4;HSD17B3;PDK4;RBMS3;AOX1;PON2;DHCR7;HSD17B11;BDH2;IFI27;RNASEL;IDUA;ASAH2
515,GO:0006629,0.409608213675877,0.750701126324348,11,47,lipid metabolic process,BP,ACSF2;HEXB;CYP11A1;HSD3B2;HSD17B3;PDK4;PON2;DHCR7;HSD17B11;BDH2;ASAH2
2644,GO:0051171,0.410025676397985,0.787446304475414,5,22,regulation of nitrogen compound metabolic process,BP,HEXB;TICAM1;RBMS3;IFI27;RNASEL
398,GO:0005790,0.412629590567835,0.947455017813219,1,2,smooth endoplasmic reticulum,CC,HSD3B2
1898,GO:0042035,0.412951234037418,0.947360015475266,1,2,regulation of cytokine biosynthetic process,BP,TICAM1
1903,GO:0042089,0.412951234037418,0.947360015475266,1,2,cytokine biosynthetic process,BP,TICAM1
1908,GO:0042107,0.412951234037418,0.947360015475266,1,2,cytokine metabolic process,BP,TICAM1
2259,GO:0045350,0.412951234037418,0.947360015475266,1,2,interferon-beta biosynthetic process,BP,TICAM1
2260,GO:0045351,0.412951234037418,0.947360015475266,1,2,type I interferon biosynthetic process,BP,TICAM1
2263,GO:0045357,0.412951234037418,0.947360015475266,1,2,regulation of interferon-beta biosynthetic process,BP,TICAM1
1187,GO:0016772,0.414117605836133,0.869527159065229,2,6,transferase activity, transferring phosphorus-containing groups,MF,PDK4;RNASEL
7,GO:0000096,0.414179487241619,0.94699619227033,1,2,sulfur amino acid metabolic process,BP,MRI1
501,GO:0006555,0.414179487241619,0.94699619227033,1,2,methionine metabolic process,BP,MRI1
792,GO:0009066,0.414179487241619,0.94699619227033,1,2,aspartate family amino acid metabolic process,BP,MRI1
999,GO:0010941,0.415468121560666,0.822074762211121,3,13,regulation of cell death,BP,CASP4;PDK4;IFI27
2019,GO:0042981,0.415468121560666,0.822074762211121,3,13,regulation of apoptotic process,BP,CASP4;PDK4;IFI27
2038,GO:0043067,0.415468121560666,0.822074762211121,3,13,regulation of programmed cell death,BP,CASP4;PDK4;IFI27
607,GO:0006919,0.415510021002562,0.923480064431849,1,4,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,IFI27
1002,GO:0010950,0.415510021002562,0.923480064431849,1,4,positive regulation of endopeptidase activity,BP,IFI27
1004,GO:0010952,0.415510021002562,0.923480064431849,1,4,positive regulation of peptidase activity,BP,IFI27
2084,GO:0043280,0.415510021002562,0.923480064431849,1,4,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,IFI27
3502,GO:2001056,0.415510021002562,0.923480064431849,1,4,positive regulation of cysteine-type endopeptidase activity,BP,IFI27
179,GO:0002684,0.416202358385501,0.863053025315645,2,7,positive regulation of immune system process,BP,PNP;TICAM1
784,GO:0009056,0.416500277232315,0.751558098911075,9,38,catabolic process,BP,PNP;HEXB;TICAM1;AOX1;PON2;HSD17B11;BDH2;WDR45;IDUA
1532,GO:0031410,0.416711549368834,0.78656983158119,5,18,cytoplasmic vesicle,CC,PNP;HEXB;SNX21;TICAM1;IDUA
3154,GO:0097708,0.416711549368834,0.78656983158119,5,18,intracellular vesicle,CC,PNP;HEXB;SNX21;TICAM1;IDUA
1307,GO:0019843,0.416800238762037,0.930454600069251,1,3,rRNA binding,MF,RNASEL
846,GO:0009435,0.424014984834765,0.944022763483442,1,2,NAD biosynthetic process,BP,PNP
1274,GO:0019359,0.424014984834765,0.944022763483442,1,2,nicotinamide nucleotide biosynthetic process,BP,PNP
1276,GO:0019363,0.424014984834765,0.944022763483442,1,2,pyridine nucleotide biosynthetic process,BP,PNP
1751,GO:0034356,0.424014984834765,0.944022763483442,1,2,NAD biosynthesis via nicotinamide riboside salvage pathway,BP,PNP
3063,GO:0072525,0.424014984834765,0.944022763483442,1,2,pyridine-containing compound biosynthetic process,BP,PNP
463,GO:0006351,0.425287618135394,0.793774818840281,4,16,transcription, DNA-templated,BP,HEXB;TICAM1;IFI27;RNASEL
3152,GO:0097659,0.425287618135394,0.793774818840281,4,16,nucleic acid-templated transcription,BP,HEXB;TICAM1;IFI27;RNASEL
927,GO:0010558,0.433142849012118,0.915907722098488,1,4,negative regulation of macromolecule biosynthetic process,BP,IFI27
2645,GO:0051172,0.435896097554119,0.909867602362441,1,5,negative regulation of nitrogen compound metabolic process,BP,IFI27
3278,GO:1901700,0.43755904200608,0.786156490035767,4,15,response to oxygen-containing compound,BP,TICAM1;CASP4;PDK4;RNASEL
688,GO:0007617,0.437649649180331,0.939720277691769,1,2,mating behavior,BP,HEXB
689,GO:0007618,0.437649649180331,0.939720277691769,1,2,mating,BP,HEXB
693,GO:0007626,0.437649649180331,0.939720277691769,1,2,locomotory behavior,BP,HEXB
1260,GO:0019098,0.437649649180331,0.939720277691769,1,2,reproductive behavior,BP,HEXB
2154,GO:0044248,0.440769613812493,0.7364862970844,8,34,cellular catabolic process,BP,PNP;HEXB;TICAM1;AOX1;PON2;BDH2;WDR45;IDUA
757,GO:0008395,0.440897935906456,0.938663575097085,1,2,steroid hydroxylase activity,MF,CYP11A1
349,GO:0005506,0.444446899923704,0.851562534713266,2,6,iron ion binding,MF,CYP11A1;AOX1
1610,GO:0032479,0.446817401760517,0.918401585146012,1,3,regulation of type I interferon production,BP,TICAM1
1629,GO:0032606,0.446817401760517,0.918401585146012,1,3,type I interferon production,BP,TICAM1
1631,GO:0032608,0.446817401760517,0.918401585146012,1,3,interferon-beta production,BP,TICAM1
1642,GO:0032648,0.446817401760517,0.918401585146012,1,3,regulation of interferon-beta production,BP,TICAM1
2630,GO:0051090,0.446817401760517,0.918401585146012,1,3,regulation of sequence-specific DNA binding transcription factor activity,BP,TICAM1
2631,GO:0051091,0.446817401760517,0.918401585146012,1,3,positive regulation of sequence-specific DNA binding transcription factor activity,BP,TICAM1
2632,GO:0051092,0.446817401760517,0.918401585146012,1,3,positive regulation of NF-kappaB transcription factor activity,BP,TICAM1
854,GO:0009607,0.448160322568756,0.806369362333428,3,10,response to biotic stimulus,BP,TICAM1;PRRT1;RNASEL
807,GO:0009116,0.44850116655898,0.936141403785693,1,2,nucleoside metabolic process,BP,PNP
815,GO:0009164,0.44850116655898,0.936141403785693,1,2,nucleoside catabolic process,BP,PNP
1151,GO:0016567,0.453393487833472,0.9155907333332,1,3,protein ubiquitination,BP,TICAM1
1525,GO:0031396,0.453393487833472,0.9155907333332,1,3,regulation of protein ubiquitination,BP,TICAM1
1527,GO:0031398,0.453393487833472,0.9155907333332,1,3,positive regulation of protein ubiquitination,BP,TICAM1
1609,GO:0032446,0.453393487833472,0.9155907333332,1,3,protein modification by small protein conjugation,BP,TICAM1
2924,GO:0070647,0.453393487833472,0.9155907333332,1,3,protein modification by small protein conjugation or removal,BP,TICAM1
3368,GO:1903320,0.453393487833472,0.9155907333332,1,3,regulation of protein modification by small protein conjugation or removal,BP,TICAM1
3370,GO:1903322,0.453393487833472,0.9155907333332,1,3,positive regulation of protein modification by small protein conjugation or removal,BP,TICAM1
1428,GO:0030323,0.453797719135347,0.915415892072531,1,3,respiratory tube development,BP,DHCR7
1429,GO:0030324,0.453797719135347,0.915415892072531,1,3,lung development,BP,DHCR7
2835,GO:0060541,0.453797719135347,0.915415892072531,1,3,respiratory system development,BP,DHCR7
1789,GO:0034654,0.45392210367714,0.753862952071097,5,21,nucleobase-containing compound biosynthetic process,BP,PNP;HEXB;TICAM1;IFI27;RNASEL
2477,GO:0048522,0.454529763655109,0.739288739116961,6,28,positive regulation of cellular process,BP,PNP;HEXB;TICAM1;RBMS3;IFI27;RNASEL
381,GO:0005758,0.454860061628357,0.933978692216014,1,2,mitochondrial intermembrane space,CC,HSD3B2
1558,GO:0031970,0.454860061628357,0.933978692216014,1,2,organelle envelope lumen,CC,HSD3B2
494,GO:0006518,0.455349882076169,0.834442527576114,2,8,peptide metabolic process,BP,RBMS3;BDH2
1211,GO:0016863,0.455677110853569,0.914599848585402,1,3,intramolecular oxidoreductase activity, transposing C=C bonds,MF,HSD3B2
2150,GO:0044237,0.455885741090852,0.731664348733054,20,93,cellular metabolic process,BP,ACSF2;PNP;HEXB;MRI1;CMBL;CYP11A1;HSD3B2;TICAM1;HSD17B3;PDK4;RBMS3;AOX1;PON2;HSD17B11;BDH2;IFI27;RNASEL;WDR45;IDUA;ASAH2
65,GO:0001568,0.457432946333848,0.913832746702478,1,3,blood vessel development,BP,DHCR7
113,GO:0001944,0.457432946333848,0.913832746702478,1,3,vasculature development,BP,DHCR7
3052,GO:0072358,0.457432946333848,0.913832746702478,1,3,cardiovascular system development,BP,DHCR7
2770,GO:0055076,0.459659776999757,0.932313536226844,1,2,transition metal ion homeostasis,BP,BDH2
1191,GO:0016788,0.460871979922978,0.827477892290028,2,9,hydrolase activity, acting on ester bonds,MF,PON2;RNASEL
2169,GO:0044283,0.46318167829499,0.735828175782354,6,23,small molecule biosynthetic process,BP,PNP;MRI1;HSD17B3;PDK4;DHCR7;BDH2
3254,GO:1901566,0.463318827619096,0.761739121455278,4,18,organonitrogen compound biosynthetic process,BP,PNP;MRI1;RBMS3;BDH2
2872,GO:0065007,0.465310236224229,0.701549360041991,15,68,biological regulation,BP,PNP;HEXB;CYP11A1;HSD3B2;TICAM1;CASP4;HSD17B3;PDK4;RBMS3;DHCR7;HSD17B11;BDH2;IFI27;RNASEL;ASAH2
255,GO:0004175,0.465523362041655,0.90077685128725,1,4,endopeptidase activity,MF,CASP4
1509,GO:0031326,0.466551526931743,0.730502041478029,6,26,regulation of cellular biosynthetic process,BP,HEXB;TICAM1;PDK4;RBMS3;IFI27;RNASEL
538,GO:0006690,0.466927623715756,0.909604981820729,1,3,icosanoid metabolic process,BP,PON2
3255,GO:1901568,0.466927623715756,0.909604981820729,1,3,fatty acid derivative metabolic process,BP,PON2
1386,GO:0030098,0.467032935696181,0.929699749650091,1,2,lymphocyte differentiation,BP,PNP
1417,GO:0030217,0.467032935696181,0.929699749650091,1,2,T cell differentiation,BP,PNP
3298,GO:1902107,0.467032935696181,0.929699749650091,1,2,positive regulation of leukocyte differentiation,BP,PNP
3402,GO:1903708,0.467032935696181,0.929699749650091,1,2,positive regulation of hemopoiesis,BP,PNP
1323,GO:0020037,0.468515318137525,0.908884750610115,1,3,heme binding,MF,CYP11A1
2418,GO:0046906,0.468515318137525,0.908884750610115,1,3,tetrapyrrole binding,MF,CYP11A1
132,GO:0002221,0.47049526103527,0.928448664600512,1,2,pattern recognition receptor signaling pathway,BP,TICAM1
134,GO:0002224,0.47049526103527,0.928448664600512,1,2,toll-like receptor signaling pathway,BP,TICAM1
196,GO:0002756,0.47049526103527,0.928448664600512,1,2,MyD88-independent toll-like receptor signaling pathway,BP,TICAM1
1843,GO:0035666,0.47049526103527,0.928448664600512,1,2,TRIF-dependent toll-like receptor signaling pathway,BP,TICAM1
3141,GO:0097342,0.47049526103527,0.928448664600512,1,2,ripoptosome,CC,TICAM1
1243,GO:0018130,0.470766879601248,0.739065615003097,5,22,heterocycle biosynthetic process,BP,PNP;HEXB;TICAM1;IFI27;RNASEL
2672,GO:0051252,0.472041860567234,0.757537880771659,4,16,regulation of RNA metabolic process,BP,HEXB;TICAM1;IFI27;RNASEL
3504,GO:2001141,0.472041860567234,0.757537880771659,4,16,regulation of RNA biosynthetic process,BP,HEXB;TICAM1;IFI27;RNASEL
418,GO:0005975,0.472049306082264,0.780718076516577,3,13,carbohydrate metabolic process,BP,HEXB;PDK4;IDUA
151,GO:0002443,0.472486328474342,0.827398671119134,2,7,leukocyte mediated immunity,BP,PNP;HEXB
2162,GO:0044267,0.472487704567785,0.723601859465571,6,29,cellular protein metabolic process,BP,HEXB;TICAM1;PDK4;RBMS3;IFI27;RNASEL
2650,GO:0051186,0.473494468091068,0.758135925975982,4,15,cofactor metabolic process,BP,ACSF2;PNP;PDK4;BDH2
545,GO:0006703,0.473810815980439,0.927236227789112,1,2,estrogen biosynthetic process,BP,HSD17B11
728,GO:0008210,0.473810815980439,0.927236227789112,1,2,estrogen metabolic process,BP,HSD17B11
656,GO:0007276,0.478779996554469,0.904134910834836,1,3,gamete generation,BP,HEXB
1319,GO:0019915,0.478957258965552,0.925326063496276,1,2,lipid storage,BP,HEXB
2602,GO:0050885,0.48006350096267,0.924910946165047,1,2,neuromuscular process controlling balance,BP,HEXB
2606,GO:0050905,0.48006350096267,0.924910946165047,1,2,neuromuscular process,BP,HEXB
3187,GO:0098805,0.48033795272502,0.750817661508723,4,16,whole membrane,CC,SNX21;TICAM1;DHCR7;IFI27
753,GO:0008375,0.480422636854912,0.92477583408937,1,2,acetylglucosaminyltransferase activity,MF,HEXB
3479,GO:2000379,0.480680065816893,0.924678880990954,1,2,positive regulation of reactive oxygen species metabolic process,BP,TICAM1
629,GO:0007033,0.480808190245191,0.924630594080122,1,2,vacuole organization,BP,HEXB
473,GO:0006397,0.481140180111272,0.903019597333769,1,3,mRNA processing,BP,RNASEL
448,GO:0006109,0.482540630671979,0.923975549506412,1,2,regulation of carbohydrate metabolic process,BP,PDK4
957,GO:0010675,0.482540630671979,0.923975549506412,1,2,regulation of cellular carbohydrate metabolic process,BP,PDK4
991,GO:0010906,0.482540630671979,0.923975549506412,1,2,regulation of glucose metabolic process,BP,PDK4
1559,GO:0031974,0.484148656469671,0.689243772706299,10,45,membrane-enclosed lumen,CC,ACSF2;PNP;HEXB;MRI1;CYP11A1;HSD3B2;PDK4;AOX1;RNASEL;IDUA
2072,GO:0043233,0.484148656469671,0.689243772706299,10,45,organelle lumen,CC,ACSF2;PNP;HEXB;MRI1;CYP11A1;HSD3B2;PDK4;AOX1;RNASEL;IDUA
2877,GO:0070013,0.484148656469671,0.689243772706299,10,45,intracellular organelle lumen,CC,ACSF2;PNP;HEXB;MRI1;CYP11A1;HSD3B2;PDK4;AOX1;RNASEL;IDUA
543,GO:0006700,0.48569527569976,0.922772519222385,1,2,C21-steroid hormone biosynthetic process,BP,CYP11A1
1100,GO:0016052,0.485951908314734,0.900718547132873,1,3,carbohydrate catabolic process,BP,HEXB
917,GO:0010468,0.486224309413408,0.728203506564651,5,20,regulation of gene expression,BP,HEXB;TICAM1;RBMS3;IFI27;RNASEL
1266,GO:0019219,0.487599518442867,0.743299335196651,4,17,regulation of nucleobase-containing compound metabolic process,BP,HEXB;TICAM1;IFI27;RNASEL
817,GO:0009166,0.488808154400961,0.899335192143016,1,3,nucleotide catabolic process,BP,PNP
3242,GO:1901292,0.488808154400961,0.899335192143016,1,3,nucleoside phosphate catabolic process,BP,PNP
1268,GO:0019221,0.490808727510459,0.80360107144673,2,10,cytokine-mediated signaling pathway,BP,IFI27;RNASEL
3010,GO:0071705,0.490937185359575,0.765934111732506,3,13,nitrogen compound transport,BP,PNP;SNX21;IFI27
1293,GO:0019674,0.490987673615501,0.898270771900348,1,3,NAD metabolic process,BP,PNP
1663,GO:0032774,0.4919257883437,0.739704217647303,4,17,RNA biosynthetic process,BP,HEXB;TICAM1;IFI27;RNASEL
1805,GO:0035091,0.493770501948229,0.919631977223185,1,2,phosphatidylinositol binding,MF,SNX21
637,GO:0007166,0.493875920616365,0.736704557670163,4,18,cell surface receptor signaling pathway,BP,TICAM1;PDK4;IFI27;RNASEL
2085,GO:0043281,0.496213015695934,0.878594944420456,1,5,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,IFI27
3465,GO:2000116,0.496213015695934,0.878594944420456,1,5,regulation of cysteine-type endopeptidase activity,BP,IFI27
633,GO:0007155,0.497912110147026,0.89483783814506,1,3,cell adhesion,BP,PNP
634,GO:0007159,0.497912110147026,0.89483783814506,1,3,leukocyte cell-cell adhesion,BP,PNP
1131,GO:0016337,0.497912110147026,0.89483783814506,1,3,single organismal cell-cell adhesion,BP,PNP
1334,GO:0022407,0.497912110147026,0.89483783814506,1,3,regulation of cell-cell adhesion,BP,PNP
1335,GO:0022409,0.497912110147026,0.89483783814506,1,3,positive regulation of cell-cell adhesion,BP,PNP
1345,GO:0022610,0.497912110147026,0.89483783814506,1,3,biological adhesion,BP,PNP
1398,GO:0030155,0.497912110147026,0.89483783814506,1,3,regulation of cell adhesion,BP,PNP
1904,GO:0042098,0.497912110147026,0.89483783814506,1,3,T cell proliferation,BP,PNP
1906,GO:0042102,0.497912110147026,0.89483783814506,1,3,positive regulation of T cell proliferation,BP,PNP
1910,GO:0042110,0.497912110147026,0.89483783814506,1,3,T cell activation,BP,PNP
1915,GO:0042129,0.497912110147026,0.89483783814506,1,3,regulation of T cell proliferation,BP,PNP
2296,GO:0045785,0.497912110147026,0.89483783814506,1,3,positive regulation of cell adhesion,BP,PNP
2593,GO:0050863,0.497912110147026,0.89483783814506,1,3,regulation of T cell activation,BP,PNP
2597,GO:0050870,0.497912110147026,0.89483783814506,1,3,positive regulation of T cell activation,BP,PNP
3165,GO:0098602,0.497912110147026,0.89483783814506,1,3,single organism cell adhesion,BP,PNP
3166,GO:0098609,0.497912110147026,0.89483783814506,1,3,cell-cell adhesion,BP,PNP
3352,GO:1903037,0.497912110147026,0.89483783814506,1,3,regulation of leukocyte cell-cell adhesion,BP,PNP
3353,GO:1903039,0.497912110147026,0.89483783814506,1,3,positive regulation of leukocyte cell-cell adhesion,BP,PNP
787,GO:0009059,0.498119417955922,0.714101462007727,5,24,macromolecule biosynthetic process,BP,HEXB;TICAM1;RBMS3;IFI27;RNASEL
1788,GO:0034645,0.498119417955922,0.714101462007727,5,24,cellular macromolecule biosynthetic process,BP,HEXB;TICAM1;RBMS3;IFI27;RNASEL
2100,GO:0043434,0.498896592735581,0.815926033709237,2,6,response to peptide hormone,BP,PDK4;RNASEL
597,GO:0006887,0.498940346598174,0.808992506900013,2,7,exocytosis,BP,PNP;HEXB
1394,GO:0030141,0.498940346598174,0.808992506900013,2,7,secretory granule,CC,PNP;HEXB
2237,GO:0045055,0.498940346598174,0.808992506900013,2,7,regulated exocytosis,BP,PNP;HEXB
520,GO:0006637,0.498965039122636,0.815878358584728,2,6,acyl-CoA metabolic process,BP,ACSF2;PDK4
1826,GO:0035383,0.498965039122636,0.815878358584728,2,6,thioester metabolic process,BP,ACSF2;PDK4
2427,GO:0046950,0.501161991654127,0.916678933766374,1,2,cellular ketone body metabolic process,BP,BDH2
2428,GO:0046951,0.501161991654127,0.916678933766374,1,2,ketone body biosynthetic process,BP,BDH2
3307,GO:1902224,0.501161991654127,0.916678933766374,1,2,ketone body metabolic process,BP,BDH2
90,GO:0001819,0.501182743913983,0.893188954471433,1,3,positive regulation of cytokine production,BP,TICAM1
1639,GO:0032640,0.501182743913983,0.893188954471433,1,3,tumor necrosis factor production,BP,TICAM1
1649,GO:0032680,0.501182743913983,0.893188954471433,1,3,regulation of tumor necrosis factor production,BP,TICAM1
1660,GO:0032760,0.501182743913983,0.893188954471433,1,3,positive regulation of tumor necrosis factor production,BP,TICAM1
3011,GO:0071706,0.501182743913983,0.893188954471433,1,3,tumor necrosis factor superfamily cytokine production,BP,TICAM1
3387,GO:1903555,0.501182743913983,0.893188954471433,1,3,regulation of tumor necrosis factor superfamily cytokine production,BP,TICAM1
3388,GO:1903557,0.501182743913983,0.893188954471433,1,3,positive regulation of tumor necrosis factor superfamily cytokine production,BP,TICAM1
1522,GO:0031347,0.501499524220843,0.802206672815283,2,8,regulation of defense response,BP,TICAM1;CASP4
434,GO:0006085,0.502402701437151,0.916175773843165,1,2,acetyl-CoA biosynthetic process,BP,PDK4
246,GO:0003996,0.503984160914542,0.915531278804749,1,2,acyl-CoA ligase activity,MF,ACSF2
1133,GO:0016405,0.503984160914542,0.915531278804749,1,2,CoA-ligase activity,MF,ACSF2
1214,GO:0016877,0.503984160914542,0.915531278804749,1,2,ligase activity, forming carbon-sulfur bonds,MF,ACSF2
1215,GO:0016878,0.503984160914542,0.915531278804749,1,2,acid-thiol ligase activity,MF,ACSF2
1000,GO:0010942,0.504342774704888,0.869663057527081,1,6,positive regulation of cell death,BP,IFI27
2036,GO:0043065,0.504342774704888,0.869663057527081,1,6,positive regulation of apoptotic process,BP,IFI27
2039,GO:0043068,0.504342774704888,0.869663057527081,1,6,positive regulation of programmed cell death,BP,IFI27
387,GO:0005768,0.504662662336289,0.811883451832627,2,6,endosome,CC,SNX21;TICAM1
197,GO:0002757,0.507131168135603,0.890144335301511,1,3,immune response-activating signal transduction,BP,TICAM1
198,GO:0002758,0.507131168135603,0.890144335301511,1,3,innate immune response-activating signal transduction,BP,TICAM1
201,GO:0002764,0.507131168135603,0.890144335301511,1,3,immune response-regulating signaling pathway,BP,TICAM1
2448,GO:0048037,0.507340841141101,0.732450943035452,4,14,cofactor binding,MF,ACCS;AOX1;DHCR7;BDH2
3252,GO:1901564,0.507366735726235,0.676922940895043,8,38,organonitrogen compound metabolic process,BP,PNP;HEXB;MRI1;RBMS3;AOX1;BDH2;IDUA;ASAH2
1823,GO:0035336,0.508184148762474,0.913802404439672,1,2,long-chain fatty-acyl-CoA metabolic process,BP,ACSF2
1824,GO:0035337,0.508184148762474,0.913802404439672,1,2,fatty-acyl-CoA metabolic process,BP,ACSF2
1825,GO:0035338,0.508184148762474,0.913802404439672,1,2,long-chain fatty-acyl-CoA biosynthetic process,BP,ACSF2
2426,GO:0046949,0.508184148762474,0.913802404439672,1,2,fatty-acyl-CoA biosynthetic process,BP,ACSF2
163,GO:0002521,0.508268592634266,0.889555374265042,1,3,leukocyte differentiation,BP,PNP
3296,GO:1902105,0.508268592634266,0.889555374265042,1,3,regulation of leukocyte differentiation,BP,PNP
3400,GO:1903706,0.508268592634266,0.889555374265042,1,3,regulation of hemopoiesis,BP,PNP
2186,GO:0044429,0.508619001744467,0.694824059209081,6,25,mitochondrial part,CC,ACSF2;CYP11A1;HSD3B2;PDK4;IFI27;RNASEL
2069,GO:0043230,0.509038050899683,0.691652311869315,6,29,extracellular organelle,CC,PNP;HEXB;CMBL;AOX1;BDH2;IDUA
2879,GO:0070062,0.509038050899683,0.691652311869315,6,29,extracellular exosome,CC,PNP;HEXB;CMBL;AOX1;BDH2;IDUA
3389,GO:1903561,0.509038050899683,0.691652311869315,6,29,extracellular vesicle,CC,PNP;HEXB;CMBL;AOX1;BDH2;IDUA
94,GO:0001882,0.509640494899747,0.913197022249561,1,2,nucleoside binding,MF,PNP
2989,GO:0071396,0.50977754832646,0.808252486605562,2,6,cellular response to lipid,BP,TICAM1;PDK4
2195,GO:0044444,0.510171341883222,0.699649011131485,21,103,cytoplasmic part,CC,ACSF2;PNP;HEXB;SNX21;MRI1;CMBL;CYP11A1;HSD3B2;TICAM1;CASP4;HSD17B3;PDK4;AOX1;PON2;DHCR7;HSD17B11;BDH2;IFI27;RNASEL;IDUA;ASAH2
2430,GO:0046982,0.511416390121117,0.887913971455742,1,3,protein heterodimerization activity,MF,HEXB
2782,GO:0055114,0.512557845474952,0.673363842287151,8,35,oxidation-reduction process,BP,CYP11A1;HSD3B2;HSD17B3;PDK4;AOX1;DHCR7;HSD17B11;BDH2
2716,GO:0051536,0.513382622318536,0.911627414843659,1,2,iron-sulfur cluster binding,MF,AOX1
2719,GO:0051540,0.513382622318536,0.911627414843659,1,2,metal cluster binding,MF,AOX1
378,GO:0005740,0.51431675291852,0.722346309995195,4,16,mitochondrial envelope,CC,CYP11A1;HSD3B2;PDK4;IFI27
1555,GO:0031966,0.51431675291852,0.722346309995195,4,16,mitochondrial membrane,CC,CYP11A1;HSD3B2;PDK4;IFI27
2273,GO:0045540,0.516248434827523,0.910411568576288,1,2,regulation of cholesterol biosynthetic process,BP,DHCR7
3346,GO:1902930,0.516248434827523,0.910411568576288,1,2,regulation of alcohol biosynthetic process,BP,DHCR7
888,GO:0009896,0.516640474255995,0.885152389933423,1,3,positive regulation of catabolic process,BP,TICAM1
1514,GO:0031331,0.516640474255995,0.885152389933423,1,3,positive regulation of cellular catabolic process,BP,TICAM1
1912,GO:0042116,0.51763692326363,0.909818148034001,1,2,macrophage activation,BP,TICAM1
592,GO:0006874,0.517757114031179,0.884555979214627,1,3,cellular calcium ion homeostasis,BP,HEXB
2769,GO:0055074,0.517757114031179,0.884555979214627,1,3,calcium ion homeostasis,BP,HEXB
3056,GO:0072503,0.517757114031179,0.884555979214627,1,3,cellular divalent inorganic cation homeostasis,BP,HEXB
3057,GO:0072507,0.517757114031179,0.884555979214627,1,3,divalent inorganic cation homeostasis,BP,HEXB
1812,GO:0035264,0.517816809037288,0.909741059007104,1,2,multicellular organism growth,BP,DHCR7
392,GO:0005776,0.518142453120887,0.909601384257975,1,2,autophagosome,CC,TICAM1
919,GO:0010506,0.518142453120887,0.909601384257975,1,2,regulation of autophagy,BP,TICAM1
775,GO:0008652,0.518338833052183,0.909517077364838,1,2,cellular amino acid biosynthetic process,BP,MRI1
3261,GO:1901607,0.518338833052183,0.909517077364838,1,2,alpha-amino acid biosynthetic process,BP,MRI1
3009,GO:0071704,0.518627368336541,0.678899998415506,20,95,organic substance metabolic process,BP,ACSF2;PNP;HEXB;MRI1;CYP11A1;HSD3B2;TICAM1;CASP4;HSD17B3;PDK4;RBMS3;AOX1;PON2;DHCR7;HSD17B11;BDH2;IFI27;RNASEL;IDUA;ASAH2
773,GO:0008643,0.518992770289345,0.909235926492645,1,2,carbohydrate transport,BP,RNASEL
774,GO:0008645,0.518992770289345,0.909235926492645,1,2,hexose transport,BP,RNASEL
1069,GO:0015749,0.518992770289345,0.909235926492645,1,2,monosaccharide transport,BP,RNASEL
1070,GO:0015758,0.518992770289345,0.909235926492645,1,2,glucose transport,BP,RNASEL
2338,GO:0046323,0.518992770289345,0.909235926492645,1,2,glucose import,BP,RNASEL
830,GO:0009267,0.519744043272728,0.908912143361338,1,2,cellular response to starvation,BP,PDK4
1541,GO:0031668,0.519744043272728,0.908912143361338,1,2,cellular response to extracellular stimulus,BP,PDK4
1542,GO:0031669,0.519744043272728,0.908912143361338,1,2,cellular response to nutrient levels,BP,PDK4
1679,GO:0032880,0.520647851211623,0.859600530772937,1,6,regulation of protein localization,BP,IFI27
2660,GO:0051223,0.520647851211623,0.859600530772937,1,6,regulation of protein transport,BP,IFI27
2887,GO:0070201,0.520647851211623,0.859600530772937,1,6,regulation of establishment of protein localization,BP,IFI27
3086,GO:0090087,0.520647851211623,0.859600530772937,1,6,regulation of peptide transport,BP,IFI27
3060,GO:0072522,0.521787859212221,0.882384977772838,1,3,purine-containing compound biosynthetic process,BP,PNP
479,GO:0006417,0.523658006543848,0.881367987736857,1,3,regulation of translation,BP,RBMS3
1741,GO:0034248,0.523658006543848,0.881367987736857,1,3,regulation of cellular amide metabolic process,BP,RBMS3
1403,GO:0030176,0.526370907570744,0.879881676637886,1,3,integral component of endoplasmic reticulum membrane,CC,DHCR7
1497,GO:0031227,0.526370907570744,0.879881676637886,1,3,intrinsic component of endoplasmic reticulum membrane,CC,DHCR7
1343,GO:0022604,0.526764584531186,0.879664903554952,1,3,regulation of cell morphogenesis,BP,HEXB
2216,GO:0044710,0.526826711568919,0.646350429244505,15,72,single-organism metabolic process,BP,ACSF2;PNP;HEXB;MRI1;CYP11A1;HSD3B2;HSD17B3;PDK4;AOX1;PON2;DHCR7;HSD17B11;BDH2;IDUA;ASAH2
1286,GO:0019438,0.528702273194546,0.687818033481239,5,23,aromatic compound biosynthetic process,BP,PNP;HEXB;TICAM1;IFI27;RNASEL
3270,GO:1901658,0.52917103493142,0.878333784374715,1,3,glycosyl compound catabolic process,BP,PNP
719,GO:0008194,0.531501440694584,0.877034786949124,1,3,UDP-glycosyltransferase activity,MF,HEXB
130,GO:0002218,0.535817743905295,0.861907101361436,1,4,activation of innate immune response,BP,TICAM1
1524,GO:0031349,0.535817743905295,0.861907101361436,1,4,positive regulation of defense response,BP,TICAM1
2244,GO:0045089,0.535817743905295,0.861907101361436,1,4,positive regulation of innate immune response,BP,TICAM1
433,GO:0006084,0.538923920178201,0.872831423385841,1,3,acetyl-CoA metabolic process,BP,PDK4
1155,GO:0016604,0.539781359834206,0.872339314865471,1,3,nuclear body,CC,AOX1
2199,GO:0044451,0.539781359834206,0.872339314865471,1,3,nucleoplasm part,CC,AOX1
2012,GO:0042802,0.539794933640435,0.695447647504533,4,19,identical protein binding,MF,HEXB;MRI1;ACCS;PON2
2528,GO:0048871,0.540198227598066,0.872099569335842,1,3,multicellular organismal homeostasis,BP,PDK4
572,GO:0006805,0.540597904153231,0.871869406983922,1,3,xenobiotic metabolic process,BP,CMBL
842,GO:0009410,0.540597904153231,0.871869406983922,1,3,response to xenobiotic stimulus,BP,CMBL
2998,GO:0071466,0.540597904153231,0.871869406983922,1,3,cellular response to xenobiotic stimulus,BP,CMBL
1184,GO:0016758,0.540826980307703,0.858792291042645,1,4,transferase activity, transferring hexosyl groups,MF,HEXB
1925,GO:0042180,0.542016779536784,0.766951688573644,2,9,cellular ketone metabolic process,BP,HSD17B3;PDK4
1671,GO:0032844,0.545359115724831,0.869104567220586,1,3,regulation of homeostatic process,BP,PDK4
1889,GO:0040007,0.547956134645477,0.867578454215501,1,3,growth,BP,DHCR7
2490,GO:0048589,0.547956134645477,0.867578454215501,1,3,developmental growth,BP,DHCR7
1930,GO:0042221,0.548975443330916,0.638181629374936,8,38,response to chemical,BP,PNP;CMBL;TICAM1;CASP4;PDK4;PON2;IFI27;RNASEL
376,GO:0005737,0.55101136880994,0.680042716322831,22,107,cytoplasm,CC,ACSF2;PNP;HEXB;SNX21;MRI1;CMBL;CYP11A1;HSD3B2;TICAM1;CASP4;HSD17B3;PDK4;RBMS3;AOX1;PON2;DHCR7;HSD17B11;BDH2;IFI27;RNASEL;IDUA;ASAH2
2662,GO:0051235,0.551047867353792,0.865744864395506,1,3,maintenance of location,BP,HEXB
2336,GO:0046320,0.551836614903762,0.865274151626202,1,3,regulation of fatty acid oxidation,BP,PDK4
3233,GO:1901135,0.552873727723544,0.711622338054868,3,14,carbohydrate derivative metabolic process,BP,PNP;HEXB;IDUA
3062,GO:0072524,0.553284917567232,0.767585404935738,2,7,pyridine-containing compound metabolic process,BP,PNP;AOX1
50,GO:0001101,0.554356936487402,0.850130816728626,1,4,response to acid chemical,BP,PDK4
2897,GO:0070266,0.555184605906487,0.863262734755012,1,3,necroptotic process,BP,TICAM1
3137,GO:0097300,0.555184605906487,0.863262734755012,1,3,programmed necrotic cell death,BP,TICAM1
162,GO:0002520,0.555452597580163,0.849413241508853,1,4,immune system development,BP,PNP
1385,GO:0030097,0.555452597580163,0.849413241508853,1,4,hemopoiesis,BP,PNP
2480,GO:0048534,0.555452597580163,0.849413241508853,1,4,hematopoietic or lymphoid organ development,BP,PNP
2222,GO:0044763,0.556250416279414,0.636130529519442,19,91,single-organism cellular process,BP,ACSF2;PNP;HEXB;MRI1;CYP11A1;HSD3B2;TICAM1;CASP4;HSD17B3;PDK4;AOX1;PON2;DHCR7;HSD17B11;BDH2;IFI27;RNASEL;IDUA;ASAH2
574,GO:0006809,0.556796565035702,0.862286523564569,1,3,nitric oxide biosynthetic process,BP,TICAM1
2266,GO:0045428,0.556796565035702,0.862286523564569,1,3,regulation of nitric oxide biosynthetic process,BP,TICAM1
2335,GO:0046209,0.556796565035702,0.862286523564569,1,3,nitric oxide metabolic process,BP,TICAM1
3373,GO:1903409,0.556796565035702,0.862286523564569,1,3,reactive oxygen species biosynthetic process,BP,TICAM1
3374,GO:1903426,0.556796565035702,0.862286523564569,1,3,regulation of reactive oxygen species biosynthetic process,BP,TICAM1
3477,GO:2000377,0.556796565035702,0.862286523564569,1,3,regulation of reactive oxygen species metabolic process,BP,TICAM1
3503,GO:2001057,0.556796565035702,0.862286523564569,1,3,reactive nitrogen species metabolic process,BP,TICAM1
455,GO:0006163,0.556979967348084,0.848408825070204,1,4,purine nucleotide metabolic process,BP,PNP
552,GO:0006725,0.557573194418743,0.629583776130508,8,39,cellular aromatic compound metabolic process,BP,PNP;HEXB;TICAM1;AOX1;PON2;BDH2;IFI27;RNASEL
1342,GO:0022603,0.559695784875971,0.846611003357949,1,4,regulation of anatomical structure morphogenesis,BP,HEXB
2537,GO:0050661,0.565926290351456,0.856660764036245,1,3,NADP binding,MF,DHCR7
2054,GO:0043167,0.566040663294572,0.617091612738079,9,40,ion binding,MF,ACSF2;PNP;SNX21;CYP11A1;ACCS;PDK4;AOX1;PON2;RNASEL
2733,GO:0051704,0.569320840427716,0.698942945653008,3,13,multi-organism process,BP,HEXB;TICAM1;RNASEL
421,GO:0006006,0.57160491417519,0.838545131043089,1,4,glucose metabolic process,BP,PDK4
2197,GO:0044446,0.572832786179285,0.60473401122113,16,76,intracellular organelle part,CC,ACSF2;PNP;HEXB;SNX21;MRI1;CYP11A1;HSD3B2;TICAM1;CASP4;HSD17B3;PDK4;AOX1;DHCR7;IFI27;RNASEL;IDUA
482,GO:0006468,0.574095528969315,0.73993533942143,2,9,protein phosphorylation,BP,PDK4;RNASEL
3263,GO:1901617,0.575153521721772,0.743471997833382,2,8,organic hydroxy compound biosynthetic process,BP,HSD17B3;DHCR7
636,GO:0007165,0.575727498213013,0.629884206904643,6,28,signal transduction,BP,TICAM1;CASP4;PDK4;IFI27;RNASEL;ASAH2
783,GO:0009055,0.578453825553803,0.833769135407108,1,4,electron carrier activity,MF,AOX1
1093,GO:0016020,0.579393724627263,0.59449174856441,14,66,membrane,CC,HEXB;SNX21;CYP11A1;HSD3B2;TICAM1;CASP4;TMEM164;HSD17B3;PDK4;PRRT1;PON2;DHCR7;IFI27;ASAH2
2557,GO:0050727,0.579556993226273,0.847947452180265,1,3,regulation of inflammatory response,BP,CASP4
1397,GO:0030154,0.579583300033985,0.642222447221194,5,21,cell differentiation,BP,PNP;HEXB;DHCR7;BDH2;RNASEL
2526,GO:0048869,0.579583300033985,0.642222447221194,5,21,cellular developmental process,BP,PNP;HEXB;DHCR7;BDH2;RNASEL
88,GO:0001817,0.581192864710804,0.831830417191087,1,4,regulation of cytokine production,BP,TICAM1
3313,GO:1902494,0.585788043867618,0.810014428105577,1,7,catalytic complex,CC,TICAM1
1105,GO:0016071,0.586416453087627,0.828086983843598,1,4,mRNA metabolic process,BP,RNASEL
3195,GO:0099503,0.586595969938322,0.733468672819166,2,8,secretory vesicle,CC,PNP;HEXB
1484,GO:0031090,0.586752322023486,0.610571559333382,7,30,organelle membrane,CC,SNX21;CYP11A1;HSD3B2;TICAM1;PDK4;DHCR7;IFI27
3008,GO:0071702,0.586996263413591,0.651174634088571,4,19,organic substance transport,BP,PNP;SNX21;IFI27;RNASEL
1,GO:0000003,0.589212869307284,0.726541607813229,2,9,reproduction,BP,HEXB;HSD17B3
1339,GO:0022414,0.589212869307284,0.726541607813229,2,9,reproductive process,BP,HEXB;HSD17B3
729,GO:0008211,0.589500514370861,0.84134538323208,1,3,glucocorticoid metabolic process,BP,HSD3B2
178,GO:0002683,0.589886879219992,0.825566077950666,1,4,negative regulation of immune system process,BP,TICAM1
476,GO:0006412,0.590881038411815,0.815881291706204,1,5,translation,BP,RBMS3
2475,GO:0048518,0.593460792759401,0.610504766278016,6,31,positive regulation of biological process,BP,PNP;HEXB;TICAM1;RBMS3;IFI27;RNASEL
3077,GO:0080090,0.59491181099197,0.60119518168052,7,32,regulation of primary metabolic process,BP,HEXB;TICAM1;PDK4;RBMS3;DHCR7;IFI27;RNASEL
2665,GO:0051240,0.595056981521497,0.725908841972905,2,8,positive regulation of multicellular organismal process,BP,PNP;TICAM1
2308,GO:0045862,0.59634377177245,0.805756531747859,1,6,positive regulation of proteolysis,BP,IFI27
2050,GO:0043123,0.596383191386664,0.820773355239879,1,4,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,TICAM1
2753,GO:0052689,0.598666005331669,0.819066037035464,1,4,carboxylic ester hydrolase activity,MF,PON2
596,GO:0006886,0.598677836988851,0.819057156477499,1,4,intracellular protein transport,BP,IFI27
564,GO:0006767,0.598889867268956,0.81889795614952,1,4,water-soluble vitamin metabolic process,BP,AOX1
203,GO:0002790,0.599028562401941,0.809585627214062,1,5,peptide secretion,BP,PNP
833,GO:0009306,0.599028562401941,0.809585627214062,1,5,protein secretion,BP,PNP
733,GO:0008233,0.600291071374949,0.808596013966587,1,5,peptidase activity,MF,CASP4
2876,GO:0070011,0.600291071374949,0.808596013966587,1,5,peptidase activity, acting on L-amino acid peptides,MF,CASP4
1306,GO:0019842,0.602258102622631,0.816354806187014,1,4,vitamin binding,MF,ACCS
1775,GO:0034470,0.603385454562654,0.815497633335026,1,4,ncRNA processing,BP,RNASEL
3262,GO:1901615,0.604965271747738,0.662859919413913,3,14,organic hydroxy compound metabolic process,BP,CYP11A1;HSD17B3;DHCR7
612,GO:0006950,0.60801106633605,0.58848713325971,7,31,response to stress,BP,TICAM1;CASP4;PDK4;AOX1;PON2;IFI27;RNASEL
816,GO:0009165,0.60885173449814,0.811298417380005,1,4,nucleotide biosynthetic process,BP,PNP
3243,GO:1901293,0.60885173449814,0.811298417380005,1,4,nucleoside phosphate biosynthetic process,BP,PNP
1816,GO:0035295,0.610259208248312,0.810205554390775,1,4,tube development,BP,DHCR7
2243,GO:0045088,0.610517436235985,0.800438197272163,1,5,regulation of innate immune response,BP,TICAM1
1322,GO:0019953,0.611257744504679,0.809427304869873,1,4,sexual reproduction,BP,HEXB
1616,GO:0032504,0.611257744504679,0.809427304869873,1,4,multicellular organism reproduction,BP,HEXB
2212,GO:0044703,0.611257744504679,0.809427304869873,1,4,multi-organism reproductive process,BP,HEXB
2497,GO:0048609,0.611257744504679,0.809427304869873,1,4,multicellular organismal reproductive process,BP,HEXB
177,GO:0002682,0.611938128165493,0.70183102352544,2,10,regulation of immune system process,BP,PNP;TICAM1
683,GO:0007605,0.612115118233102,0.825517668349372,1,3,sensory perception of sound,BP,HEXB
2610,GO:0050954,0.612115118233102,0.825517668349372,1,3,sensory perception of mechanical stimulus,BP,HEXB
2496,GO:0048608,0.612661322070906,0.798695472201507,1,5,reproductive structure development,BP,HSD17B3
2866,GO:0061458,0.612661322070906,0.798695472201507,1,5,reproductive system development,BP,HSD17B3
726,GO:0008207,0.612937007868618,0.824920355554138,1,3,C21-steroid hormone metabolic process,BP,CYP11A1
275,GO:0004497,0.613130216212632,0.807961365408047,1,4,monooxygenase activity,MF,CYP11A1
3204,GO:0101002,0.614002251851293,0.824143812897485,1,3,ficolin-1-rich granule,CC,PNP
3426,GO:1904813,0.614002251851293,0.824143812897485,1,3,ficolin-1-rich granule lumen,CC,PNP
1714,GO:0033554,0.614642520204386,0.699244583723624,2,10,cellular response to stress,BP,CASP4;PDK4
1310,GO:0019866,0.61619109187645,0.654156740636332,3,13,organelle inner membrane,CC,HSD3B2;PDK4;IFI27
2896,GO:0070265,0.617118538514385,0.804810236099349,1,4,necrotic cell death,BP,TICAM1
1779,GO:0034613,0.618453239584734,0.793929913986564,1,5,cellular protein localization,BP,IFI27
2932,GO:0070727,0.618453239584734,0.793929913986564,1,5,cellular macromolecule localization,BP,IFI27
3053,GO:0072359,0.620727708960389,0.792035321690259,1,5,circulatory system development,BP,DHCR7
382,GO:0005759,0.621860447133849,0.617768127850694,4,18,mitochondrial matrix,CC,ACSF2;CYP11A1;PDK4;RNASEL
492,GO:0006508,0.622131234030827,0.688973289116508,2,11,proteolysis,BP,CASP4;IFI27
2182,GO:0044422,0.626944890468454,0.550302232474498,16,77,organelle part,CC,ACSF2;PNP;HEXB;SNX21;MRI1;CYP11A1;HSD3B2;TICAM1;CASP4;HSD17B3;PDK4;AOX1;DHCR7;IFI27;RNASEL;IDUA
591,GO:0006873,0.627397649175135,0.796505380365881,1,4,cellular ion homeostasis,BP,HEXB
593,GO:0006875,0.627397649175135,0.796505380365881,1,4,cellular metal ion homeostasis,BP,HEXB
1369,GO:0030003,0.627397649175135,0.796505380365881,1,4,cellular cation homeostasis,BP,HEXB
1271,GO:0019318,0.627603573548072,0.786227085255974,1,5,hexose metabolic process,BP,PDK4
1791,GO:0034660,0.63094830286885,0.783357207400766,1,5,ncRNA metabolic process,BP,RNASEL
396,GO:0005783,0.631392500186263,0.601200947054934,4,24,endoplasmic reticulum,CC,HSD3B2;CASP4;HSD17B3;DHCR7
1562,GO:0031982,0.631631564154724,0.554463882819833,8,40,vesicle,CC,PNP;HEXB;SNX21;CMBL;TICAM1;AOX1;BDH2;IDUA
681,GO:0007600,0.636615818633847,0.788826761392286,1,4,sensory perception,BP,HEXB
3000,GO:0071496,0.63679342075259,0.806868850397627,1,3,cellular response to external stimulus,BP,PDK4
573,GO:0006807,0.637042663079568,0.536763609187424,11,56,nitrogen compound metabolic process,BP,PNP;HEXB;MRI1;TICAM1;RBMS3;AOX1;BDH2;IFI27;RNASEL;IDUA;ASAH2
1301,GO:0019748,0.639322977817435,0.804871153609351,1,3,secondary metabolic process,BP,BDH2
1576,GO:0032268,0.642507774719622,0.620870055969477,3,16,regulation of cellular protein metabolic process,BP,TICAM1;RBMS3;IFI27
1936,GO:0042304,0.643928706802597,0.782574957967425,1,4,regulation of fatty acid biosynthetic process,BP,PDK4
1213,GO:0016874,0.646340271902637,0.799241785665588,1,3,ligase activity,MF,ACSF2
420,GO:0005996,0.646421783879531,0.762761269453753,1,6,monosaccharide metabolic process,BP,PDK4
377,GO:0005739,0.647416673502304,0.531767994537817,9,47,mitochondrion,CC,ACSF2;CYP11A1;HSD3B2;CASP4;PDK4;PON2;IFI27;RNASEL;ASAH2
1681,GO:0032940,0.648677611963903,0.665366559822482,2,10,secretion by cell,BP,PNP;HEXB
2417,GO:0046903,0.648677611963903,0.665366559822482,2,10,secretion,BP,PNP;HEXB
3269,GO:1901657,0.649195290029409,0.777982410273343,1,4,glycosyl compound metabolic process,BP,PNP
1473,GO:0030855,0.649627523755325,0.796559723083141,1,3,epithelial cell differentiation,BP,BDH2
2354,GO:0046434,0.650232519852365,0.766223596413709,1,5,organophosphate catabolic process,BP,PNP
2750,GO:0052547,0.651305383617618,0.758210066353845,1,6,regulation of peptidase activity,BP,IFI27
2751,GO:0052548,0.651305383617618,0.758210066353845,1,6,regulation of endopeptidase activity,BP,IFI27
2530,GO:0048878,0.651499031320954,0.617807933290601,3,13,chemical homeostasis,BP,HEXB;PDK4;BDH2
724,GO:0008203,0.652553447201395,0.665381831808636,2,9,cholesterol metabolic process,BP,CYP11A1;DHCR7
3327,GO:1902652,0.652553447201395,0.665381831808636,2,9,secondary alcohol metabolic process,BP,CYP11A1;DHCR7
2538,GO:0050662,0.652720802044617,0.619564206458083,3,12,coenzyme binding,MF,AOX1;DHCR7;BDH2
554,GO:0006732,0.657439377974038,0.608902609968959,3,14,coenzyme metabolic process,BP,ACSF2;PNP;PDK4
1992,GO:0042594,0.657702158521072,0.789846862545102,1,3,response to starvation,BP,PDK4
2146,GO:0044093,0.658083159004852,0.647507758861654,2,13,positive regulation of molecular function,BP,TICAM1;IFI27
3110,GO:0090407,0.659888889453687,0.650398883656372,2,11,organophosphate biosynthetic process,BP,PNP;HEXB
3092,GO:0090181,0.660206150725826,0.787728472357285,1,3,regulation of cholesterol metabolic process,BP,DHCR7
1787,GO:0034641,0.660491941211414,0.517567951539896,9,47,cellular nitrogen compound metabolic process,BP,PNP;HEXB;TICAM1;RBMS3;AOX1;BDH2;IFI27;RNASEL;ASAH2
2583,GO:0050810,0.665694889029819,0.78302288497907,1,3,regulation of steroid biosynthetic process,BP,DHCR7
2604,GO:0050896,0.666508571124078,0.503898233215131,12,56,response to stimulus,BP,PNP;HEXB;CMBL;TICAM1;CASP4;PDK4;PRRT1;AOX1;PON2;IFI27;RNASEL;ASAH2
882,GO:0009890,0.667725404327753,0.737255119919083,1,7,negative regulation of biosynthetic process,BP,IFI27
1510,GO:0031327,0.667725404327753,0.737255119919083,1,7,negative regulation of cellular biosynthetic process,BP,IFI27
1317,GO:0019901,0.668644664375835,0.780458238892607,1,3,protein kinase binding,MF,TICAM1
2600,GO:0050877,0.670567352969739,0.747016578076539,1,5,neurological system process,BP,HEXB
1790,GO:0034655,0.670573972689319,0.747010125740727,1,5,nucleobase-containing compound catabolic process,BP,PNP
1104,GO:0016070,0.672560389355816,0.558365586026312,4,22,RNA metabolic process,BP,HEXB;TICAM1;IFI27;RNASEL
645,GO:0007249,0.673392504013854,0.736759519489662,1,6,I-kappaB kinase/NF-kappaB signaling,BP,TICAM1
2049,GO:0043122,0.673392504013854,0.736759519489662,1,6,regulation of I-kappaB kinase/NF-kappaB signaling,BP,TICAM1
1264,GO:0019217,0.675067006391036,0.74259977627629,1,5,regulation of fatty acid metabolic process,BP,PDK4
138,GO:0002253,0.679508553651586,0.738178572047844,1,5,activation of immune response,BP,TICAM1
2570,GO:0050778,0.679508553651586,0.738178572047844,1,5,positive regulation of immune response,BP,TICAM1
2775,GO:0055086,0.682311195261772,0.629308416089253,2,10,nucleobase-containing small molecule metabolic process,BP,PNP;AOX1
2218,GO:0044712,0.683578302853674,0.51437819823964,6,31,single-organism catabolic process,BP,PNP;HEXB;AOX1;HSD17B11;BDH2;IDUA
2063,GO:0043207,0.685324252300055,0.630206338909115,2,9,response to external biotic stimulus,BP,TICAM1;RNASEL
2735,GO:0051707,0.685324252300055,0.630206338909115,2,9,response to other organism,BP,TICAM1;RNASEL
905,GO:0010033,0.686042936682336,0.523597651046573,5,28,response to organic substance,BP,TICAM1;CASP4;PDK4;IFI27;RNASEL
2013,GO:0042803,0.686657988875287,0.621058943525256,2,11,protein homodimerization activity,MF,HEXB;ACCS
2184,GO:0044425,0.687161718007598,0.492773783884063,8,43,membrane part,CC,HSD3B2;CASP4;TMEM164;HSD17B3;PRRT1;DHCR7;IFI27;ASAH2
916,GO:0010467,0.689616406895913,0.520189683332707,5,27,gene expression,BP,HEXB;TICAM1;RBMS3;IFI27;RNASEL
374,GO:0005654,0.690131941817987,0.617121788597836,2,11,nucleoplasm,CC,MRI1;AOX1
3107,GO:0090304,0.691883301661236,0.535420808794461,4,23,nucleic acid metabolic process,BP,HEXB;TICAM1;IFI27;RNASEL
2279,GO:0045597,0.693645531545381,0.735989634358375,1,4,positive regulation of cell differentiation,BP,PNP
1263,GO:0019216,0.699893987589585,0.613704240354575,2,9,regulation of lipid metabolic process,BP,PDK4;DHCR7
2415,GO:0046890,0.699893987589585,0.613704240354575,2,9,regulation of lipid biosynthetic process,BP,PDK4;DHCR7
638,GO:0007167,0.701342842792228,0.728085006416902,1,4,enzyme linked receptor protein signaling pathway,BP,PDK4
639,GO:0007169,0.701342842792228,0.728085006416902,1,4,transmembrane receptor protein tyrosine kinase signaling pathway,BP,PDK4
861,GO:0009636,0.704375513857683,0.712246943584481,1,5,response to toxic substance,BP,PON2
472,GO:0006396,0.705756835046623,0.702569886238812,1,6,RNA processing,BP,RNASEL
1129,GO:0016310,0.705867668573557,0.598896318931553,2,11,phosphorylation,BP,PDK4;RNASEL
674,GO:0007548,0.709534882143916,0.698348633177621,1,6,sex differentiation,BP,HSD17B3
2231,GO:0044877,0.711689937096867,0.70421948586661,1,5,macromolecular complex binding,MF,RNASEL
1561,GO:0031981,0.712853100507206,0.538553257678248,3,18,nuclear lumen,CC,MRI1;AOX1;RNASEL
2667,GO:0051246,0.713623633776013,0.539083388697573,3,17,regulation of protein metabolic process,BP,TICAM1;RBMS3;IFI27
1141,GO:0016477,0.714152387446348,0.693120464707156,1,6,cell migration,BP,HEXB
2167,GO:0044281,0.714198743027654,0.44968110149803,12,60,small molecule metabolic process,BP,ACSF2;PNP;HEXB;MRI1;CYP11A1;HSD17B3;PDK4;AOX1;PON2;DHCR7;BDH2;IDUA
1378,GO:0030054,0.714863228664428,0.700677492586039,1,5,cell junction,CC,PRRT1
229,GO:0003723,0.715341251905357,0.58237169877708,2,13,RNA binding,MF,RBMS3;RNASEL
866,GO:0009719,0.715351965026675,0.538675550266631,3,16,response to endogenous stimulus,BP,CASP4;PDK4;RNASEL
1108,GO:0016125,0.717827793705094,0.58813953417072,2,10,sterol metabolic process,BP,CYP11A1;DHCR7
3078,GO:0080134,0.717931968804054,0.584472950824859,2,11,regulation of response to stress,BP,TICAM1;CASP4
853,GO:0009605,0.721029178257543,0.507176873902316,4,18,response to external stimulus,BP,TICAM1;CASP4;PDK4;RNASEL
2420,GO:0046914,0.721679493739607,0.577023562201176,2,12,transition metal ion binding,MF,CYP11A1;AOX1
449,GO:0006139,0.721934082778772,0.468084402980486,6,34,nucleobase-containing compound metabolic process,BP,PNP;HEXB;TICAM1;AOX1;IFI27;RNASEL
1316,GO:0019900,0.722510935281838,0.705280543204788,1,4,kinase binding,MF,TICAM1
2159,GO:0044260,0.726654913457424,0.452897461947201,7,40,cellular macromolecule metabolic process,BP,HEXB;TICAM1;PDK4;RBMS3;IFI27;RNASEL;IDUA
1530,GO:0031401,0.726713678903893,0.67250760462567,1,7,positive regulation of protein modification process,BP,TICAM1
2736,GO:0051716,0.726847215627793,0.454529577417747,7,35,cellular response to stimulus,BP,CMBL;TICAM1;CASP4;PDK4;IFI27;RNASEL;ASAH2
53,GO:0001501,0.729377078647887,0.675326523174201,1,6,skeletal system development,BP,HEXB
2568,GO:0050776,0.731763455735667,0.672457595425867,1,6,regulation of immune response,BP,TICAM1
2251,GO:0045202,0.732412087007706,0.694045208674314,1,4,synapse,CC,PRRT1
430,GO:0006066,0.733706575900864,0.564992937063342,2,11,alcohol metabolic process,BP,CYP11A1;DHCR7
541,GO:0006695,0.734760800101461,0.677612096008604,1,5,cholesterol biosynthetic process,BP,DHCR7
1109,GO:0016126,0.734760800101461,0.677612096008604,1,5,sterol biosynthetic process,BP,DHCR7
2333,GO:0046165,0.734760800101461,0.677612096008604,1,5,alcohol biosynthetic process,BP,DHCR7
3328,GO:1902653,0.734760800101461,0.677612096008604,1,5,secondary alcohol biosynthetic process,BP,DHCR7
2181,GO:0044421,0.735825800612894,0.451222927741652,6,34,extracellular region part,CC,PNP;HEXB;CMBL;AOX1;BDH2;IDUA
481,GO:0006464,0.738729626479175,0.505292222588182,3,19,cellular protein modification process,BP,TICAM1;PDK4;RNASEL
1872,GO:0036211,0.738729626479175,0.505292222588182,3,19,protein modification process,BP,TICAM1;PDK4;RNASEL
3257,GO:1901575,0.738995271649297,0.447787946073395,6,33,organic substance catabolic process,BP,PNP;HEXB;AOX1;HSD17B11;BDH2;IDUA
1269,GO:0019222,0.74106177959055,0.436806590033616,7,36,regulation of metabolic process,BP,HEXB;TICAM1;PDK4;RBMS3;DHCR7;IFI27;RNASEL
1094,GO:0016021,0.742715365594523,0.442301311917758,6,35,integral component of membrane,CC,HSD3B2;TMEM164;PRRT1;DHCR7;IFI27;ASAH2
1179,GO:0016740,0.74339451855416,0.475258891099223,4,21,transferase activity,MF,PNP;HEXB;PDK4;RNASEL
2624,GO:0051049,0.746180906950508,0.541584921641072,2,14,regulation of transport,BP,IFI27;RNASEL
1116,GO:0016192,0.747261495278813,0.5446912500543,2,12,vesicle-mediated transport,BP,PNP;HEXB
1506,GO:0031323,0.748906801004668,0.435976824890673,6,32,regulation of cellular metabolic process,BP,HEXB;TICAM1;PDK4;RBMS3;IFI27;RNASEL
1015,GO:0012506,0.753046005838217,0.669367187317036,1,4,vesicle membrane,CC,SNX21
1450,GO:0030659,0.753046005838217,0.669367187317036,1,4,cytoplasmic vesicle membrane,CC,SNX21
900,GO:0009987,0.753112797789194,0.472603702687587,22,109,cellular process,BP,ACSF2;PNP;HEXB;MRI1;CMBL;CYP11A1;HSD3B2;TICAM1;CASP4;HSD17B3;PDK4;RBMS3;AOX1;PON2;DHCR7;HSD17B11;BDH2;IFI27;RNASEL;WDR45;IDUA;ASAH2
2536,GO:0050660,0.753342740637497,0.668999190403652,1,4,flavin adenine dinucleotide binding,MF,AOX1
370,GO:0005634,0.755966697646975,0.416866298034819,7,40,nucleus,CC,PNP;MRI1;AOX1;PON2;DHCR7;IFI27;RNASEL
32,GO:0000902,0.757314459284829,0.649552724454337,1,5,cell morphogenesis,BP,HEXB
1689,GO:0032989,0.757314459284829,0.649552724454337,1,5,cellular component morphogenesis,BP,HEXB
1570,GO:0032101,0.760825892593373,0.644987157380241,1,5,regulation of response to external stimulus,BP,CASP4
776,GO:0008654,0.761342480729184,0.628486796376342,1,7,phospholipid biosynthetic process,BP,HEXB
569,GO:0006793,0.763588060284023,0.427600604671125,5,31,phosphorus metabolic process,BP,ACSF2;PNP;HEXB;PDK4;RNASEL
1734,GO:0034097,0.764506779578882,0.519257919330502,2,13,response to cytokine,BP,IFI27;RNASEL
2974,GO:0071345,0.764506779578882,0.519257919330502,2,13,cellular response to cytokine stimulus,BP,IFI27;RNASEL
358,GO:0005543,0.764542783714751,0.640093706569508,1,5,phospholipid binding,MF,SNX21
570,GO:0006796,0.770644791852691,0.434775510150599,4,27,phosphate-containing compound metabolic process,BP,PNP;HEXB;PDK4;RNASEL
2694,GO:0051345,0.770758734622525,0.610776871692297,1,8,positive regulation of hydrolase activity,BP,IFI27
2806,GO:0060255,0.771340957660469,0.420680479544351,5,26,regulation of macromolecule metabolic process,BP,HEXB;TICAM1;RBMS3;IFI27;RNASEL
1265,GO:0019218,0.771390735534159,0.630910431025091,1,5,regulation of steroid metabolic process,BP,DHCR7
2057,GO:0043170,0.771577860293098,0.390489727299371,8,46,macromolecule metabolic process,BP,HEXB;TICAM1;CASP4;PDK4;RBMS3;IFI27;RNASEL;IDUA
886,GO:0009894,0.774136025441977,0.617563317758701,1,6,regulation of catabolic process,BP,TICAM1
1512,GO:0031329,0.774136025441977,0.617563317758701,1,6,regulation of cellular catabolic process,BP,TICAM1
2473,GO:0048513,0.774411644944011,0.457231990539675,3,20,animal organ development,BP,PNP;HSD17B3;DHCR7
2431,GO:0046983,0.775336946450773,0.504323728290446,2,13,protein dimerization activity,MF,HEXB;ACCS
935,GO:0010605,0.775841963975074,0.599872891339065,1,9,negative regulation of macromolecule metabolic process,BP,IFI27
2368,GO:0046483,0.779415591560562,0.386862105655233,7,40,heterocycle metabolic process,BP,PNP;HEXB;TICAM1;AOX1;BDH2;IFI27;RNASEL
1990,GO:0042592,0.779594121150025,0.455839927260351,3,16,homeostatic process,BP,HEXB;PDK4;BDH2
2954,GO:0071216,0.784130410507186,0.613223207641863,1,5,cellular response to biotic stimulus,BP,TICAM1
2955,GO:0071219,0.784130410507186,0.613223207641863,1,5,cellular response to molecule of bacterial origin,BP,TICAM1
2956,GO:0071222,0.784130410507186,0.613223207641863,1,5,cellular response to lipopolysaccharide,BP,TICAM1
2096,GO:0043412,0.787062275322413,0.438713166481041,3,21,macromolecule modification,BP,TICAM1;PDK4;RNASEL
1494,GO:0031224,0.788347304298027,0.383223860669539,6,36,intrinsic component of membrane,CC,HSD3B2;TMEM164;PRRT1;DHCR7;IFI27;ASAH2
2527,GO:0048870,0.789397892776259,0.588912266763409,1,7,cell motility,BP,HEXB
2729,GO:0051674,0.789397892776259,0.588912266763409,1,7,localization of cell,BP,HEXB
1171,GO:0016705,0.789782742378952,0.595200574436761,1,6,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,MF,CYP11A1
714,GO:0008150,0.791614244763378,0.613662528454591,25,122,biological_process,BP,ACSF2;PNP;HEXB;SNX21;MRI1;CMBL;CYP11A1;HSD3B2;TICAM1;ACCS;CASP4;HSD17B3;PDK4;RBMS3;PRRT1;AOX1;PON2;DHCR7;HSD17B11;BDH2;IFI27;RNASEL;WDR45;IDUA;ASAH2
931,GO:0010565,0.792872187504507,0.583739333272641,1,7,regulation of cellular ketone metabolic process,BP,PDK4
982,GO:0010876,0.793673837050035,0.582536717096894,1,7,lipid localization,BP,HEXB
868,GO:0009725,0.797321984606396,0.478352138026967,2,11,response to hormone,BP,PDK4;RNASEL
525,GO:0006644,0.800115669362514,0.563730104461918,1,9,phospholipid metabolic process,BP,HEXB
2625,GO:0051050,0.804603130198497,0.560640470831574,1,8,positive regulation of transport,BP,RNASEL
2831,GO:0060429,0.807109035501899,0.568932060000455,1,6,epithelium development,BP,BDH2
1300,GO:0019725,0.810173688725375,0.56410909031949,1,6,cellular homeostasis,BP,HEXB
2773,GO:0055082,0.810173688725375,0.56410909031949,1,6,cellular chemical homeostasis,BP,HEXB
555,GO:0006733,0.810402446096617,0.563746865075723,1,6,oxidoreduction coenzyme metabolic process,BP,PNP
1275,GO:0019362,0.810402446096617,0.563746865075723,1,6,pyridine nucleotide metabolic process,BP,PNP
2374,GO:0046496,0.810402446096617,0.563746865075723,1,6,nicotinamide nucleotide metabolic process,BP,PNP
368,GO:0005622,0.812369694889893,0.401902694649102,22,113,intracellular,CC,ACSF2;PNP;HEXB;SNX21;MRI1;CMBL;CYP11A1;HSD3B2;TICAM1;CASP4;HSD17B3;PDK4;RBMS3;AOX1;PON2;DHCR7;HSD17B11;BDH2;IFI27;RNASEL;IDUA;ASAH2
2183,GO:0044424,0.812369694889893,0.401902694649102,22,113,intracellular part,CC,ACSF2;PNP;HEXB;SNX21;MRI1;CMBL;CYP11A1;HSD3B2;TICAM1;CASP4;HSD17B3;PDK4;RBMS3;AOX1;PON2;DHCR7;HSD17B11;BDH2;IFI27;RNASEL;IDUA;ASAH2
684,GO:0007610,0.818353725120926,0.550960093151876,1,6,behavior,BP,HEXB
2524,GO:0048856,0.818414916131453,0.353541560074818,5,30,anatomical structure development,BP,PNP;HEXB;HSD17B3;DHCR7;BDH2
1726,GO:0033993,0.819736242303473,0.438547801990238,2,13,response to lipid,BP,TICAM1;PDK4
2576,GO:0050794,0.825185435471537,0.312312290657442,10,54,regulation of cellular process,BP,PNP;HEXB;TICAM1;CASP4;PDK4;RBMS3;DHCR7;IFI27;RNASEL;ASAH2
2634,GO:0051094,0.825281691987166,0.539497335903028,1,6,positive regulation of developmental process,BP,PNP
901,GO:0009991,0.825833304742612,0.549135125279452,1,5,response to extracellular stimulus,BP,PDK4
1540,GO:0031667,0.825833304742612,0.549135125279452,1,5,response to nutrient levels,BP,PDK4
2067,GO:0043228,0.827732050984726,0.379056866643827,3,21,non-membrane-bounded organelle,CC,PNP;MRI1;HSD17B11
2071,GO:0043232,0.827732050984726,0.379056866643827,3,21,intracellular non-membrane-bounded organelle,CC,PNP;MRI1;HSD17B11
2516,GO:0048731,0.830741098096275,0.350658171185459,4,26,system development,BP,PNP;HEXB;HSD17B3;DHCR7
2664,GO:0051239,0.831979751039108,0.37158442256307,3,22,regulation of multicellular organismal process,BP,PNP;TICAM1;PDK4
1831,GO:0035556,0.832256103121201,0.414539094073726,2,15,intracellular signal transduction,BP,TICAM1;CASP4
1364,GO:0023052,0.832783056583711,0.321831898035654,6,35,signaling,BP,TICAM1;CASP4;PDK4;IFI27;RNASEL;ASAH2
2210,GO:0044700,0.832783056583711,0.321831898035654,6,35,single organism signaling,BP,TICAM1;CASP4;PDK4;IFI27;RNASEL;ASAH2
2070,GO:0043231,0.835812253753845,0.308369935509487,17,95,intracellular membrane-bounded organelle,CC,ACSF2;PNP;HEXB;MRI1;CYP11A1;HSD3B2;TICAM1;CASP4;HSD17B3;PDK4;AOX1;PON2;DHCR7;IFI27;RNASEL;IDUA;ASAH2
623,GO:0006996,0.836069126340711,0.500907571541864,1,10,organelle organization,BP,HEXB
1399,GO:0030162,0.836607448728936,0.503180920213069,1,9,regulation of proteolysis,BP,IFI27
214,GO:0003008,0.836677608438272,0.5030563747172,1,9,system process,BP,HEXB
632,GO:0007154,0.837019422694853,0.315667361109374,6,35,cell communication,BP,TICAM1;CASP4;PDK4;IFI27;RNASEL;ASAH2
223,GO:0003676,0.840581456264378,0.400813114522159,2,15,nucleic acid binding,MF,RBMS3;RNASEL
2488,GO:0048584,0.841061883365186,0.401831841891462,2,14,positive regulation of response to stimulus,BP,TICAM1;RNASEL
1712,GO:0033500,0.841784880851711,0.510895548365104,1,6,carbohydrate homeostasis,BP,PDK4
1991,GO:0042593,0.841784880851711,0.510895548365104,1,6,glucose homeostasis,BP,PDK4
609,GO:0006928,0.843854300259607,0.494274840903816,1,8,movement of cell or subcellular component,BP,HEXB
1891,GO:0040011,0.843854300259607,0.494274840903816,1,8,locomotion,BP,HEXB
1292,GO:0019637,0.844449026770607,0.39140406410972,2,17,organophosphate metabolic process,BP,PNP;HEXB
2409,GO:0046872,0.846769194926447,0.326159094461074,4,26,metal ion binding,MF,CYP11A1;AOX1;PON2;RNASEL
380,GO:0005743,0.847139286659456,0.396274627702383,2,12,mitochondrial inner membrane,CC,HSD3B2;PDK4
1528,GO:0031399,0.847839910420492,0.482799185430068,1,9,regulation of protein modification process,BP,TICAM1
135,GO:0002237,0.848534767770926,0.491133821636678,1,7,response to molecule of bacterial origin,BP,TICAM1
858,GO:0009617,0.848534767770926,0.491133821636678,1,7,response to bacterium,BP,TICAM1
1613,GO:0032496,0.848534767770926,0.491133821636678,1,7,response to lipopolysaccharide,BP,TICAM1
407,GO:0005856,0.849083153501897,0.490117614370471,1,7,cytoskeleton,CC,PNP
2056,GO:0043169,0.850505619826253,0.319695056419613,4,27,cation binding,MF,CYP11A1;AOX1;PON2;RNASEL
375,GO:0005730,0.851889678227044,0.475224169925897,1,9,nucleolus,CC,MRI1
2225,GO:0044767,0.852903345238372,0.291722896974185,6,36,single-organism developmental process,BP,PNP;HEXB;HSD17B3;DHCR7;BDH2;RNASEL
3318,GO:1902533,0.853479152631405,0.476394378330576,1,8,positive regulation of intracellular signal transduction,BP,TICAM1
432,GO:0006082,0.854465291877406,0.277310034978263,8,44,organic acid metabolic process,BP,ACSF2;PNP;HEXB;MRI1;PDK4;PON2;BDH2;IDUA
2224,GO:0044765,0.855471925144241,0.334890180494279,3,21,single-organism transport,BP,PNP;HEXB;RNASEL
3321,GO:1902578,0.855471925144241,0.334890180494279,3,21,single-organism localization,BP,PNP;HEXB;RNASEL
621,GO:0006979,0.855940027382087,0.477212793365007,1,7,response to oxidative stress,BP,PON2
575,GO:0006810,0.857157861249706,0.294448327641554,5,33,transport,BP,PNP;HEXB;SNX21;IFI27;RNASEL
2661,GO:0051234,0.857157861249706,0.294448327641554,5,33,establishment of localization,BP,PNP;HEXB;SNX21;IFI27;RNASEL
2037,GO:0043066,0.858429682729747,0.472433825786041,1,7,negative regulation of apoptotic process,BP,PDK4
2040,GO:0043069,0.858429682729747,0.472433825786041,1,7,negative regulation of programmed cell death,BP,PDK4
2839,GO:0060548,0.858429682729747,0.472433825786041,1,7,negative regulation of cell death,BP,PDK4
2874,GO:0065009,0.858448524452145,0.364150118702694,2,20,regulation of molecular function,BP,TICAM1;IFI27
745,GO:0008289,0.863161547966455,0.457671721500917,1,8,lipid binding,MF,SNX21
1101,GO:0016053,0.863707318281887,0.367273022455223,2,12,organic acid biosynthetic process,BP,MRI1;PDK4
2349,GO:0046394,0.863707318281887,0.367273022455223,2,12,carboxylic acid biosynthetic process,BP,MRI1;PDK4
2073,GO:0043234,0.864497629049263,0.444846553558161,1,11,protein complex,CC,CASP4
2041,GO:0043085,0.866118235583185,0.439418669702391,1,12,positive regulation of catalytic activity,BP,IFI27
2066,GO:0043227,0.868491577084445,0.286357641831135,20,108,membrane-bounded organelle,CC,ACSF2;PNP;HEXB;SNX21;MRI1;CMBL;CYP11A1;HSD3B2;TICAM1;CASP4;HSD17B3;PDK4;AOX1;PON2;DHCR7;BDH2;IFI27;RNASEL;IDUA;ASAH2
2688,GO:0051336,0.868914452049607,0.435970122768796,1,11,regulation of hydrolase activity,BP,IFI27
1678,GO:0032879,0.870548731918845,0.345557124594809,2,17,regulation of localization,BP,IFI27;RNASEL
897,GO:0009968,0.872541755195107,0.434543675621434,1,9,negative regulation of signal transduction,BP,TICAM1
946,GO:0010648,0.872541755195107,0.434543675621434,1,9,negative regulation of cell communication,BP,TICAM1
1366,GO:0023057,0.872541755195107,0.434543675621434,1,9,negative regulation of signaling,BP,TICAM1
308,GO:0004871,0.873042031987984,0.443312654450289,1,7,signal transducer activity,MF,TICAM1
2476,GO:0048519,0.873669569588003,0.280786812158963,4,30,negative regulation of biological process,BP,TICAM1;PDK4;IFI27;RNASEL
2478,GO:0048523,0.873669569588003,0.280786812158963,4,30,negative regulation of cellular process,BP,TICAM1;PDK4;IFI27;RNASEL
1096,GO:0016042,0.874985675233379,0.301800390057905,3,21,lipid catabolic process,BP,HEXB;HSD17B11;BDH2
1615,GO:0032502,0.87730908588259,0.253565310667817,6,37,developmental process,BP,PNP;HEXB;HSD17B3;DHCR7;BDH2;RNASEL
1330,GO:0022008,0.877648539423898,0.43372735661588,1,7,neurogenesis,BP,HEXB
655,GO:0007275,0.87850942110744,0.273632408045755,4,28,multicellular organism development,BP,PNP;HEXB;HSD17B3;DHCR7
863,GO:0009653,0.881083501151559,0.413291963004269,1,10,anatomical structure morphogenesis,BP,HEXB
880,GO:0009888,0.881319740447137,0.412786097803655,1,10,tissue development,BP,BDH2
562,GO:0006753,0.883327562250474,0.411790213469977,1,9,nucleoside phosphate metabolic process,BP,PNP
808,GO:0009117,0.883327562250474,0.411790213469977,1,9,nucleotide metabolic process,BP,PNP
2065,GO:0043226,0.883966865249012,0.276534473113687,21,112,organelle,CC,ACSF2;PNP;HEXB;SNX21;MRI1;CMBL;CYP11A1;HSD3B2;TICAM1;CASP4;HSD17B3;PDK4;AOX1;PON2;DHCR7;HSD17B11;BDH2;IFI27;RNASEL;IDUA;ASAH2
2647,GO:0051174,0.886189456431146,0.399559519836056,1,11,regulation of phosphorus metabolic process,BP,PDK4
411,GO:0005886,0.88648773541592,0.261777531929416,4,25,plasma membrane,CC,CASP4;PRRT1;PON2;ASAH2
1970,GO:0042493,0.886693544494326,0.408696700893493,1,8,response to drug,BP,PNP
1691,GO:0032991,0.888680789429104,0.307513440365629,2,21,macromolecular complex,CC,TICAM1;CASP4
2068,GO:0043229,0.889169859551191,0.242439971473689,19,104,intracellular organelle,CC,ACSF2;PNP;HEXB;SNX21;MRI1;CYP11A1;HSD3B2;TICAM1;CASP4;HSD17B3;PDK4;AOX1;PON2;DHCR7;HSD17B11;IFI27;RNASEL;IDUA;ASAH2
2419,GO:0046907,0.89384697178069,0.388465865974687,1,9,intracellular transport,BP,IFI27
2489,GO:0048585,0.894042552882477,0.384700010698511,1,10,negative regulation of response to stimulus,BP,TICAM1
2575,GO:0050793,0.896318598824856,0.297484509325597,2,16,regulation of developmental process,BP,PNP;HEXB
345,GO:0005488,0.902672728624318,0.207222464263665,17,96,binding,MF,ACSF2;PNP;HEXB;SNX21;MRI1;CYP11A1;TICAM1;ACCS;PDK4;RBMS3;AOX1;PON2;DHCR7;BDH2;IFI27;RNASEL;IDUA
2467,GO:0048468,0.906634226262643,0.358417812506733,1,9,cell development,BP,HEXB
896,GO:0009967,0.907032648241126,0.351507413834086,1,11,positive regulation of signal transduction,BP,TICAM1
2487,GO:0048583,0.90877373627359,0.238854786118385,3,22,regulation of response to stimulus,BP,TICAM1;CASP4;RNASEL
3259,GO:1901605,0.909469235429198,0.35567905034911,1,8,alpha-amino acid metabolic process,BP,MRI1
884,GO:0009892,0.913382487035252,0.331868467863895,1,13,negative regulation of metabolic process,BP,IFI27
1507,GO:0031324,0.913382487035252,0.331868467863895,1,13,negative regulation of cellular metabolic process,BP,IFI27
3031,GO:0071944,0.913516092161696,0.212550247756581,4,26,cell periphery,CC,CASP4;PRRT1;PON2;ASAH2
3046,GO:0072329,0.915688331607803,0.25842324888381,2,15,monocarboxylic acid catabolic process,BP,BDH2;IDUA
517,GO:0006633,0.915751478963793,0.339879078032335,1,8,fatty acid biosynthetic process,BP,PDK4
1019,GO:0014070,0.918431505374133,0.332962461838594,1,8,response to organic cyclic compound,BP,TICAM1
2101,GO:0043436,0.91843549176573,0.178882051659728,7,43,oxoacid metabolic process,BP,ACSF2;HEXB;MRI1;PDK4;PON2;BDH2;IDUA
3457,GO:2000026,0.919154873122268,0.318940471567987,1,12,regulation of multicellular organismal development,BP,PNP
2277,GO:0045595,0.919977598120014,0.324775858300747,1,9,regulation of cell differentiation,BP,PNP
665,GO:0007399,0.920166039767167,0.324282065097458,1,9,nervous system development,BP,HEXB
2209,GO:0044699,0.921017243765356,0.186456880585734,19,102,single-organism process,BP,ACSF2;PNP;HEXB;MRI1;CYP11A1;HSD3B2;TICAM1;CASP4;HSD17B3;PDK4;AOX1;PON2;DHCR7;HSD17B11;BDH2;IFI27;RNASEL;IDUA;ASAH2
2024,GO:0042995,0.921743324423566,0.32012708424876,1,9,cell projection,CC,MRI1
2156,GO:0044255,0.921917632312117,0.177643594823847,6,39,cellular lipid metabolic process,BP,ACSF2;HEXB;PDK4;PON2;BDH2;ASAH2
2728,GO:0051649,0.922244224666248,0.31557139230844,1,10,establishment of localization in cell,BP,IFI27
516,GO:0006631,0.923196971378365,0.194058195911615,4,26,fatty acid metabolic process,BP,ACSF2;PDK4;PON2;BDH2
2648,GO:0051179,0.923809337103361,0.180496103054029,5,37,localization,BP,PNP;HEXB;SNX21;IFI27;RNASEL
1282,GO:0019395,0.924615642069987,0.237207086087503,2,16,fatty acid oxidation,BP,PDK4;BDH2
1773,GO:0034440,0.924615642069987,0.237207086087503,2,16,lipid oxidation,BP,PDK4;BDH2
2637,GO:0051128,0.92533713315363,0.304728343060328,1,11,regulation of cellular component organization,BP,HEXB
1667,GO:0032787,0.925866041984602,0.178718876627089,5,30,monocarboxylic acid metabolic process,BP,ACSF2;PDK4;PON2;BDH2;IDUA
2727,GO:0051641,0.926418174122921,0.301807120354041,1,11,cellular localization,BP,IFI27
2572,GO:0050789,0.928481421645494,0.153606299037734,10,60,regulation of biological process,BP,PNP;HEXB;TICAM1;CASP4;PDK4;RBMS3;DHCR7;IFI27;RNASEL;ASAH2
3316,GO:1902531,0.931448435657822,0.287952838626268,1,11,regulation of intracellular signal transduction,BP,TICAM1
369,GO:0005623,0.938465193923728,0.220128287365152,23,119,cell,CC,ACSF2;PNP;HEXB;SNX21;MRI1;CMBL;CYP11A1;HSD3B2;TICAM1;CASP4;HSD17B3;PDK4;RBMS3;PRRT1;AOX1;PON2;DHCR7;HSD17B11;BDH2;IFI27;RNASEL;IDUA;ASAH2
2205,GO:0044464,0.938465193923728,0.220128287365152,23,119,cell part,CC,ACSF2;PNP;HEXB;SNX21;MRI1;CMBL;CYP11A1;HSD3B2;TICAM1;CASP4;HSD17B3;PDK4;RBMS3;PRRT1;AOX1;PON2;DHCR7;HSD17B11;BDH2;IFI27;RNASEL;IDUA;ASAH2
367,GO:0005615,0.940981681167023,0.256723641134567,1,13,extracellular space,CC,HEXB
945,GO:0010647,0.941861585496659,0.254101699174665,1,13,positive regulation of cell communication,BP,TICAM1
1365,GO:0023056,0.941861585496659,0.254101699174665,1,13,positive regulation of signaling,BP,TICAM1
2214,GO:0044707,0.942547564572277,0.13859342855191,6,42,single-multicellular organism process,BP,PNP;HEXB;TICAM1;HSD17B3;PDK4;DHCR7
2774,GO:0055085,0.944099544517216,0.249011178837883,1,12,transmembrane transport,BP,RNASEL
1315,GO:0019899,0.944802895511977,0.248842993884442,1,11,enzyme binding,MF,TICAM1
495,GO:0006520,0.947019274780841,0.24002298145241,1,12,cellular amino acid metabolic process,BP,MRI1
1102,GO:0016054,0.947966748402722,0.179020823371361,2,18,organic acid catabolic process,BP,BDH2;IDUA
2350,GO:0046395,0.947966748402722,0.179020823371361,2,18,carboxylic acid catabolic process,BP,BDH2;IDUA
1614,GO:0032501,0.948688899458042,0.126394260000828,6,43,multicellular organismal process,BP,PNP;HEXB;TICAM1;HSD17B3;PDK4;DHCR7
1302,GO:0019752,0.948744686857771,0.126542679796302,6,41,carboxylic acid metabolic process,BP,ACSF2;MRI1;PDK4;PON2;BDH2;IDUA
2152,GO:0044242,0.95128354570827,0.16967762492495,2,19,cellular lipid catabolic process,BP,HEXB;BDH2
2168,GO:0044282,0.954587531791838,0.160974109828151,2,19,small molecule catabolic process,BP,BDH2;IDUA
2573,GO:0050790,0.95481474910383,0.209175852006832,1,17,regulation of catalytic activity,BP,IFI27
222,GO:0003674,0.961328952329919,0.161685386758059,23,119,molecular_function,MF,ACSF2;PNP;HEXB;SNX21;MRI1;CMBL;CYP11A1;HSD3B2;TICAM1;ACCS;CASP4;HSD17B3;PDK4;RBMS3;AOX1;PON2;DHCR7;HSD17B11;BDH2;IFI27;RNASEL;IDUA;ASAH2
3047,GO:0072330,0.962044193255908,0.194187369680012,1,10,monocarboxylic acid biosynthetic process,BP,PDK4
1421,GO:0030258,0.962203717609381,0.139518848206044,2,20,lipid modification,BP,PDK4;BDH2
518,GO:0006635,0.96477794134127,0.180424254289859,1,12,fatty acid beta-oxidation,BP,BDH2
2141,GO:0044085,0.964982189400736,0.175999989295149,1,15,cellular component biogenesis,BP,RNASEL
319,GO:0005102,0.970742532317679,0.152358380312458,1,18,receptor binding,MF,IDUA
895,GO:0009966,0.979553633628446,0.118026367259609,1,16,regulation of signal transduction,BP,TICAM1
789,GO:0009062,0.980853968377305,0.113884677885643,1,14,fatty acid catabolic process,BP,BDH2
362,GO:0005575,0.982632176083478,0.172077025372478,24,125,cellular_component,CC,ACSF2;PNP;HEXB;SNX21;MRI1;CMBL;CYP11A1;HSD3B2;TICAM1;CASP4;TMEM164;HSD17B3;PDK4;RBMS3;PRRT1;AOX1;PON2;DHCR7;HSD17B11;BDH2;IFI27;RNASEL;IDUA;ASAH2
3018,GO:0071840,0.989047147368898,0.0513140197502617,2,28,cellular component organization or biogenesis,BP,HEXB;RNASEL
352,GO:0005515,0.991934249522735,0.0251635587553453,9,74,protein binding,MF,ACSF2;HEXB;MRI1;TICAM1;ACCS;PON2;IFI27;RNASEL;IDUA
944,GO:0010646,0.994418747113931,0.0424493681023218,1,20,regulation of cell communication,BP,TICAM1
1363,GO:0023051,0.994611871810459,0.0410869405287515,1,21,regulation of signaling,BP,TICAM1
1097,GO:0016043,0.998251706728375,0.0161290510696406,1,27,cellular component organization,BP,HEXB
2170,GO:0044297,0.999999999999999,0.170209287066178,0,7,cell body,CC,
2,GO:0000030,1,0.981296617652802,0,1,mannosyltransferase activity,MF,
3,GO:0000038,1,0.695794073033159,0,1,very long-chain fatty acid metabolic process,BP,
4,GO:0000041,1,0.778136964138319,0,1,transition metal ion transport,BP,
5,GO:0000045,1,0.694113237147052,0,1,autophagosome assembly,BP,
6,GO:0000086,1,0.932766532291112,0,1,G2/M transition of mitotic cell cycle,BP,
10,GO:0000139,1,0.696563650306504,0,1,Golgi membrane,CC,
11,GO:0000165,1,0.50821984453777,0,4,MAPK cascade,BP,
13,GO:0000187,1,0.694332314327877,0,1,activation of MAPK activity,BP,
14,GO:0000209,1,0.786464901776412,0,2,protein polyubiquitination,BP,
15,GO:0000245,1,0.864933823131346,0,1,spliceosomal complex assembly,BP,
16,GO:0000247,1,0.9068568801805,0,1,C-8 sterol isomerase activity,MF,
17,GO:0000248,1,0.694297055380902,0,1,C-5 sterol desaturase activity,MF,
18,GO:0000255,1,0.694332314327877,0,1,allantoin metabolic process,BP,
19,GO:0000278,1,0.932766532291112,0,1,mitotic cell cycle,BP,
20,GO:0000285,1,0.864322510360387,0,1,1-phosphatidylinositol-3-phosphate 5-kinase activity,MF,
21,GO:0000287,1,0.475481595347848,0,3,magnesium ion binding,MF,
22,GO:0000302,1,0.519433456699955,0,2,response to reactive oxygen species,BP,
23,GO:0000303,1,0.747407444585123,0,1,response to superoxide,BP,
24,GO:0000305,1,0.747407444585123,0,1,response to oxygen radical,BP,
25,GO:0000313,1,0.863382075063917,0,2,organellar ribosome,CC,
26,GO:0000315,1,0.863382075063917,0,2,organellar large ribosomal subunit,CC,
28,GO:0000375,1,0.864933823131346,0,1,RNA splicing, via transesterification reactions,BP,
29,GO:0000377,1,0.864933823131346,0,1,RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,BP,
30,GO:0000398,1,0.864933823131346,0,1,mRNA splicing, via spliceosome,BP,
31,GO:0000502,1,0.932766532291112,0,1,proteasome complex,CC,
33,GO:0000904,1,0.327164991205054,0,4,cell morphogenesis involved in differentiation,BP,
34,GO:0000922,1,0.694689250747339,0,1,spindle pole,CC,
35,GO:0000932,1,0.694332314327877,0,1,P-body,CC,
36,GO:0000959,1,0.75055146595722,0,2,mitochondrial RNA metabolic process,BP,
37,GO:0000963,1,0.75055146595722,0,2,mitochondrial RNA processing,BP,
38,GO:0000975,1,0.695903409309486,0,1,regulatory region DNA binding,MF,
39,GO:0000976,1,0.695903409309486,0,1,transcription regulatory region sequence-specific DNA binding,MF,
40,GO:0000977,1,0.695903409309486,0,1,RNA polymerase II regulatory region sequence-specific DNA binding,MF,
41,GO:0000981,1,0.695903409309486,0,1,RNA polymerase II transcription factor activity, sequence-specific DNA binding,MF,
42,GO:0000982,1,0.695903409309486,0,1,transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,
43,GO:0000988,1,0.783822915803807,0,2,transcription factor activity, protein binding,MF,
44,GO:0000989,1,0.783822915803807,0,2,transcription factor activity, transcription factor binding,MF,
45,GO:0001012,1,0.695903409309486,0,1,RNA polymerase II regulatory region DNA binding,MF,
46,GO:0001067,1,0.695903409309486,0,1,regulatory region nucleic acid binding,MF,
47,GO:0001071,1,0.695903409309486,0,1,nucleic acid binding transcription factor activity,MF,
48,GO:0001077,1,0.695903409309486,0,1,transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,
52,GO:0001228,1,0.695903409309486,0,1,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,MF,
54,GO:0001503,1,0.836616111386651,0,1,ossification,BP,
55,GO:0001504,1,0.695099127173731,0,1,neurotransmitter uptake,BP,
56,GO:0001505,1,0.520190401282656,0,2,regulation of neurotransmitter levels,BP,
57,GO:0001510,1,0.936872137023806,0,1,RNA methylation,BP,
58,GO:0001522,1,0.801693816427004,0,1,pseudouridine synthesis,BP,
59,GO:0001523,1,0.939570220896901,0,1,retinoid metabolic process,BP,
60,GO:0001525,1,0.780448033435557,0,2,angiogenesis,BP,
61,GO:0001533,1,0.718768411418121,0,1,cornified envelope,CC,
62,GO:0001541,1,0.933430464161949,0,1,ovarian follicle development,BP,
63,GO:0001556,1,0.933430464161949,0,1,oocyte maturation,BP,
64,GO:0001561,1,0.584363045286179,0,2,fatty acid alpha-oxidation,BP,
67,GO:0001608,1,0.698431002476331,0,1,G-protein coupled nucleotide receptor activity,MF,
68,GO:0001614,1,0.698431002476331,0,1,purinergic nucleotide receptor activity,MF,
70,GO:0001654,1,0.705216484249791,0,2,eye development,BP,
71,GO:0001655,1,0.502208845297894,0,3,urogenital system development,BP,
72,GO:0001656,1,0.719058751904449,0,1,metanephros development,BP,
73,GO:0001659,1,0.708832017662095,0,1,temperature homeostasis,BP,
74,GO:0001664,1,0.924336395971075,0,2,G-protein coupled receptor binding,MF,
75,GO:0001666,1,0.378077335569273,0,6,response to hypoxia,BP,
76,GO:0001667,1,0.836616111386651,0,1,ameboidal-type cell migration,BP,
78,GO:0001676,1,0.480790797629792,0,2,long-chain fatty acid metabolic process,BP,
79,GO:0001678,1,0.522121728666879,0,2,cellular glucose homeostasis,BP,
80,GO:0001726,1,0.910467635192227,0,1,ruffle,CC,
81,GO:0001736,1,0.932766532291112,0,1,establishment of planar polarity,BP,
82,GO:0001738,1,0.932766532291112,0,1,morphogenesis of a polarized epithelium,BP,
83,GO:0001754,1,0.751229237583286,0,1,eye photoreceptor cell differentiation,BP,
84,GO:0001773,1,0.943785593081157,0,1,myeloid dendritic cell activation,BP,
86,GO:0001776,1,0.761888585522679,0,1,leukocyte homeostasis,BP,
89,GO:0001818,1,0.795813072902997,0,2,negative regulation of cytokine production,BP,
91,GO:0001822,1,0.535530861444646,0,2,kidney development,BP,
92,GO:0001836,1,0.815946865122908,0,2,release of cytochrome c from mitochondria,BP,
93,GO:0001848,1,0.697867488744479,0,1,complement binding,MF,
95,GO:0001883,1,0.701667730772414,0,1,purine nucleoside binding,MF,
96,GO:0001889,1,0.535530861444646,0,2,liver development,BP,
97,GO:0001890,1,0.933430464161949,0,1,placenta development,BP,
99,GO:0001906,1,0.761888585522679,0,1,cell killing,BP,
100,GO:0001909,1,0.761888585522679,0,1,leukocyte mediated cytotoxicity,BP,
101,GO:0001910,1,0.761888585522679,0,1,regulation of leukocyte mediated cytotoxicity,BP,
102,GO:0001912,1,0.761888585522679,0,1,positive regulation of leukocyte mediated cytotoxicity,BP,
103,GO:0001913,1,0.761888585522679,0,1,T cell mediated cytotoxicity,BP,
104,GO:0001914,1,0.761888585522679,0,1,regulation of T cell mediated cytotoxicity,BP,
105,GO:0001916,1,0.761888585522679,0,1,positive regulation of T cell mediated cytotoxicity,BP,
106,GO:0001932,1,0.287163776535355,0,6,regulation of protein phosphorylation,BP,
107,GO:0001933,1,0.540160745020479,0,3,negative regulation of protein phosphorylation,BP,
108,GO:0001934,1,0.508589373990247,0,4,positive regulation of protein phosphorylation,BP,
109,GO:0001935,1,0.933430464161949,0,1,endothelial cell proliferation,BP,
110,GO:0001936,1,0.933430464161949,0,1,regulation of endothelial cell proliferation,BP,
111,GO:0001938,1,0.933430464161949,0,1,positive regulation of endothelial cell proliferation,BP,
112,GO:0001942,1,0.843648241871817,0,1,hair follicle development,BP,
114,GO:0001957,1,0.836616111386651,0,1,intramembranous ossification,BP,
115,GO:0001958,1,0.836616111386651,0,1,endochondral ossification,BP,
116,GO:0001959,1,0.521401462268001,0,4,regulation of cytokine-mediated signaling pathway,BP,
117,GO:0001960,1,0.864933823131346,0,1,negative regulation of cytokine-mediated signaling pathway,BP,
118,GO:0001961,1,0.761888585522679,0,1,positive regulation of cytokine-mediated signaling pathway,BP,
119,GO:0001963,1,0.751229237583286,0,1,synaptic transmission, dopaminergic,BP,
120,GO:0001974,1,0.864933823131346,0,1,blood vessel remodeling,BP,
121,GO:0001975,1,0.751229237583286,0,1,response to amphetamine,BP,
122,GO:0002009,1,0.932766532291112,0,1,morphogenesis of an epithelium,BP,
123,GO:0002020,1,0.620166453264176,0,3,protease binding,MF,
124,GO:0002028,1,0.976084701408914,0,1,regulation of sodium ion transport,BP,
127,GO:0002062,1,0.836616111386651,0,1,chondrocyte differentiation,BP,
128,GO:0002063,1,0.836616111386651,0,1,chondrocyte development,BP,
129,GO:0002084,1,0.753988517867515,0,1,protein depalmitoylation,BP,
131,GO:0002220,1,0.932766532291112,0,1,innate immune response activating cell surface receptor signaling pathway,BP,
133,GO:0002223,1,0.932766532291112,0,1,stimulatory C-type lectin receptor signaling pathway,BP,
136,GO:0002250,1,0.718490506941261,0,2,adaptive immune response,BP,
139,GO:0002260,1,0.761888585522679,0,1,lymphocyte homeostasis,BP,
143,GO:0002277,1,0.943785593081157,0,1,myeloid dendritic cell activation involved in immune response,BP,
148,GO:0002377,1,0.939570220896901,0,1,immunoglobulin production,BP,
149,GO:0002429,1,0.932766532291112,0,1,immune response-activating cell surface receptor signaling pathway,BP,
150,GO:0002440,1,0.939570220896901,0,1,production of molecular mediator of immune response,BP,
154,GO:0002449,1,0.761888585522679,0,1,lymphocyte mediated immunity,BP,
155,GO:0002456,1,0.761888585522679,0,1,T cell mediated immunity,BP,
156,GO:0002460,1,0.761888585522679,0,1,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
157,GO:0002474,1,0.863091121236512,0,2,antigen processing and presentation of peptide antigen via MHC class I,BP,
158,GO:0002478,1,0.863091121236512,0,2,antigen processing and presentation of exogenous peptide antigen,BP,
159,GO:0002479,1,0.932766532291112,0,1,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,
160,GO:0002495,1,0.87332096336581,0,2,antigen processing and presentation of peptide antigen via MHC class II,BP,
161,GO:0002504,1,0.87332096336581,0,2,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
164,GO:0002526,1,0.697867488744479,0,1,acute inflammatory response,BP,
165,GO:0002573,1,0.761888585522679,0,1,myeloid leukocyte differentiation,BP,
166,GO:0002577,1,0.943785593081157,0,1,regulation of antigen processing and presentation,BP,
167,GO:0002579,1,0.943785593081157,0,1,positive regulation of antigen processing and presentation,BP,
168,GO:0002580,1,0.943785593081157,0,1,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
169,GO:0002582,1,0.943785593081157,0,1,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
170,GO:0002583,1,0.943785593081157,0,1,regulation of antigen processing and presentation of peptide antigen,BP,
171,GO:0002585,1,0.943785593081157,0,1,positive regulation of antigen processing and presentation of peptide antigen,BP,
172,GO:0002586,1,0.943785593081157,0,1,regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
173,GO:0002588,1,0.943785593081157,0,1,positive regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
174,GO:0002637,1,0.939570220896901,0,1,regulation of immunoglobulin production,BP,
175,GO:0002639,1,0.939570220896901,0,1,positive regulation of immunoglobulin production,BP,
176,GO:0002673,1,0.697867488744479,0,1,regulation of acute inflammatory response,BP,
180,GO:0002685,1,0.718490506941261,0,2,regulation of leukocyte migration,BP,
181,GO:0002687,1,0.718490506941261,0,2,positive regulation of leukocyte migration,BP,
182,GO:0002691,1,0.761888585522679,0,1,regulation of cellular extravasation,BP,
183,GO:0002693,1,0.761888585522679,0,1,positive regulation of cellular extravasation,BP,
186,GO:0002697,1,0.496803609755928,0,3,regulation of immune effector process,BP,
187,GO:0002699,1,0.71525169541569,0,2,positive regulation of immune effector process,BP,
188,GO:0002700,1,0.939570220896901,0,1,regulation of production of molecular mediator of immune response,BP,
189,GO:0002702,1,0.939570220896901,0,1,positive regulation of production of molecular mediator of immune response,BP,
190,GO:0002703,1,0.761888585522679,0,1,regulation of leukocyte mediated immunity,BP,
191,GO:0002705,1,0.761888585522679,0,1,positive regulation of leukocyte mediated immunity,BP,
192,GO:0002706,1,0.761888585522679,0,1,regulation of lymphocyte mediated immunity,BP,
193,GO:0002708,1,0.761888585522679,0,1,positive regulation of lymphocyte mediated immunity,BP,
194,GO:0002709,1,0.761888585522679,0,1,regulation of T cell mediated immunity,BP,
195,GO:0002711,1,0.761888585522679,0,1,positive regulation of T cell mediated immunity,BP,
199,GO:0002761,1,0.761888585522679,0,1,regulation of myeloid leukocyte differentiation,BP,
200,GO:0002763,1,0.761888585522679,0,1,positive regulation of myeloid leukocyte differentiation,BP,
202,GO:0002768,1,0.932766532291112,0,1,immune response-regulating cell surface receptor signaling pathway,BP,
204,GO:0002791,1,0.575716379805678,0,4,regulation of peptide secretion,BP,
205,GO:0002793,1,0.575716379805678,0,4,positive regulation of peptide secretion,BP,
206,GO:0002819,1,0.718490506941261,0,2,regulation of adaptive immune response,BP,
207,GO:0002821,1,0.718490506941261,0,2,positive regulation of adaptive immune response,BP,
208,GO:0002822,1,0.761888585522679,0,1,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
209,GO:0002824,1,0.761888585522679,0,1,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
210,GO:0002920,1,0.697867488744479,0,1,regulation of humoral immune response,BP,
211,GO:0002931,1,0.864933823131346,0,1,response to ischemia,BP,
213,GO:0003007,1,0.705216484249791,0,2,heart morphogenesis,BP,
215,GO:0003012,1,0.738467670079547,0,3,muscle system process,BP,
216,GO:0003013,1,0.732894496640572,0,2,circulatory system process,BP,
217,GO:0003014,1,0.695903409309486,0,1,renal system process,BP,
218,GO:0003015,1,0.732894496640572,0,2,heart process,BP,
219,GO:0003205,1,0.939570220896901,0,1,cardiac chamber development,BP,
220,GO:0003206,1,0.939570220896901,0,1,cardiac chamber morphogenesis,BP,
221,GO:0003333,1,0.695099127173731,0,1,amino acid transmembrane transport,BP,
224,GO:0003677,1,0.447637538927755,0,3,DNA binding,MF,
225,GO:0003690,1,0.695903409309486,0,1,double-stranded DNA binding,MF,
226,GO:0003700,1,0.695903409309486,0,1,transcription factor activity, sequence-specific DNA binding,MF,
227,GO:0003712,1,0.783822915803807,0,2,transcription cofactor activity,MF,
228,GO:0003713,1,0.92965217786867,0,1,transcription coactivator activity,MF,
232,GO:0003735,1,0.863382075063917,0,2,structural constituent of ribosome,MF,
233,GO:0003746,1,0.736460913827081,0,1,translation elongation factor activity,MF,
234,GO:0003779,1,0.595162874788212,0,3,actin binding,MF,
237,GO:0003857,1,0.936872137023806,0,1,3-hydroxyacyl-CoA dehydrogenase activity,MF,
239,GO:0003874,1,0.939074574481556,0,1,6-pyruvoyltetrahydropterin synthase activity,MF,
241,GO:0003985,1,0.59386006440258,0,2,acetyl-CoA C-acetyltransferase activity,MF,
242,GO:0003986,1,0.928823333484811,0,1,acetyl-CoA hydrolase activity,MF,
243,GO:0003988,1,0.440232712928276,0,3,acetyl-CoA C-acyltransferase activity,MF,
244,GO:0003993,1,0.821260517451259,0,1,acid phosphatase activity,MF,
245,GO:0003995,1,0.708832017662095,0,1,acyl-CoA dehydrogenase activity,MF,
248,GO:0004033,1,0.952054095564578,0,1,aldo-keto reductase (NADP) activity,MF,
250,GO:0004095,1,0.483162738064911,0,2,carnitine O-palmitoyltransferase activity,MF,
251,GO:0004129,1,0.952054095564578,0,1,cytochrome-c oxidase activity,MF,
252,GO:0004139,1,0.788063762325555,0,1,deoxyribose-phosphate aldolase activity,MF,
253,GO:0004165,1,0.769211113770212,0,1,dodecenoyl-CoA delta-isomerase activity,MF,
254,GO:0004174,1,0.704322975564546,0,1,electron-transferring-flavoprotein dehydrogenase activity,MF,
256,GO:0004177,1,0.753245494607556,0,1,aminopeptidase activity,MF,
257,GO:0004180,1,0.753245494607556,0,1,carboxypeptidase activity,MF,
258,GO:0004181,1,0.753245494607556,0,1,metallocarboxypeptidase activity,MF,
260,GO:0004252,1,0.697867488744479,0,1,serine-type endopeptidase activity,MF,
261,GO:0004298,1,0.932766532291112,0,1,threonine-type endopeptidase activity,MF,
262,GO:0004300,1,0.693648719675919,0,2,enoyl-CoA hydratase activity,MF,
264,GO:0004312,1,0.695794073033159,0,1,fatty acid synthase activity,MF,
265,GO:0004321,1,0.701667730772414,0,1,fatty-acyl-CoA synthase activity,MF,
266,GO:0004341,1,0.747407444585123,0,1,gluconolactonase activity,MF,
267,GO:0004364,1,0.954268878312379,0,1,glutathione transferase activity,MF,
268,GO:0004448,1,0.705287574490218,0,1,isocitrate dehydrogenase activity,MF,
269,GO:0004450,1,0.705287574490218,0,1,isocitrate dehydrogenase (NADP+) activity,MF,
270,GO:0004457,1,0.730609063525042,0,1,lactate dehydrogenase activity,MF,
271,GO:0004458,1,0.730609063525042,0,1,D-lactate dehydrogenase (cytochrome) activity,MF,
272,GO:0004464,1,0.954268878312379,0,1,leukotriene-C4 synthase activity,MF,
273,GO:0004466,1,0.708832017662095,0,1,long-chain-acyl-CoA dehydrogenase activity,MF,
274,GO:0004470,1,0.886207777244638,0,1,malic enzyme activity,MF,
276,GO:0004505,1,0.92965217786867,0,1,phenylalanine 4-monooxygenase activity,MF,
277,GO:0004508,1,0.757779355427395,0,1,steroid 17-alpha-monooxygenase activity,MF,
278,GO:0004511,1,0.751229237583286,0,1,tyrosine 3-monooxygenase activity,MF,
284,GO:0004557,1,0.856884470493401,0,1,alpha-galactosidase activity,MF,
286,GO:0004576,1,0.904259787207722,0,1,oligosaccharyl transferase activity,MF,
287,GO:0004581,1,0.904259787207722,0,1,dolichyl-phosphate beta-glucosyltransferase activity,MF,
288,GO:0004582,1,0.981296617652802,0,1,dolichyl-phosphate beta-D-mannosyltransferase activity,MF,
289,GO:0004601,1,0.954268878312379,0,1,peroxidase activity,MF,
290,GO:0004602,1,0.954268878312379,0,1,glutathione peroxidase activity,MF,
291,GO:0004620,1,0.671366140734006,0,2,phospholipase activity,MF,
292,GO:0004622,1,0.753988517867515,0,1,lysophospholipase activity,MF,
293,GO:0004623,1,0.891636723651273,0,1,phospholipase A2 activity,MF,
295,GO:0004713,1,0.836616111386651,0,1,protein tyrosine kinase activity,MF,
296,GO:0004721,1,0.964984050020043,0,1,phosphoprotein phosphatase activity,MF,
297,GO:0004725,1,0.964984050020043,0,1,protein tyrosine phosphatase activity,MF,
298,GO:0004730,1,0.801693816427004,0,1,pseudouridylate synthase activity,MF,
303,GO:0004857,1,0.591166194847141,0,3,enzyme inhibitor activity,MF,
304,GO:0004859,1,0.980476126491385,0,1,phospholipase inhibitor activity,MF,
305,GO:0004866,1,0.603434602546963,0,2,endopeptidase inhibitor activity,MF,
306,GO:0004867,1,0.699109736897407,0,1,serine-type endopeptidase inhibitor activity,MF,
307,GO:0004869,1,0.864933823131346,0,1,cysteine-type endopeptidase inhibitor activity,MF,
309,GO:0004872,1,0.29947561182879,0,4,receptor activity,MF,
310,GO:0004888,1,0.29947561182879,0,4,transmembrane signaling receptor activity,MF,
311,GO:0004896,1,0.694332314327877,0,1,cytokine receptor activity,MF,
312,GO:0004930,1,0.698431002476331,0,1,G-protein coupled receptor activity,MF,
313,GO:0004970,1,0.694072074177941,0,1,ionotropic glutamate receptor activity,MF,
314,GO:0004971,1,0.694072074177941,0,1,AMPA glutamate receptor activity,MF,
315,GO:0005057,1,0.754361961097869,0,1,signal transducer activity, downstream of receptor,MF,
316,GO:0005085,1,0.836616111386651,0,1,guanyl-nucleotide exchange factor activity,MF,
317,GO:0005088,1,0.836616111386651,0,1,Ras guanyl-nucleotide exchange factor activity,MF,
318,GO:0005096,1,0.694113237147052,0,1,GTPase activator activity,MF,
320,GO:0005104,1,0.836616111386651,0,1,fibroblast growth factor receptor binding,MF,
321,GO:0005105,1,0.836616111386651,0,1,type 1 fibroblast growth factor receptor binding,MF,
322,GO:0005111,1,0.836616111386651,0,1,type 2 fibroblast growth factor receptor binding,MF,
323,GO:0005123,1,0.657928246177915,0,2,death receptor binding,MF,
324,GO:0005126,1,0.505065957794468,0,5,cytokine receptor binding,MF,
325,GO:0005138,1,0.943785593081157,0,1,interleukin-6 receptor binding,MF,
326,GO:0005154,1,0.696728333256898,0,1,epidermal growth factor receptor binding,MF,
327,GO:0005158,1,0.754361961097869,0,1,insulin receptor binding,MF,
328,GO:0005164,1,0.641588149434177,0,2,tumor necrosis factor receptor binding,MF,
329,GO:0005198,1,0.619174974565623,0,3,structural molecule activity,MF,
330,GO:0005215,1,0.122967202605545,0,10,transporter activity,MF,
331,GO:0005216,1,0.677042443569163,0,2,ion channel activity,MF,
332,GO:0005230,1,0.694072074177941,0,1,extracellular ligand-gated ion channel activity,MF,
333,GO:0005231,1,0.694072074177941,0,1,excitatory extracellular ligand-gated ion channel activity,MF,
334,GO:0005234,1,0.694072074177941,0,1,extracellular-glutamate-gated ion channel activity,MF,
335,GO:0005253,1,0.976084701408914,0,1,anion channel activity,MF,
336,GO:0005254,1,0.976084701408914,0,1,chloride channel activity,MF,
337,GO:0005261,1,0.694072074177941,0,1,cation channel activity,MF,
338,GO:0005310,1,0.695099127173731,0,1,dicarboxylic acid transmembrane transporter activity,MF,
339,GO:0005313,1,0.695099127173731,0,1,L-glutamate transmembrane transporter activity,MF,
340,GO:0005314,1,0.695099127173731,0,1,high-affinity glutamate transmembrane transporter activity,MF,
341,GO:0005319,1,0.414213327509184,0,4,lipid transporter activity,MF,
342,GO:0005324,1,0.916336727632546,0,1,long-chain fatty acid transporter activity,MF,
343,GO:0005342,1,0.695099127173731,0,1,organic acid transmembrane transporter activity,MF,
344,GO:0005375,1,0.778136964138319,0,1,copper ion transmembrane transporter activity,MF,
346,GO:0005496,1,0.48368524984853,0,2,steroid binding,MF,
347,GO:0005501,1,0.939570220896901,0,1,retinoid binding,MF,
348,GO:0005504,1,0.898308432523336,0,2,fatty acid binding,MF,
350,GO:0005507,1,0.933430464161949,0,1,copper ion binding,MF,
351,GO:0005509,1,0.406527036613408,0,4,calcium ion binding,MF,
354,GO:0005523,1,0.826321000735877,0,2,tropomyosin binding,MF,
356,GO:0005525,1,0.701667730772414,0,1,GTP binding,MF,
357,GO:0005539,1,0.933430464161949,0,1,glycosaminoglycan binding,MF,
359,GO:0005544,1,0.698348976994063,0,1,calcium-dependent phospholipid binding,MF,
361,GO:0005548,1,0.696563650306504,0,1,phospholipid transporter activity,MF,
364,GO:0005578,1,0.649588788569117,0,2,proteinaceous extracellular matrix,CC,
365,GO:0005604,1,0.933430464161949,0,1,basement membrane,CC,
366,GO:0005605,1,0.933430464161949,0,1,basal lamina,CC,
383,GO:0005761,1,0.863382075063917,0,2,mitochondrial ribosome,CC,
384,GO:0005762,1,0.863382075063917,0,2,mitochondrial large ribosomal subunit,CC,
389,GO:0005770,1,0.778136964138319,0,1,late endosome,CC,
393,GO:0005777,1,0.159297746449074,0,8,peroxisome,CC,
394,GO:0005778,1,0.434271669536358,0,4,peroxisomal membrane,CC,
395,GO:0005782,1,0.378968750988072,0,4,peroxisomal matrix,CC,
399,GO:0005793,1,0.969995247214235,0,1,endoplasmic reticulum-Golgi intermediate compartment,CC,
400,GO:0005794,1,0.356804274038976,0,4,Golgi apparatus,CC,
402,GO:0005815,1,0.505209355136079,0,2,microtubule organizing center,CC,
403,GO:0005819,1,0.694689250747339,0,1,spindle,CC,
405,GO:0005839,1,0.932766532291112,0,1,proteasome core complex,CC,
406,GO:0005840,1,0.863382075063917,0,2,ribosome,CC,
408,GO:0005865,1,0.875900879520659,0,1,striated muscle thin filament,CC,
409,GO:0005874,1,0.694689250747339,0,1,microtubule,CC,
410,GO:0005882,1,0.718768411418121,0,1,intermediate filament,CC,
412,GO:0005887,1,0.103967732805221,0,8,integral component of plasma membrane,CC,
413,GO:0005890,1,0.976084701408914,0,1,sodium:potassium-exchanging ATPase complex,CC,
414,GO:0005912,1,0.864322510360387,0,1,adherens junction,CC,
415,GO:0005924,1,0.864322510360387,0,1,cell-substrate adherens junction,CC,
416,GO:0005925,1,0.864322510360387,0,1,focal adhesion,CC,
417,GO:0005938,1,0.694689250747339,0,1,cell cortex,CC,
422,GO:0006011,1,0.873547569641283,0,1,UDP-glucose metabolic process,BP,
423,GO:0006012,1,0.873547569641283,0,1,galactose metabolic process,BP,
425,GO:0006023,1,0.694623670811036,0,1,aminoglycan biosynthetic process,BP,
426,GO:0006024,1,0.694623670811036,0,1,glycosaminoglycan biosynthetic process,BP,
431,GO:0006081,1,0.381964938489128,0,3,cellular aldehyde metabolic process,BP,
437,GO:0006091,1,0.27875957653797,0,5,generation of precursor metabolites and energy,BP,
438,GO:0006094,1,0.83231945072769,0,2,gluconeogenesis,BP,
439,GO:0006097,1,0.705287574490218,0,1,glyoxylate cycle,BP,
440,GO:0006098,1,0.545804209021376,0,2,pentose-phosphate shunt,BP,
441,GO:0006099,1,0.623947206499021,0,2,tricarboxylic acid cycle,BP,
442,GO:0006101,1,0.43043938235757,0,3,citrate metabolic process,BP,
443,GO:0006102,1,0.705287574490218,0,1,isocitrate metabolic process,BP,
444,GO:0006103,1,0.388675094932522,0,3,2-oxoglutarate metabolic process,BP,
445,GO:0006105,1,0.694332314327877,0,1,succinate metabolic process,BP,
446,GO:0006107,1,0.614210537123151,0,2,oxaloacetate metabolic process,BP,
447,GO:0006108,1,0.886207777244638,0,1,malate metabolic process,BP,
450,GO:0006140,1,0.953041941460832,0,1,regulation of nucleotide metabolic process,BP,
456,GO:0006164,1,0.684717250127041,0,2,purine nucleotide biosynthetic process,BP,
457,GO:0006171,1,0.953041941460832,0,1,cAMP biosynthetic process,BP,
459,GO:0006258,1,0.873547569641283,0,1,UDP-glucose catabolic process,BP,
460,GO:0006259,1,0.677826465352411,0,2,DNA metabolic process,BP,
461,GO:0006260,1,0.908015415755097,0,1,DNA replication,BP,
462,GO:0006308,1,0.747407444585123,0,1,DNA catabolic process,BP,
464,GO:0006352,1,0.695903409309486,0,1,DNA-templated transcription, initiation,BP,
465,GO:0006354,1,0.736460913827081,0,1,DNA-templated transcription, elongation,BP,
470,GO:0006367,1,0.695903409309486,0,1,transcription initiation from RNA polymerase II promoter,BP,
471,GO:0006376,1,0.864933823131346,0,1,mRNA splice site selection,BP,
474,GO:0006399,1,0.575554872884352,0,3,tRNA metabolic process,BP,
475,GO:0006400,1,0.75055146595722,0,2,tRNA modification,BP,
477,GO:0006414,1,0.634514931652741,0,3,translational elongation,BP,
478,GO:0006415,1,0.863382075063917,0,2,translational termination,BP,
480,GO:0006461,1,0.119736598725994,0,11,protein complex assembly,BP,
483,GO:0006469,1,0.540160745020479,0,3,negative regulation of protein kinase activity,BP,
484,GO:0006470,1,0.720785977006769,0,2,protein dephosphorylation,BP,
485,GO:0006479,1,0.914461546570485,0,1,protein methylation,BP,
486,GO:0006486,1,0.614948783441457,0,3,protein glycosylation,BP,
487,GO:0006487,1,0.887195742142593,0,2,protein N-linked glycosylation,BP,
488,GO:0006493,1,0.981296617652802,0,1,protein O-linked glycosylation,BP,
489,GO:0006497,1,0.981296617652802,0,1,protein lipidation,BP,
490,GO:0006505,1,0.981296617652802,0,1,GPI anchor metabolic process,BP,
491,GO:0006506,1,0.981296617652802,0,1,GPI anchor biosynthetic process,BP,
493,GO:0006511,1,0.932766532291112,0,1,ubiquitin-dependent protein catabolic process,BP,
496,GO:0006521,1,0.932766532291112,0,1,regulation of cellular amino acid metabolic process,BP,
497,GO:0006536,1,0.695099127173731,0,1,glutamate metabolic process,BP,
498,GO:0006537,1,0.695099127173731,0,1,glutamate biosynthetic process,BP,
499,GO:0006549,1,0.497092625534475,0,2,isoleucine metabolic process,BP,
500,GO:0006550,1,0.719058751904449,0,1,isoleucine catabolic process,BP,
502,GO:0006558,1,0.92965217786867,0,1,L-phenylalanine metabolic process,BP,
503,GO:0006559,1,0.92965217786867,0,1,L-phenylalanine catabolic process,BP,
504,GO:0006570,1,0.751229237583286,0,1,tyrosine metabolic process,BP,
505,GO:0006573,1,0.694332314327877,0,1,valine metabolic process,BP,
506,GO:0006575,1,0.283463452697522,0,5,cellular modified amino acid metabolic process,BP,
507,GO:0006576,1,0.69574435000495,0,1,cellular biogenic amine metabolic process,BP,
508,GO:0006577,1,0.697202049102828,0,1,amino-acid betaine metabolic process,BP,
509,GO:0006584,1,0.751229237583286,0,1,catecholamine metabolic process,BP,
510,GO:0006585,1,0.751229237583286,0,1,dopamine biosynthetic process from tyrosine,BP,
511,GO:0006600,1,0.694332314327877,0,1,creatine metabolic process,BP,
512,GO:0006605,1,0.864933823131346,0,1,protein targeting,BP,
513,GO:0006606,1,0.864933823131346,0,1,protein import into nucleus,BP,
519,GO:0006636,1,0.694297055380902,0,1,unsaturated fatty acid biosynthetic process,BP,
521,GO:0006638,1,0.555673682123163,0,5,neutral lipid metabolic process,BP,
522,GO:0006639,1,0.555673682123163,0,5,acylglycerol metabolic process,BP,
523,GO:0006641,1,0.596415497343883,0,4,triglyceride metabolic process,BP,
526,GO:0006650,1,0.564743096580077,0,6,glycerophospholipid metabolic process,BP,
527,GO:0006651,1,0.933430464161949,0,1,diacylglycerol biosynthetic process,BP,
528,GO:0006656,1,0.916336727632546,0,1,phosphatidylcholine biosynthetic process,BP,
529,GO:0006658,1,0.891636723651273,0,1,phosphatidylserine metabolic process,BP,
530,GO:0006661,1,0.820731790099378,0,2,phosphatidylinositol biosynthetic process,BP,
531,GO:0006662,1,0.891636723651273,0,1,glycerol ether metabolic process,BP,
535,GO:0006677,1,0.856884470493401,0,1,glycosylceramide metabolic process,BP,
539,GO:0006691,1,0.954268878312379,0,1,leukotriene metabolic process,BP,
542,GO:0006699,1,0.697654729170719,0,1,bile acid biosynthetic process,BP,
550,GO:0006720,1,0.292339612631389,0,5,isoprenoid metabolic process,BP,
551,GO:0006721,1,0.493170563990898,0,3,terpenoid metabolic process,BP,
553,GO:0006729,1,0.872778904713787,0,2,tetrahydrobiopterin biosynthetic process,BP,
556,GO:0006734,1,0.886207777244638,0,1,NADH metabolic process,BP,
558,GO:0006739,1,0.381964938489128,0,3,NADP metabolic process,BP,
559,GO:0006740,1,0.705287574490218,0,1,NADPH regeneration,BP,
560,GO:0006749,1,0.672447065799838,0,2,glutathione metabolic process,BP,
561,GO:0006750,1,0.954268878312379,0,1,glutathione biosynthetic process,BP,
565,GO:0006771,1,0.821260517451259,0,1,riboflavin metabolic process,BP,
571,GO:0006801,1,0.747407444585123,0,1,superoxide metabolic process,BP,
576,GO:0006811,1,0.0890499987480886,0,11,ion transport,BP,
577,GO:0006812,1,0.463171829320582,0,5,cation transport,BP,
578,GO:0006814,1,0.976084701408914,0,1,sodium ion transport,BP,
579,GO:0006816,1,0.645356071201875,0,2,calcium ion transport,BP,
580,GO:0006818,1,0.952054095564578,0,1,hydrogen transport,BP,
581,GO:0006820,1,0.288973541043601,0,6,anion transport,BP,
582,GO:0006821,1,0.976084701408914,0,1,chloride transport,BP,
583,GO:0006825,1,0.778136964138319,0,1,copper ion transport,BP,
584,GO:0006835,1,0.695099127173731,0,1,dicarboxylic acid transport,BP,
585,GO:0006836,1,0.520190401282656,0,2,neurotransmitter transport,BP,
586,GO:0006839,1,0.445558376452278,0,3,mitochondrial transport,BP,
587,GO:0006853,1,0.696271990189966,0,1,carnitine shuttle,BP,
588,GO:0006855,1,0.9068568801805,0,1,drug transmembrane transport,BP,
589,GO:0006865,1,0.695099127173731,0,1,amino acid transport,BP,
590,GO:0006869,1,0.278766473201403,0,6,lipid transport,BP,
594,GO:0006878,1,0.778136964138319,0,1,cellular copper ion homeostasis,BP,
598,GO:0006888,1,0.969995247214235,0,1,ER to Golgi vesicle-mediated transport,BP,
599,GO:0006897,1,0.641389294337254,0,3,endocytosis,BP,
600,GO:0006898,1,0.980476126491385,0,1,receptor-mediated endocytosis,BP,
601,GO:0006906,1,0.694113237147052,0,1,vesicle fusion,BP,
602,GO:0006907,1,0.943785593081157,0,1,pinocytosis,BP,
603,GO:0006909,1,0.943785593081157,0,1,phagocytosis,BP,
608,GO:0006924,1,0.761888585522679,0,1,activation-induced cell death of T cells,BP,
610,GO:0006935,1,0.629865537308081,0,2,chemotaxis,BP,
611,GO:0006936,1,0.854743634370674,0,2,muscle contraction,BP,
616,GO:0006956,1,0.697867488744479,0,1,complement activation,BP,
617,GO:0006957,1,0.697867488744479,0,1,complement activation, alternative pathway,BP,
618,GO:0006959,1,0.650185775409981,0,2,humoral immune response,BP,
619,GO:0006970,1,0.751229237583286,0,1,response to osmotic stress,BP,
620,GO:0006974,1,0.943785593081157,0,1,cellular response to DNA damage stimulus,BP,
622,GO:0006986,1,0.708832017662095,0,1,response to unfolded protein,BP,
624,GO:0007005,1,0.452608888374528,0,5,mitochondrion organization,BP,
625,GO:0007006,1,0.64378764821232,0,2,mitochondrial membrane organization,BP,
626,GO:0007010,1,0.770761955450571,0,3,cytoskeleton organization,BP,
627,GO:0007015,1,0.770761955450571,0,3,actin filament organization,BP,
628,GO:0007031,1,0.891636723651273,0,1,peroxisome organization,BP,
631,GO:0007049,1,0.831341880353266,0,2,cell cycle,BP,
635,GO:0007164,1,0.932766532291112,0,1,establishment of tissue polarity,BP,
640,GO:0007173,1,0.754361961097869,0,1,epidermal growth factor receptor signaling pathway,BP,
641,GO:0007186,1,0.485486121497603,0,2,G-protein coupled receptor signaling pathway,BP,
642,GO:0007202,1,0.933430464161949,0,1,activation of phospholipase C activity,BP,
643,GO:0007204,1,0.864933823131346,0,1,positive regulation of cytosolic calcium ion concentration,BP,
644,GO:0007215,1,0.694072074177941,0,1,glutamate receptor signaling pathway,BP,
646,GO:0007254,1,0.943785593081157,0,1,JNK cascade,BP,
647,GO:0007259,1,0.584363043782668,0,2,JAK-STAT cascade,BP,
648,GO:0007260,1,0.694332314327877,0,1,tyrosine phosphorylation of STAT protein,BP,
649,GO:0007264,1,0.754361961097869,0,1,small GTPase mediated signal transduction,BP,
650,GO:0007265,1,0.754361961097869,0,1,Ras protein signal transduction,BP,
651,GO:0007267,1,0.0768773274807505,0,10,cell-cell signaling,BP,
652,GO:0007268,1,0.159966161023842,0,6,chemical synaptic transmission,BP,
653,GO:0007270,1,0.751229237583286,0,1,neuron-neuron synaptic transmission,BP,
658,GO:0007283,1,0.747407444585123,0,1,spermatogenesis,BP,
662,GO:0007346,1,0.932766532291112,0,1,regulation of mitotic cell cycle,BP,
663,GO:0007368,1,0.904259787207722,0,1,determination of left/right symmetry,BP,
664,GO:0007389,1,0.904259787207722,0,1,pattern specification process,BP,
666,GO:0007409,1,0.475473553676654,0,3,axonogenesis,BP,
667,GO:0007411,1,0.754361961097869,0,1,axon guidance,BP,
668,GO:0007417,1,0.31609616138244,0,5,central nervous system development,BP,
669,GO:0007420,1,0.372489062350937,0,3,brain development,BP,
670,GO:0007423,1,0.705216484249791,0,2,sensory organ development,BP,
671,GO:0007507,1,0.705216484249791,0,2,heart development,BP,
672,GO:0007517,1,0.85516985302707,0,2,muscle organ development,BP,
673,GO:0007519,1,0.910467635192227,0,1,skeletal muscle tissue development,BP,
675,GO:0007568,1,0.55973408399933,0,2,aging,BP,
676,GO:0007584,1,0.697654729170719,0,1,response to nutrient,BP,
677,GO:0007586,1,0.939570220896901,0,1,digestion,BP,
678,GO:0007596,1,0.482943756904327,0,2,blood coagulation,BP,
679,GO:0007598,1,0.699109736897407,0,1,blood coagulation, extrinsic pathway,BP,
680,GO:0007599,1,0.482943756904327,0,2,hemostasis,BP,
682,GO:0007601,1,0.705216484249791,0,2,visual perception,BP,
685,GO:0007611,1,0.683163917658201,0,2,learning or memory,BP,
686,GO:0007612,1,0.751229237583286,0,1,learning,BP,
687,GO:0007613,1,0.683163917658201,0,2,memory,BP,
691,GO:0007622,1,0.522121728666879,0,2,rhythmic behavior,BP,
692,GO:0007623,1,0.522121728666879,0,2,circadian rhythm,BP,
694,GO:0007631,1,0.751229237583286,0,1,feeding behavior,BP,
695,GO:0007638,1,0.695099127173731,0,1,mechanosensory behavior,BP,
696,GO:0008015,1,0.732894496640572,0,2,blood circulation,BP,
697,GO:0008016,1,0.732894496640572,0,2,regulation of heart contraction,BP,
698,GO:0008021,1,0.751229237583286,0,1,synaptic vesicle,CC,
699,GO:0008033,1,0.575554872884352,0,3,tRNA processing,BP,
700,GO:0008047,1,0.611128323727397,0,4,enzyme activator activity,MF,
702,GO:0008064,1,0.826321000735877,0,2,regulation of actin polymerization or depolymerization,BP,
703,GO:0008066,1,0.694072074177941,0,1,glutamate receptor activity,MF,
704,GO:0008083,1,0.764222285658421,0,2,growth factor activity,MF,
705,GO:0008092,1,0.21951906248115,0,8,cytoskeletal protein binding,MF,
707,GO:0008108,1,0.873547569641283,0,1,UDP-glucose:hexose-1-phosphate uridylyltransferase activity,MF,
708,GO:0008112,1,0.822633999518179,0,1,nicotinamide N-methyltransferase activity,MF,
709,GO:0008113,1,0.843430501767646,0,1,peptide-methionine (S)-S-oxide reductase activity,MF,
710,GO:0008124,1,0.92965217786867,0,1,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,MF,
712,GO:0008135,1,0.736460913827081,0,1,translation factor activity, RNA binding,MF,
716,GO:0008154,1,0.770761955450571,0,3,actin polymerization or depolymerization,BP,
717,GO:0008168,1,0.822633999518179,0,1,methyltransferase activity,MF,
718,GO:0008170,1,0.822633999518179,0,1,N-methyltransferase activity,MF,
720,GO:0008198,1,0.491755540518806,0,3,ferrous iron binding,MF,
721,GO:0008199,1,0.615609281327187,0,2,ferric iron binding,MF,
722,GO:0008201,1,0.933430464161949,0,1,heparin binding,MF,
725,GO:0008206,1,0.697654729170719,0,1,bile acid metabolic process,BP,
731,GO:0008213,1,0.914461546570485,0,1,protein alkylation,BP,
735,GO:0008235,1,0.753245494607556,0,1,metalloexopeptidase activity,MF,
736,GO:0008236,1,0.697867488744479,0,1,serine-type peptidase activity,MF,
737,GO:0008237,1,0.753245494607556,0,1,metallopeptidase activity,MF,
738,GO:0008238,1,0.753245494607556,0,1,exopeptidase activity,MF,
739,GO:0008270,1,0.59240759605829,0,3,zinc ion binding,MF,
740,GO:0008277,1,0.698348976994063,0,1,regulation of G-protein coupled receptor protein signaling pathway,BP,
743,GO:0008285,1,0.552668057743361,0,5,negative regulation of cell proliferation,BP,
746,GO:0008324,1,0.352353079793662,0,4,cation transmembrane transporter activity,MF,
747,GO:0008328,1,0.481617645613711,0,2,ionotropic glutamate receptor complex,CC,
750,GO:0008361,1,0.769211113770212,0,1,regulation of cell size,BP,
752,GO:0008374,1,0.483162738064911,0,2,O-acyltransferase activity,MF,
754,GO:0008380,1,0.750237599884948,0,2,RNA splicing,BP,
755,GO:0008385,1,0.943785593081157,0,1,IkappaB kinase complex,CC,
758,GO:0008406,1,0.456148756607111,0,3,gonad development,BP,
759,GO:0008474,1,0.753988517867515,0,1,palmitoyl-(protein) hydrolase activity,MF,
760,GO:0008480,1,0.69574435000495,0,1,sarcosine dehydrogenase activity,MF,
761,GO:0008509,1,0.678045978536181,0,2,anion transmembrane transporter activity,MF,
762,GO:0008514,1,0.695099127173731,0,1,organic anion transmembrane transporter activity,MF,
763,GO:0008543,1,0.836616111386651,0,1,fibroblast growth factor receptor signaling pathway,BP,
764,GO:0008544,1,0.605058501875226,0,2,epidermis development,BP,
765,GO:0008565,1,0.696563650306504,0,1,protein transporter activity,MF,
766,GO:0008584,1,0.697654729170719,0,1,male gonad development,BP,
767,GO:0008585,1,0.657593481630454,0,2,female gonad development,BP,
769,GO:0008625,1,0.641588149434177,0,2,extrinsic apoptotic signaling pathway via death domain receptors,BP,
770,GO:0008630,1,0.943785593081157,0,1,intrinsic apoptotic signaling pathway in response to DNA damage,BP,
771,GO:0008631,1,0.864933823131346,0,1,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
772,GO:0008637,1,0.606801412101406,0,3,apoptotic mitochondrial changes,BP,
777,GO:0008656,1,0.943785593081157,0,1,cysteine-type endopeptidase activator activity involved in apoptotic process,MF,
778,GO:0008670,1,0.889170363159422,0,1,2,4-dienoyl-CoA reductase (NADPH) activity,MF,
779,GO:0008709,1,0.936872137023806,0,1,cholate 7-alpha-dehydrogenase activity,MF,
780,GO:0008757,1,0.822633999518179,0,1,S-adenosylmethionine-dependent methyltransferase activity,MF,
781,GO:0008970,1,0.891636723651273,0,1,phosphatidylcholine 1-acylhydrolase activity,MF,
782,GO:0009052,1,0.694832717893905,0,1,pentose-phosphate shunt, non-oxidative branch,BP,
788,GO:0009060,1,0.623947206499021,0,2,aerobic respiration,BP,
790,GO:0009063,1,0.431740964834815,0,4,cellular amino acid catabolic process,BP,
791,GO:0009064,1,0.695099127173731,0,1,glutamine family amino acid metabolic process,BP,
794,GO:0009072,1,0.697700327321015,0,2,aromatic amino acid family metabolic process,BP,
795,GO:0009074,1,0.92965217786867,0,1,aromatic amino acid family catabolic process,BP,
796,GO:0009081,1,0.464692551895629,0,3,branched-chain amino acid metabolic process,BP,
797,GO:0009083,1,0.672972570692446,0,2,branched-chain amino acid catabolic process,BP,
798,GO:0009084,1,0.695099127173731,0,1,glutamine family amino acid biosynthetic process,BP,
801,GO:0009101,1,0.614948783441457,0,3,glycoprotein biosynthetic process,BP,
803,GO:0009109,1,0.667127256667468,0,2,coenzyme catabolic process,BP,
804,GO:0009110,1,0.747407444585123,0,1,vitamin biosynthetic process,BP,
810,GO:0009120,1,0.788063762325555,0,1,deoxyribonucleoside metabolic process,BP,
811,GO:0009132,1,0.928823333484811,0,1,nucleoside diphosphate metabolic process,BP,
812,GO:0009150,1,0.635117805001324,0,3,purine ribonucleotide metabolic process,BP,
813,GO:0009152,1,0.684717250127041,0,2,purine ribonucleotide biosynthetic process,BP,
814,GO:0009154,1,0.928823333484811,0,1,purine ribonucleotide catabolic process,BP,
818,GO:0009187,1,0.953041941460832,0,1,cyclic nucleotide metabolic process,BP,
819,GO:0009190,1,0.953041941460832,0,1,cyclic nucleotide biosynthetic process,BP,
820,GO:0009225,1,0.873547569641283,0,1,nucleotide-sugar metabolic process,BP,
821,GO:0009227,1,0.873547569641283,0,1,nucleotide-sugar catabolic process,BP,
823,GO:0009247,1,0.981296617652802,0,1,glycolipid biosynthetic process,BP,
824,GO:0009259,1,0.635117805001324,0,3,ribonucleotide metabolic process,BP,
825,GO:0009260,1,0.684717250127041,0,2,ribonucleotide biosynthetic process,BP,
826,GO:0009261,1,0.928823333484811,0,1,ribonucleotide catabolic process,BP,
827,GO:0009262,1,0.788063762325555,0,1,deoxyribonucleotide metabolic process,BP,
828,GO:0009264,1,0.788063762325555,0,1,deoxyribonucleotide catabolic process,BP,
829,GO:0009266,1,0.708832017662095,0,1,response to temperature stimulus,BP,
831,GO:0009295,1,0.708832017662095,0,1,nucleoid,CC,
832,GO:0009303,1,0.933430464161949,0,1,rRNA transcription,BP,
834,GO:0009308,1,0.6482016152171,0,2,amine metabolic process,BP,
835,GO:0009310,1,0.69574435000495,0,1,amine catabolic process,BP,
838,GO:0009314,1,0.359807074656518,0,3,response to radiation,BP,
839,GO:0009395,1,0.691132724011711,0,2,phospholipid catabolic process,BP,
840,GO:0009404,1,0.522121728666879,0,2,toxin metabolic process,BP,
841,GO:0009409,1,0.708832017662095,0,1,response to cold,BP,
843,GO:0009414,1,0.751229237583286,0,1,response to water deprivation,BP,
844,GO:0009415,1,0.751229237583286,0,1,response to water,BP,
845,GO:0009416,1,0.520190401282656,0,2,response to light stimulus,BP,
847,GO:0009437,1,0.697202049102828,0,1,carnitine metabolic process,BP,
848,GO:0009448,1,0.695099127173731,0,1,gamma-aminobutyric acid metabolic process,BP,
849,GO:0009449,1,0.695099127173731,0,1,gamma-aminobutyric acid biosynthetic process,BP,
850,GO:0009451,1,0.75055146595722,0,2,RNA modification,BP,
852,GO:0009593,1,0.696563650306504,0,1,detection of chemical stimulus,BP,
855,GO:0009611,1,0.285733396696469,0,4,response to wounding,BP,
856,GO:0009612,1,0.527662205822354,0,2,response to mechanical stimulus,BP,
859,GO:0009628,1,0.0914850301812909,0,10,response to abiotic stimulus,BP,
860,GO:0009635,1,0.522121728666879,0,2,response to herbicide,BP,
862,GO:0009651,1,0.751229237583286,0,1,response to salt stress,BP,
864,GO:0009712,1,0.751229237583286,0,1,catechol-containing compound metabolic process,BP,
865,GO:0009713,1,0.751229237583286,0,1,catechol-containing compound biosynthetic process,BP,
867,GO:0009720,1,0.696563650306504,0,1,detection of hormone stimulus,BP,
869,GO:0009726,1,0.696563650306504,0,1,detection of endogenous stimulus,BP,
870,GO:0009743,1,0.522121728666879,0,2,response to carbohydrate,BP,
871,GO:0009746,1,0.522121728666879,0,2,response to hexose,BP,
872,GO:0009749,1,0.522121728666879,0,2,response to glucose,BP,
873,GO:0009790,1,0.705216484249791,0,2,embryo development,BP,
875,GO:0009792,1,0.939570220896901,0,1,embryo development ending in birth or egg hatching,BP,
876,GO:0009799,1,0.904259787207722,0,1,specification of symmetry,BP,
877,GO:0009820,1,0.751229237583286,0,1,alkaloid metabolic process,BP,
878,GO:0009855,1,0.904259787207722,0,1,determination of bilateral symmetry,BP,
879,GO:0009887,1,0.547894952797572,0,4,animal organ morphogenesis,BP,
887,GO:0009895,1,0.506142283493121,0,3,negative regulation of catabolic process,BP,
889,GO:0009897,1,0.696563650306504,0,1,external side of plasma membrane,CC,
890,GO:0009898,1,0.751229237583286,0,1,cytoplasmic side of plasma membrane,CC,
891,GO:0009913,1,0.718768411418121,0,1,epidermal cell differentiation,BP,
892,GO:0009914,1,0.939570220896901,0,1,hormone transport,BP,
894,GO:0009922,1,0.695794073033159,0,1,fatty acid elongase activity,MF,
898,GO:0009982,1,0.801693816427004,0,1,pseudouridine synthase activity,MF,
899,GO:0009986,1,0.228350292661211,0,4,cell surface,CC,
902,GO:0009994,1,0.933430464161949,0,1,oocyte differentiation,BP,
903,GO:0010001,1,0.910467635192227,0,1,glial cell differentiation,BP,
906,GO:0010035,1,0.368008233373285,0,4,response to inorganic substance,BP,
907,GO:0010038,1,0.496247217974555,0,3,response to metal ion,BP,
908,GO:0010042,1,0.751229237583286,0,1,response to manganese ion,BP,
909,GO:0010043,1,0.751229237583286,0,1,response to zinc ion,BP,
910,GO:0010212,1,0.697654729170719,0,1,response to ionizing radiation,BP,
912,GO:0010259,1,0.751229237583286,0,1,multicellular organism aging,BP,
913,GO:0010288,1,0.697654729170719,0,1,response to lead ion,BP,
914,GO:0010389,1,0.932766532291112,0,1,regulation of G2/M transition of mitotic cell cycle,BP,
915,GO:0010466,1,0.603434602546963,0,2,negative regulation of peptidase activity,BP,
918,GO:0010498,1,0.932766532291112,0,1,proteasomal protein catabolic process,BP,
920,GO:0010507,1,0.694113237147052,0,1,negative regulation of autophagy,BP,
923,GO:0010517,1,0.933430464161949,0,1,regulation of phospholipase activity,BP,
924,GO:0010518,1,0.933430464161949,0,1,positive regulation of phospholipase activity,BP,
928,GO:0010562,1,0.32707290878946,0,7,positive regulation of phosphorus metabolic process,BP,
929,GO:0010563,1,0.52907235125553,0,4,negative regulation of phosphorus metabolic process,BP,
930,GO:0010564,1,0.932766532291112,0,1,regulation of cell cycle process,BP,
932,GO:0010594,1,0.836616111386651,0,1,regulation of endothelial cell migration,BP,
933,GO:0010595,1,0.836616111386651,0,1,positive regulation of endothelial cell migration,BP,
939,GO:0010631,1,0.836616111386651,0,1,epithelial cell migration,BP,
940,GO:0010632,1,0.836616111386651,0,1,regulation of epithelial cell migration,BP,
941,GO:0010634,1,0.836616111386651,0,1,positive regulation of epithelial cell migration,BP,
942,GO:0010638,1,0.943785593081157,0,1,positive regulation of organelle organization,BP,
943,GO:0010639,1,0.562506389595479,0,3,negative regulation of organelle organization,BP,
947,GO:0010656,1,0.864933823131346,0,1,negative regulation of muscle cell apoptotic process,BP,
948,GO:0010657,1,0.864933823131346,0,1,muscle cell apoptotic process,BP,
949,GO:0010658,1,0.864933823131346,0,1,striated muscle cell apoptotic process,BP,
950,GO:0010659,1,0.864933823131346,0,1,cardiac muscle cell apoptotic process,BP,
951,GO:0010660,1,0.864933823131346,0,1,regulation of muscle cell apoptotic process,BP,
952,GO:0010662,1,0.864933823131346,0,1,regulation of striated muscle cell apoptotic process,BP,
953,GO:0010664,1,0.864933823131346,0,1,negative regulation of striated muscle cell apoptotic process,BP,
954,GO:0010665,1,0.864933823131346,0,1,regulation of cardiac muscle cell apoptotic process,BP,
955,GO:0010667,1,0.864933823131346,0,1,negative regulation of cardiac muscle cell apoptotic process,BP,
956,GO:0010669,1,0.939570220896901,0,1,epithelial structure maintenance,BP,
958,GO:0010676,1,0.747407444585123,0,1,positive regulation of cellular carbohydrate metabolic process,BP,
959,GO:0010720,1,0.697654729170719,0,1,positive regulation of cell development,BP,
960,GO:0010721,1,0.696728333256898,0,1,negative regulation of cell development,BP,
961,GO:0010742,1,0.696563650306504,0,1,macrophage derived foam cell differentiation,BP,
962,GO:0010743,1,0.696563650306504,0,1,regulation of macrophage derived foam cell differentiation,BP,
963,GO:0010745,1,0.696563650306504,0,1,negative regulation of macrophage derived foam cell differentiation,BP,
964,GO:0010765,1,0.976084701408914,0,1,positive regulation of sodium ion transport,BP,
965,GO:0010769,1,0.696728333256898,0,1,regulation of cell morphogenesis involved in differentiation,BP,
966,GO:0010771,1,0.696728333256898,0,1,negative regulation of cell morphogenesis involved in differentiation,BP,
967,GO:0010803,1,0.687288222870396,0,3,regulation of tumor necrosis factor-mediated signaling pathway,BP,
968,GO:0010804,1,0.864933823131346,0,1,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,
970,GO:0010821,1,0.606801412101406,0,3,regulation of mitochondrion organization,BP,
971,GO:0010822,1,0.943785593081157,0,1,positive regulation of mitochondrion organization,BP,
972,GO:0010823,1,0.64378764821232,0,2,negative regulation of mitochondrion organization,BP,
975,GO:0010863,1,0.933430464161949,0,1,positive regulation of phospholipase C activity,BP,
976,GO:0010866,1,0.747407444585123,0,1,regulation of triglyceride biosynthetic process,BP,
977,GO:0010867,1,0.747407444585123,0,1,positive regulation of triglyceride biosynthetic process,BP,
978,GO:0010872,1,0.682570813562739,0,2,regulation of cholesterol esterification,BP,
979,GO:0010873,1,0.980476126491385,0,1,positive regulation of cholesterol esterification,BP,
980,GO:0010874,1,0.696563650306504,0,1,regulation of cholesterol efflux,BP,
981,GO:0010875,1,0.696563650306504,0,1,positive regulation of cholesterol efflux,BP,
983,GO:0010878,1,0.696563650306504,0,1,cholesterol storage,BP,
984,GO:0010883,1,0.696563650306504,0,1,regulation of lipid storage,BP,
985,GO:0010885,1,0.696563650306504,0,1,regulation of cholesterol storage,BP,
986,GO:0010887,1,0.696563650306504,0,1,negative regulation of cholesterol storage,BP,
987,GO:0010888,1,0.696563650306504,0,1,negative regulation of lipid storage,BP,
988,GO:0010893,1,0.48368524984853,0,2,positive regulation of steroid biosynthetic process,BP,
989,GO:0010899,1,0.980476126491385,0,1,regulation of phosphatidylcholine catabolic process,BP,
990,GO:0010900,1,0.980476126491385,0,1,negative regulation of phosphatidylcholine catabolic process,BP,
992,GO:0010907,1,0.747407444585123,0,1,positive regulation of glucose metabolic process,BP,
993,GO:0010915,1,0.980476126491385,0,1,regulation of very-low-density lipoprotein particle clearance,BP,
994,GO:0010916,1,0.980476126491385,0,1,negative regulation of very-low-density lipoprotein particle clearance,BP,
995,GO:0010921,1,0.747407444585123,0,1,regulation of phosphatase activity,BP,
996,GO:0010922,1,0.747407444585123,0,1,positive regulation of phosphatase activity,BP,
997,GO:0010923,1,0.747407444585123,0,1,negative regulation of phosphatase activity,BP,
998,GO:0010939,1,0.55344739271292,0,3,regulation of necrotic cell death,BP,
1001,GO:0010948,1,0.932766532291112,0,1,negative regulation of cell cycle process,BP,
1003,GO:0010951,1,0.603434602546963,0,2,negative regulation of endopeptidase activity,BP,
1005,GO:0010955,1,0.864933823131346,0,1,negative regulation of protein processing,BP,
1006,GO:0010959,1,0.565566921198172,0,3,regulation of metal ion transport,BP,
1007,GO:0010972,1,0.932766532291112,0,1,negative regulation of G2/M transition of mitotic cell cycle,BP,
1008,GO:0010975,1,0.696728333256898,0,1,regulation of neuron projection development,BP,
1009,GO:0010977,1,0.696728333256898,0,1,negative regulation of neuron projection development,BP,
1010,GO:0010984,1,0.980476126491385,0,1,regulation of lipoprotein particle clearance,BP,
1011,GO:0010985,1,0.980476126491385,0,1,negative regulation of lipoprotein particle clearance,BP,
1012,GO:0010996,1,0.695099127173731,0,1,response to auditory stimulus,BP,
1016,GO:0014047,1,0.695099127173731,0,1,glutamate secretion,BP,
1017,GO:0014065,1,0.836616111386651,0,1,phosphatidylinositol 3-kinase signaling,BP,
1018,GO:0014066,1,0.836616111386651,0,1,regulation of phosphatidylinositol 3-kinase signaling,BP,
1020,GO:0014072,1,0.761888585522679,0,1,response to isoquinoline alkaloid,BP,
1021,GO:0014074,1,0.697654729170719,0,1,response to purine-containing compound,BP,
1022,GO:0014075,1,0.751229237583286,0,1,response to amine,BP,
1023,GO:0014706,1,0.85516985302707,0,2,striated muscle tissue development,BP,
1024,GO:0014735,1,0.864933823131346,0,1,regulation of muscle atrophy,BP,
1025,GO:0014736,1,0.864933823131346,0,1,negative regulation of muscle atrophy,BP,
1026,GO:0014745,1,0.864933823131346,0,1,negative regulation of muscle adaptation,BP,
1027,GO:0014808,1,0.864933823131346,0,1,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
1028,GO:0014823,1,0.522121728666879,0,2,response to activity,BP,
1029,GO:0014855,1,0.939570220896901,0,1,striated muscle cell proliferation,BP,
1030,GO:0014874,1,0.864933823131346,0,1,response to stimulus involved in regulation of muscle adaptation,BP,
1031,GO:0014876,1,0.864933823131346,0,1,response to injury involved in regulation of muscle adaptation,BP,
1032,GO:0014889,1,0.864933823131346,0,1,muscle atrophy,BP,
1033,GO:0015002,1,0.952054095564578,0,1,heme-copper terminal oxidase activity,MF,
1034,GO:0015012,1,0.694623670811036,0,1,heparan sulfate proteoglycan biosynthetic process,BP,
1036,GO:0015065,1,0.698431002476331,0,1,uridine nucleotide receptor activity,MF,
1037,GO:0015075,1,0.343276459624823,0,5,ion transmembrane transporter activity,MF,
1038,GO:0015077,1,0.661153419007173,0,2,monovalent inorganic cation transmembrane transporter activity,MF,
1039,GO:0015078,1,0.952054095564578,0,1,hydrogen ion transmembrane transporter activity,MF,
1040,GO:0015081,1,0.695099127173731,0,1,sodium ion transmembrane transporter activity,MF,
1041,GO:0015103,1,0.976084701408914,0,1,inorganic anion transmembrane transporter activity,MF,
1042,GO:0015108,1,0.976084701408914,0,1,chloride transmembrane transporter activity,MF,
1043,GO:0015171,1,0.695099127173731,0,1,amino acid transmembrane transporter activity,MF,
1044,GO:0015172,1,0.695099127173731,0,1,acidic amino acid transmembrane transporter activity,MF,
1045,GO:0015179,1,0.695099127173731,0,1,L-amino acid transmembrane transporter activity,MF,
1046,GO:0015197,1,0.696563650306504,0,1,peptide transporter activity,MF,
1047,GO:0015238,1,0.9068568801805,0,1,drug transmembrane transporter activity,MF,
1048,GO:0015245,1,0.916336727632546,0,1,fatty acid transporter activity,MF,
1049,GO:0015248,1,0.48368524984853,0,2,sterol transporter activity,MF,
1050,GO:0015267,1,0.677042443569163,0,2,channel activity,MF,
1051,GO:0015276,1,0.694072074177941,0,1,ligand-gated ion channel activity,MF,
1052,GO:0015291,1,0.695099127173731,0,1,secondary active transmembrane transporter activity,MF,
1053,GO:0015293,1,0.695099127173731,0,1,symporter activity,MF,
1054,GO:0015294,1,0.695099127173731,0,1,solute:cation symporter activity,MF,
1055,GO:0015370,1,0.695099127173731,0,1,solute:sodium symporter activity,MF,
1056,GO:0015399,1,0.696563650306504,0,1,primary active transmembrane transporter activity,MF,
1057,GO:0015405,1,0.696563650306504,0,1,P-P-bond-hydrolysis-driven transmembrane transporter activity,MF,
1058,GO:0015485,1,0.48368524984853,0,2,cholesterol binding,MF,
1059,GO:0015629,1,0.738041329746765,0,2,actin cytoskeleton,CC,
1060,GO:0015630,1,0.505209355136079,0,2,microtubule cytoskeleton,CC,
1061,GO:0015631,1,0.694689250747339,0,1,tubulin binding,MF,
1062,GO:0015645,1,0.701667730772414,0,1,fatty acid ligase activity,MF,
1063,GO:0015672,1,0.929187493649482,0,2,monovalent inorganic cation transport,BP,
1064,GO:0015698,1,0.976084701408914,0,1,inorganic anion transport,BP,
1065,GO:0015711,1,0.296715187836532,0,5,organic anion transport,BP,
1066,GO:0015718,1,0.63713192210194,0,2,monocarboxylic acid transport,BP,
1067,GO:0015740,1,0.695099127173731,0,1,C4-dicarboxylate transport,BP,
1068,GO:0015748,1,0.682570813562739,0,2,organophosphate ester transport,BP,
1071,GO:0015800,1,0.695099127173731,0,1,acidic amino acid transport,BP,
1072,GO:0015807,1,0.695099127173731,0,1,L-amino acid transport,BP,
1073,GO:0015810,1,0.695099127173731,0,1,aspartate transport,BP,
1074,GO:0015813,1,0.695099127173731,0,1,L-glutamate transport,BP,
1076,GO:0015837,1,0.751229237583286,0,1,amine transport,BP,
1077,GO:0015842,1,0.751229237583286,0,1,aminergic neurotransmitter loading into synaptic vesicle,BP,
1078,GO:0015849,1,0.440141535995694,0,3,organic acid transport,BP,
1079,GO:0015850,1,0.444025968949109,0,4,organic hydroxy compound transport,BP,
1080,GO:0015893,1,0.9068568801805,0,1,drug transport,BP,
1081,GO:0015908,1,0.63713192210194,0,2,fatty acid transport,BP,
1082,GO:0015909,1,0.63713192210194,0,2,long-chain fatty acid transport,BP,
1083,GO:0015914,1,0.682570813562739,0,2,phospholipid transport,BP,
1084,GO:0015918,1,0.473688969393836,0,3,sterol transport,BP,
1085,GO:0015925,1,0.856884470493401,0,1,galactosidase activity,MF,
1087,GO:0015934,1,0.863382075063917,0,2,large ribosomal subunit,CC,
1088,GO:0015936,1,0.667127256667468,0,2,coenzyme A metabolic process,BP,
1089,GO:0015937,1,0.719058751904449,0,1,coenzyme A biosynthetic process,BP,
1090,GO:0015938,1,0.928823333484811,0,1,coenzyme A catabolic process,BP,
1091,GO:0015980,1,0.27875957653797,0,5,energy derivation by oxidation of organic compounds,BP,
1092,GO:0015992,1,0.952054095564578,0,1,proton transport,BP,
1098,GO:0016050,1,0.694113237147052,0,1,vesicle organization,BP,
1099,GO:0016051,1,0.620611724240103,0,3,carbohydrate biosynthetic process,BP,
1103,GO:0016055,1,0.932766532291112,0,1,Wnt signaling pathway,BP,
1107,GO:0016101,1,0.493170563990898,0,3,diterpenoid metabolic process,BP,
1114,GO:0016137,1,0.642578637334875,0,2,glycoside metabolic process,BP,
1115,GO:0016139,1,0.856884470493401,0,1,glycoside catabolic process,BP,
1117,GO:0016197,1,0.598670005301796,0,2,endosomal transport,BP,
1118,GO:0016202,1,0.85516985302707,0,2,regulation of striated muscle tissue development,BP,
1119,GO:0016209,1,0.954268878312379,0,1,antioxidant activity,MF,
1121,GO:0016236,1,0.694113237147052,0,1,macroautophagy,BP,
1122,GO:0016241,1,0.694113237147052,0,1,regulation of macroautophagy,BP,
1123,GO:0016247,1,0.976084701408914,0,1,channel regulator activity,MF,
1124,GO:0016289,1,0.928823333484811,0,1,CoA hydrolase activity,MF,
1125,GO:0016298,1,0.671366140734006,0,2,lipase activity,MF,
1127,GO:0016303,1,0.836616111386651,0,1,1-phosphatidylinositol-3-kinase activity,MF,
1128,GO:0016307,1,0.864322510360387,0,1,phosphatidylinositol phosphate kinase activity,MF,
1130,GO:0016311,1,0.590377420240489,0,3,dephosphorylation,BP,
1134,GO:0016406,1,0.483162738064911,0,2,carnitine O-acyltransferase activity,MF,
1135,GO:0016407,1,0.59386006440258,0,2,acetyltransferase activity,MF,
1136,GO:0016408,1,0.305568583341601,0,4,C-acyltransferase activity,MF,
1137,GO:0016409,1,0.483162738064911,0,2,palmitoyltransferase activity,MF,
1138,GO:0016416,1,0.483162738064911,0,2,O-palmitoyltransferase activity,MF,
1139,GO:0016453,1,0.59386006440258,0,2,C-acetyltransferase activity,MF,
1140,GO:0016462,1,0.696563650306504,0,1,pyrophosphatase activity,MF,
1142,GO:0016482,1,0.598670005301796,0,2,cytosolic transport,BP,
1143,GO:0016485,1,0.456525045822019,0,3,protein processing,BP,
1145,GO:0016502,1,0.698431002476331,0,1,nucleotide receptor activity,MF,
1146,GO:0016504,1,0.943785593081157,0,1,peptidase activator activity,MF,
1147,GO:0016505,1,0.943785593081157,0,1,peptidase activator activity involved in apoptotic process,MF,
1148,GO:0016528,1,0.792090241968203,0,2,sarcoplasm,CC,
1149,GO:0016529,1,0.864933823131346,0,1,sarcoplasmic reticulum,CC,
1150,GO:0016556,1,0.801693816427004,0,1,mRNA modification,BP,
1152,GO:0016579,1,0.932766532291112,0,1,protein deubiquitination,BP,
1153,GO:0016595,1,0.695099127173731,0,1,glutamate binding,MF,
1154,GO:0016597,1,0.520190401282656,0,2,amino acid binding,MF,
1156,GO:0016607,1,0.868171566548753,0,1,nuclear speck,CC,
1158,GO:0016615,1,0.886207777244638,0,1,malate dehydrogenase activity,MF,
1163,GO:0016645,1,0.487783681883063,0,2,oxidoreductase activity, acting on the CH-NH group of donors,MF,
1164,GO:0016649,1,0.704322975564546,0,1,oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor,MF,
1165,GO:0016651,1,0.889170363159422,0,1,oxidoreductase activity, acting on NAD(P)H,MF,
1166,GO:0016667,1,0.780168531849915,0,2,oxidoreductase activity, acting on a sulfur group of donors,MF,
1167,GO:0016671,1,0.843430501767646,0,1,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,MF,
1168,GO:0016675,1,0.952054095564578,0,1,oxidoreductase activity, acting on a heme group of donors,MF,
1169,GO:0016676,1,0.952054095564578,0,1,oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor,MF,
1170,GO:0016684,1,0.954268878312379,0,1,oxidoreductase activity, acting on peroxide as acceptor,MF,
1172,GO:0016706,1,0.80215306869843,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,MF,
1174,GO:0016714,1,0.697700327321015,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen,MF,
1175,GO:0016717,1,0.694297055380902,0,1,oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water,MF,
1176,GO:0016722,1,0.704322975564546,0,1,oxidoreductase activity, oxidizing metal ions,MF,
1180,GO:0016741,1,0.822633999518179,0,1,transferase activity, transferring one-carbon groups,MF,
1181,GO:0016746,1,0.0853745912767074,0,8,transferase activity, transferring acyl groups,MF,
1186,GO:0016765,1,0.954268878312379,0,1,transferase activity, transferring alkyl or aryl (other than methyl) groups,MF,
1189,GO:0016779,1,0.873547569641283,0,1,nucleotidyltransferase activity,MF,
1192,GO:0016790,1,0.699640829803229,0,2,thiolester hydrolase activity,MF,
1193,GO:0016791,1,0.792160037434877,0,2,phosphatase activity,MF,
1195,GO:0016805,1,0.753245494607556,0,1,dipeptidase activity,MF,
1198,GO:0016817,1,0.696563650306504,0,1,hydrolase activity, acting on acid anhydrides,MF,
1199,GO:0016818,1,0.696563650306504,0,1,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,
1200,GO:0016820,1,0.696563650306504,0,1,hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,MF,
1201,GO:0016829,1,0.135787444158409,0,10,lyase activity,MF,
1202,GO:0016830,1,0.3077507266039,0,4,carbon-carbon lyase activity,MF,
1203,GO:0016832,1,0.595678857813587,0,2,aldehyde-lyase activity,MF,
1204,GO:0016835,1,0.481830932978868,0,5,carbon-oxygen lyase activity,MF,
1205,GO:0016836,1,0.51421211407246,0,4,hydro-lyase activity,MF,
1206,GO:0016838,1,0.939074574481556,0,1,carbon-oxygen lyase activity, acting on phosphates,MF,
1207,GO:0016846,1,0.954268878312379,0,1,carbon-sulfur lyase activity,MF,
1212,GO:0016866,1,0.801693816427004,0,1,intramolecular transferase activity,MF,
1216,GO:0016885,1,0.719058751904449,0,1,ligase activity, forming carbon-carbon bonds,MF,
1217,GO:0016887,1,0.696563650306504,0,1,ATPase activity,MF,
1218,GO:0016898,1,0.730609063525042,0,1,oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor,MF,
1220,GO:0016918,1,0.939570220896901,0,1,retinal binding,MF,
1221,GO:0016936,1,0.856884470493401,0,1,galactoside binding,MF,
1222,GO:0017016,1,0.482448624128952,0,2,Ras GTPase binding,MF,
1223,GO:0017022,1,0.943785593081157,0,1,myosin binding,MF,
1224,GO:0017024,1,0.943785593081157,0,1,myosin I binding,MF,
1225,GO:0017038,1,0.864933823131346,0,1,protein import,BP,
1227,GO:0017046,1,0.694332314327877,0,1,peptide hormone binding,MF,
1229,GO:0017080,1,0.976084701408914,0,1,sodium channel regulator activity,MF,
1230,GO:0017085,1,0.522121728666879,0,2,response to insecticide,BP,
1231,GO:0017111,1,0.696563650306504,0,1,nucleoside-triphosphatase activity,MF,
1232,GO:0017127,1,0.48368524984853,0,2,cholesterol transporter activity,MF,
1233,GO:0017133,1,0.704322975564546,0,1,mitochondrial electron transfer flavoprotein complex,CC,
1234,GO:0017137,1,0.482448624128952,0,2,Rab GTPase binding,MF,
1235,GO:0017143,1,0.697654729170719,0,1,insecticide metabolic process,BP,
1236,GO:0017148,1,0.933430464161949,0,1,negative regulation of translation,BP,
1237,GO:0017156,1,0.698348976994063,0,1,calcium ion regulated exocytosis,BP,
1238,GO:0017157,1,0.698348976994063,0,1,regulation of exocytosis,BP,
1239,GO:0017158,1,0.698348976994063,0,1,regulation of calcium ion-dependent exocytosis,BP,
1240,GO:0017171,1,0.697867488744479,0,1,serine hydrolase activity,MF,
1241,GO:0018103,1,0.981296617652802,0,1,protein C-linked glycosylation,BP,
1242,GO:0018108,1,0.579433012529212,0,2,peptidyl-tyrosine phosphorylation,BP,
1244,GO:0018149,1,0.718768411418121,0,1,peptide cross-linking,BP,
1245,GO:0018193,1,0.512383942230669,0,4,peptidyl-amino acid modification,BP,
1246,GO:0018196,1,0.887195742142593,0,2,peptidyl-asparagine modification,BP,
1247,GO:0018211,1,0.981296617652802,0,1,peptidyl-tryptophan modification,BP,
1248,GO:0018212,1,0.579433012529212,0,2,peptidyl-tyrosine modification,BP,
1249,GO:0018279,1,0.887195742142593,0,2,protein N-linked glycosylation via asparagine,BP,
1250,GO:0018317,1,0.981296617652802,0,1,protein C-linked glycosylation via tryptophan,BP,
1251,GO:0018406,1,0.981296617652802,0,1,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,BP,
1252,GO:0018879,1,0.697654729170719,0,1,biphenyl metabolic process,BP,
1253,GO:0018894,1,0.697654729170719,0,1,dibenzo-p-dioxin metabolic process,BP,
1254,GO:0018904,1,0.891636723651273,0,1,ether metabolic process,BP,
1255,GO:0018958,1,0.522121728666879,0,2,phenol-containing compound metabolic process,BP,
1256,GO:0018963,1,0.522121728666879,0,2,phthalate metabolic process,BP,
1257,GO:0019001,1,0.701667730772414,0,1,guanyl nucleotide binding,MF,
1261,GO:0019166,1,0.756629123575041,0,1,trans-2-enoyl-CoA reductase (NADPH) activity,MF,
1267,GO:0019220,1,0.168060465849641,0,10,regulation of phosphate metabolic process,BP,
1272,GO:0019319,1,0.83231945072769,0,2,hexose biosynthetic process,BP,
1273,GO:0019320,1,0.873547569641283,0,1,hexose catabolic process,BP,
1277,GO:0019367,1,0.695794073033159,0,1,fatty acid elongation, saturated fatty acid,BP,
1278,GO:0019370,1,0.954268878312379,0,1,leukotriene biosynthetic process,BP,
1281,GO:0019388,1,0.873547569641283,0,1,galactose catabolic process,BP,
1283,GO:0019430,1,0.747407444585123,0,1,removal of superoxide radicals,BP,
1284,GO:0019432,1,0.747407444585123,0,1,triglyceride biosynthetic process,BP,
1285,GO:0019433,1,0.916336727632546,0,1,triglyceride catabolic process,BP,
1289,GO:0019530,1,0.694332314327877,0,1,taurine metabolic process,BP,
1290,GO:0019534,1,0.696563650306504,0,1,toxin transporter activity,MF,
1294,GO:0019682,1,0.545804209021376,0,2,glyceraldehyde-3-phosphate metabolic process,BP,
1295,GO:0019692,1,0.788063762325555,0,1,deoxyribose phosphate metabolic process,BP,
1296,GO:0019693,1,0.34280571138423,0,5,ribose phosphate metabolic process,BP,
1297,GO:0019694,1,0.694332314327877,0,1,alkanesulfonate metabolic process,BP,
1298,GO:0019695,1,0.69574435000495,0,1,choline metabolic process,BP,
1299,GO:0019722,1,0.747407444585123,0,1,calcium-mediated signaling,BP,
1303,GO:0019825,1,0.567578146495582,0,2,oxygen binding,MF,
1304,GO:0019840,1,0.939570220896901,0,1,isoprenoid binding,MF,
1305,GO:0019841,1,0.939570220896901,0,1,retinol binding,MF,
1308,GO:0019852,1,0.711033441807323,0,2,L-ascorbic acid metabolic process,BP,
1309,GO:0019853,1,0.747407444585123,0,1,L-ascorbic acid biosynthetic process,BP,
1312,GO:0019882,1,0.814156852656112,0,3,antigen processing and presentation,BP,
1313,GO:0019884,1,0.863091121236512,0,2,antigen processing and presentation of exogenous antigen,BP,
1314,GO:0019886,1,0.925582526412575,0,1,antigen processing and presentation of exogenous peptide antigen via MHC class II,BP,
1318,GO:0019904,1,0.164002574682922,0,8,protein domain specific binding,MF,
1320,GO:0019932,1,0.747407444585123,0,1,second-messenger-mediated signaling,BP,
1321,GO:0019941,1,0.932766532291112,0,1,modification-dependent protein catabolic process,BP,
1324,GO:0021537,1,0.751229237583286,0,1,telencephalon development,BP,
1325,GO:0021543,1,0.751229237583286,0,1,pallium development,BP,
1326,GO:0021545,1,0.695099127173731,0,1,cranial nerve development,BP,
1327,GO:0021675,1,0.695099127173731,0,1,nerve development,BP,
1328,GO:0021700,1,0.933430464161949,0,1,developmental maturation,BP,
1329,GO:0021987,1,0.751229237583286,0,1,cerebral cortex development,BP,
1331,GO:0022402,1,0.932766532291112,0,1,cell cycle process,BP,
1332,GO:0022404,1,0.843648241871817,0,1,molting cycle process,BP,
1333,GO:0022405,1,0.843648241871817,0,1,hair cycle process,BP,
1336,GO:0022410,1,0.697654729170719,0,1,circadian sleep/wake cycle process,BP,
1337,GO:0022411,1,0.75549102206036,0,3,cellular component disassembly,BP,
1340,GO:0022600,1,0.939570220896901,0,1,digestive system process,BP,
1341,GO:0022602,1,0.933430464161949,0,1,ovulation cycle process,BP,
1347,GO:0022618,1,0.864933823131346,0,1,ribonucleoprotein complex assembly,BP,
1348,GO:0022803,1,0.677042443569163,0,2,passive transmembrane transporter activity,MF,
1349,GO:0022804,1,0.481891920609221,0,2,active transmembrane transporter activity,MF,
1350,GO:0022824,1,0.694072074177941,0,1,transmitter-gated ion channel activity,MF,
1351,GO:0022834,1,0.694072074177941,0,1,ligand-gated channel activity,MF,
1352,GO:0022835,1,0.694072074177941,0,1,transmitter-gated channel activity,MF,
1353,GO:0022836,1,0.694072074177941,0,1,gated channel activity,MF,
1354,GO:0022838,1,0.677042443569163,0,2,substrate-specific channel activity,MF,
1355,GO:0022857,1,0.212273569361393,0,7,transmembrane transporter activity,MF,
1356,GO:0022890,1,0.352353079793662,0,4,inorganic cation transmembrane transporter activity,MF,
1357,GO:0022891,1,0.343276459624823,0,5,substrate-specific transmembrane transporter activity,MF,
1358,GO:0022892,1,0.136833994580535,0,9,substrate-specific transporter activity,MF,
1359,GO:0022898,1,0.729159739479172,0,2,regulation of transmembrane transporter activity,BP,
1360,GO:0022900,1,0.643191586487803,0,2,electron transport chain,BP,
1361,GO:0022904,1,0.643191586487803,0,2,respiratory electron transport chain,BP,
1362,GO:0023014,1,0.50821984453777,0,4,signal transduction by protein phosphorylation,BP,
1367,GO:0023061,1,0.939570220896901,0,1,signal release,BP,
1368,GO:0030001,1,0.487462358041372,0,4,metal ion transport,BP,
1370,GO:0030016,1,0.875900879520659,0,1,myofibril,CC,
1371,GO:0030017,1,0.875900879520659,0,1,sarcomere,CC,
1372,GO:0030029,1,0.770761955450571,0,3,actin filament-based process,BP,
1373,GO:0030030,1,0.326967043471224,0,4,cell projection organization,BP,
1374,GO:0030031,1,0.694689250747339,0,1,cell projection assembly,BP,
1375,GO:0030036,1,0.770761955450571,0,3,actin cytoskeleton organization,BP,
1376,GO:0030041,1,0.770761955450571,0,3,actin filament polymerization,BP,
1377,GO:0030042,1,0.875900879520659,0,1,actin filament depolymerization,BP,
1379,GO:0030055,1,0.864322510360387,0,1,cell-substrate junction,CC,
1380,GO:0030060,1,0.886207777244638,0,1,L-malate dehydrogenase activity,MF,
1381,GO:0030061,1,0.697654729170719,0,1,mitochondrial crista,CC,
1382,GO:0030072,1,0.939570220896901,0,1,peptide hormone secretion,BP,
1383,GO:0030073,1,0.939570220896901,0,1,insulin secretion,BP,
1384,GO:0030091,1,0.843430501767646,0,1,protein repair,BP,
1387,GO:0030099,1,0.761888585522679,0,1,myeloid cell differentiation,BP,
1388,GO:0030100,1,0.925259393591811,0,2,regulation of endocytosis,BP,
1390,GO:0030111,1,0.932766532291112,0,1,regulation of Wnt signaling pathway,BP,
1391,GO:0030133,1,0.522646399371424,0,2,transport vesicle,CC,
1393,GO:0030139,1,0.694072074177941,0,1,endocytic vesicle,CC,
1395,GO:0030145,1,0.698949153322206,0,2,manganese ion binding,MF,
1400,GO:0030163,1,0.523035572546446,0,3,protein catabolic process,BP,
1401,GO:0030166,1,0.694623670811036,0,1,proteoglycan biosynthetic process,BP,
1404,GO:0030177,1,0.932766532291112,0,1,positive regulation of Wnt signaling pathway,BP,
1405,GO:0030178,1,0.932766532291112,0,1,negative regulation of Wnt signaling pathway,BP,
1406,GO:0030182,1,0.242807174822077,0,5,neuron differentiation,BP,
1407,GO:0030193,1,0.694060852856155,0,1,regulation of blood coagulation,BP,
1408,GO:0030201,1,0.694623670811036,0,1,heparan sulfate proteoglycan metabolic process,BP,
1416,GO:0030216,1,0.718768411418121,0,1,keratinocyte differentiation,BP,
1418,GO:0030225,1,0.761888585522679,0,1,macrophage differentiation,BP,
1419,GO:0030234,1,0.269499663669492,0,7,enzyme regulator activity,MF,
1420,GO:0030246,1,0.80215306869843,0,1,carbohydrate binding,MF,
1422,GO:0030274,1,0.698348976994063,0,1,LIM domain binding,MF,
1423,GO:0030277,1,0.939570220896901,0,1,maintenance of gastrointestinal epithelium,BP,
1424,GO:0030280,1,0.718768411418121,0,1,structural constituent of epidermis,MF,
1425,GO:0030283,1,0.936872137023806,0,1,testosterone dehydrogenase [NAD(P)] activity,MF,
1426,GO:0030301,1,0.473688969393836,0,3,cholesterol transport,BP,
1427,GO:0030317,1,0.747407444585123,0,1,flagellated sperm motility,BP,
1430,GO:0030334,1,0.41352449583698,0,4,regulation of cell migration,BP,
1431,GO:0030335,1,0.41352449583698,0,4,positive regulation of cell migration,BP,
1432,GO:0030414,1,0.603434602546963,0,2,peptidase inhibitor activity,MF,
1433,GO:0030424,1,0.392743161157857,0,3,axon,CC,
1434,GO:0030425,1,0.521779622995879,0,2,dendrite,CC,
1435,GO:0030426,1,0.933430464161949,0,1,growth cone,CC,
1436,GO:0030427,1,0.933430464161949,0,1,site of polarized growth,CC,
1437,GO:0030431,1,0.697654729170719,0,1,sleep,BP,
1438,GO:0030449,1,0.697867488744479,0,1,regulation of complement activation,BP,
1439,GO:0030488,1,0.936872137023806,0,1,tRNA methylation,BP,
1440,GO:0030497,1,0.695794073033159,0,1,fatty acid elongation,BP,
1441,GO:0030515,1,0.928823333484811,0,1,snoRNA binding,MF,
1442,GO:0030529,1,0.559282423818243,0,4,intracellular ribonucleoprotein complex,CC,
1443,GO:0030534,1,0.761888585522679,0,1,adult behavior,BP,
1445,GO:0030540,1,0.939570220896901,0,1,female genitalia development,BP,
1447,GO:0030574,1,0.753245494607556,0,1,collagen catabolic process,BP,
1448,GO:0030594,1,0.694072074177941,0,1,neurotransmitter receptor activity,MF,
1449,GO:0030658,1,0.698348976994063,0,1,transport vesicle membrane,CC,
1451,GO:0030666,1,0.694072074177941,0,1,endocytic vesicle membrane,CC,
1452,GO:0030667,1,0.698348976994063,0,1,secretory granule membrane,CC,
1453,GO:0030677,1,0.936872137023806,0,1,ribonuclease P complex,CC,
1454,GO:0030678,1,0.936872137023806,0,1,mitochondrial ribonuclease P complex,CC,
1455,GO:0030695,1,0.694113237147052,0,1,GTPase regulator activity,MF,
1456,GO:0030760,1,0.822633999518179,0,1,pyridine N-methyltransferase activity,MF,
1457,GO:0030799,1,0.953041941460832,0,1,regulation of cyclic nucleotide metabolic process,BP,
1458,GO:0030801,1,0.953041941460832,0,1,positive regulation of cyclic nucleotide metabolic process,BP,
1459,GO:0030802,1,0.953041941460832,0,1,regulation of cyclic nucleotide biosynthetic process,BP,
1460,GO:0030804,1,0.953041941460832,0,1,positive regulation of cyclic nucleotide biosynthetic process,BP,
1461,GO:0030808,1,0.953041941460832,0,1,regulation of nucleotide biosynthetic process,BP,
1462,GO:0030810,1,0.953041941460832,0,1,positive regulation of nucleotide biosynthetic process,BP,
1463,GO:0030814,1,0.953041941460832,0,1,regulation of cAMP metabolic process,BP,
1464,GO:0030816,1,0.953041941460832,0,1,positive regulation of cAMP metabolic process,BP,
1465,GO:0030817,1,0.953041941460832,0,1,regulation of cAMP biosynthetic process,BP,
1466,GO:0030819,1,0.953041941460832,0,1,positive regulation of cAMP biosynthetic process,BP,
1467,GO:0030832,1,0.826321000735877,0,2,regulation of actin filament length,BP,
1468,GO:0030833,1,0.826321000735877,0,2,regulation of actin filament polymerization,BP,
1469,GO:0030834,1,0.875900879520659,0,1,regulation of actin filament depolymerization,BP,
1470,GO:0030835,1,0.875900879520659,0,1,negative regulation of actin filament depolymerization,BP,
1471,GO:0030837,1,0.875900879520659,0,1,negative regulation of actin filament polymerization,BP,
1472,GO:0030838,1,0.943785593081157,0,1,positive regulation of actin filament polymerization,BP,
1477,GO:0030900,1,0.751229237583286,0,1,forebrain development,BP,
1478,GO:0030947,1,0.836616111386651,0,1,regulation of vascular endothelial growth factor receptor signaling pathway,BP,
1479,GO:0030949,1,0.836616111386651,0,1,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,
1480,GO:0030968,1,0.708832017662095,0,1,endoplasmic reticulum unfolded protein response,BP,
1481,GO:0030976,1,0.730412373491716,0,1,thiamine pyrophosphate binding,MF,
1482,GO:0031012,1,0.649588788569117,0,2,extracellular matrix,CC,
1483,GO:0031076,1,0.751229237583286,0,1,embryonic camera-type eye development,BP,
1485,GO:0031098,1,0.943785593081157,0,1,stress-activated protein kinase signaling cascade,BP,
1486,GO:0031099,1,0.613489961333129,0,2,regeneration,BP,
1487,GO:0031100,1,0.613489961333129,0,2,animal organ regeneration,BP,
1488,GO:0031119,1,0.801693816427004,0,1,tRNA pseudouridine synthesis,BP,
1489,GO:0031145,1,0.932766532291112,0,1,anaphase-promoting complex-dependent catabolic process,BP,
1490,GO:0031146,1,0.932766532291112,0,1,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,
1491,GO:0031175,1,0.475473553676654,0,3,neuron projection development,BP,
1492,GO:0031210,1,0.980476126491385,0,1,phosphatidylcholine binding,MF,
1493,GO:0031223,1,0.695099127173731,0,1,auditory behavior,BP,
1495,GO:0031225,1,0.699109736897407,0,1,anchored component of membrane,CC,
1496,GO:0031226,1,0.103967732805221,0,8,intrinsic component of plasma membrane,CC,
1498,GO:0031252,1,0.910467635192227,0,1,cell leading edge,CC,
1499,GO:0031264,1,0.641588149434177,0,2,death-inducing signaling complex,CC,
1500,GO:0031265,1,0.761888585522679,0,1,CD95 death-inducing signaling complex,CC,
1501,GO:0031267,1,0.482448624128952,0,2,small GTPase binding,MF,
1502,GO:0031300,1,0.704322975564546,0,1,intrinsic component of organelle membrane,CC,
1503,GO:0031301,1,0.704322975564546,0,1,integral component of organelle membrane,CC,
1504,GO:0031304,1,0.704322975564546,0,1,intrinsic component of mitochondrial inner membrane,CC,
1505,GO:0031305,1,0.704322975564546,0,1,integral component of mitochondrial inner membrane,CC,
1513,GO:0031330,1,0.506142283493121,0,3,negative regulation of cellular catabolic process,BP,
1515,GO:0031333,1,0.875900879520659,0,1,negative regulation of protein complex assembly,BP,
1516,GO:0031334,1,0.656102479742112,0,2,positive regulation of protein complex assembly,BP,
1517,GO:0031338,1,0.694113237147052,0,1,regulation of vesicle fusion,BP,
1518,GO:0031341,1,0.761888585522679,0,1,regulation of cell killing,BP,
1519,GO:0031343,1,0.761888585522679,0,1,positive regulation of cell killing,BP,
1520,GO:0031344,1,0.481719564866174,0,2,regulation of cell projection organization,BP,
1521,GO:0031345,1,0.696728333256898,0,1,negative regulation of cell projection organization,BP,
1523,GO:0031348,1,0.843648241871817,0,1,negative regulation of defense response,BP,
1526,GO:0031397,1,0.932766532291112,0,1,negative regulation of protein ubiquitination,BP,
1529,GO:0031400,1,0.50278007658501,0,4,negative regulation of protein modification process,BP,
1531,GO:0031406,1,0.37095136201529,0,5,carboxylic acid binding,MF,
1533,GO:0031418,1,0.80215306869843,0,1,L-ascorbic acid binding,MF,
1534,GO:0031424,1,0.718768411418121,0,1,keratinization,BP,
1535,GO:0031501,1,0.981296617652802,0,1,mannosyltransferase complex,CC,
1536,GO:0031503,1,0.864933823131346,0,1,protein complex localization,BP,
1537,GO:0031638,1,0.761888585522679,0,1,zymogen activation,BP,
1538,GO:0031647,1,0.856778119349059,0,3,regulation of protein stability,BP,
1543,GO:0031730,1,0.969995247214235,0,1,CCR5 chemokine receptor binding,MF,
1544,GO:0031779,1,0.953041941460832,0,1,melanocortin receptor binding,MF,
1545,GO:0031780,1,0.953041941460832,0,1,corticotropin hormone receptor binding,MF,
1546,GO:0031781,1,0.953041941460832,0,1,type 3 melanocortin receptor binding,MF,
1547,GO:0031782,1,0.953041941460832,0,1,type 4 melanocortin receptor binding,MF,
1548,GO:0031783,1,0.953041941460832,0,1,type 5 melanocortin receptor binding,MF,
1550,GO:0031903,1,0.434271669536358,0,4,microbody membrane,CC,
1551,GO:0031907,1,0.378968750988072,0,4,microbody lumen,CC,
1552,GO:0031929,1,0.769211113770212,0,1,TOR signaling,BP,
1553,GO:0031960,1,0.474105566544681,0,3,response to corticosteroid,BP,
1564,GO:0032006,1,0.769211113770212,0,1,regulation of TOR signaling,BP,
1565,GO:0032007,1,0.769211113770212,0,1,negative regulation of TOR signaling,BP,
1566,GO:0032024,1,0.939570220896901,0,1,positive regulation of insulin secretion,BP,
1567,GO:0032088,1,0.943785593081157,0,1,negative regulation of NF-kappaB transcription factor activity,BP,
1568,GO:0032090,1,0.943785593081157,0,1,Pyrin domain binding,MF,
1571,GO:0032103,1,0.836616111386651,0,1,positive regulation of response to external stimulus,BP,
1572,GO:0032147,1,0.647348059193898,0,2,activation of protein kinase activity,BP,
1573,GO:0032148,1,0.933430464161949,0,1,activation of protein kinase B activity,BP,
1574,GO:0032259,1,0.703533166960753,0,3,methylation,BP,
1577,GO:0032269,1,0.27806133083343,0,7,negative regulation of cellular protein metabolic process,BP,
1579,GO:0032271,1,0.826321000735877,0,2,regulation of protein polymerization,BP,
1580,GO:0032272,1,0.875900879520659,0,1,negative regulation of protein polymerization,BP,
1581,GO:0032273,1,0.943785593081157,0,1,positive regulation of protein polymerization,BP,
1582,GO:0032281,1,0.481617645613711,0,2,AMPA glutamate receptor complex,CC,
1583,GO:0032311,1,0.933430464161949,0,1,angiogenin-PRI complex,CC,
1584,GO:0032330,1,0.836616111386651,0,1,regulation of chondrocyte differentiation,BP,
1585,GO:0032332,1,0.836616111386651,0,1,positive regulation of chondrocyte differentiation,BP,
1586,GO:0032354,1,0.697654729170719,0,1,response to follicle-stimulating hormone,BP,
1587,GO:0032355,1,0.523221341585626,0,2,response to estradiol,BP,
1588,GO:0032365,1,0.333579945679865,0,3,intracellular lipid transport,BP,
1589,GO:0032366,1,0.48368524984853,0,2,intracellular sterol transport,BP,
1590,GO:0032367,1,0.48368524984853,0,2,intracellular cholesterol transport,BP,
1591,GO:0032368,1,0.682570813562739,0,2,regulation of lipid transport,BP,
1592,GO:0032369,1,0.980476126491385,0,1,negative regulation of lipid transport,BP,
1593,GO:0032370,1,0.696563650306504,0,1,positive regulation of lipid transport,BP,
1594,GO:0032371,1,0.682570813562739,0,2,regulation of sterol transport,BP,
1595,GO:0032372,1,0.980476126491385,0,1,negative regulation of sterol transport,BP,
1596,GO:0032373,1,0.696563650306504,0,1,positive regulation of sterol transport,BP,
1597,GO:0032374,1,0.682570813562739,0,2,regulation of cholesterol transport,BP,
1598,GO:0032375,1,0.980476126491385,0,1,negative regulation of cholesterol transport,BP,
1599,GO:0032376,1,0.696563650306504,0,1,positive regulation of cholesterol transport,BP,
1601,GO:0032403,1,0.420176958552224,0,4,protein complex binding,MF,
1602,GO:0032409,1,0.729159739479172,0,2,regulation of transporter activity,BP,
1603,GO:0032411,1,0.747407444585123,0,1,positive regulation of transporter activity,BP,
1604,GO:0032412,1,0.729159739479172,0,2,regulation of ion transmembrane transporter activity,BP,
1605,GO:0032414,1,0.747407444585123,0,1,positive regulation of ion transmembrane transporter activity,BP,
1606,GO:0032429,1,0.933430464161949,0,1,regulation of phospholipase A2 activity,BP,
1607,GO:0032430,1,0.933430464161949,0,1,positive regulation of phospholipase A2 activity,BP,
1608,GO:0032431,1,0.933430464161949,0,1,activation of phospholipase A2 activity,BP,
1611,GO:0032480,1,0.795813072902997,0,2,negative regulation of type I interferon production,BP,
1617,GO:0032515,1,0.747407444585123,0,1,negative regulation of phosphoprotein phosphatase activity,BP,
1618,GO:0032526,1,0.939570220896901,0,1,response to retinoic acid,BP,
1619,GO:0032535,1,0.634209419079781,0,3,regulation of cellular component size,BP,
1620,GO:0032543,1,0.634514931652741,0,3,mitochondrial translation,BP,
1621,GO:0032549,1,0.701667730772414,0,1,ribonucleoside binding,MF,
1622,GO:0032550,1,0.701667730772414,0,1,purine ribonucleoside binding,MF,
1626,GO:0032561,1,0.701667730772414,0,1,guanyl ribonucleotide binding,MF,
1627,GO:0032592,1,0.704322975564546,0,1,integral component of mitochondrial membrane,CC,
1630,GO:0032607,1,0.843648241871817,0,1,interferon-alpha production,BP,
1632,GO:0032609,1,0.718490506941261,0,2,interferon-gamma production,BP,
1633,GO:0032611,1,0.943785593081157,0,1,interleukin-1 beta production,BP,
1634,GO:0032612,1,0.943785593081157,0,1,interleukin-1 production,BP,
1635,GO:0032613,1,0.943785593081157,0,1,interleukin-10 production,BP,
1638,GO:0032637,1,0.718490506941261,0,2,interleukin-8 production,BP,
1641,GO:0032647,1,0.843648241871817,0,1,regulation of interferon-alpha production,BP,
1643,GO:0032649,1,0.718490506941261,0,2,regulation of interferon-gamma production,BP,
1644,GO:0032651,1,0.943785593081157,0,1,regulation of interleukin-1 beta production,BP,
1645,GO:0032652,1,0.943785593081157,0,1,regulation of interleukin-1 production,BP,
1646,GO:0032653,1,0.943785593081157,0,1,regulation of interleukin-10 production,BP,
1648,GO:0032677,1,0.718490506941261,0,2,regulation of interleukin-8 production,BP,
1650,GO:0032687,1,0.843648241871817,0,1,negative regulation of interferon-alpha production,BP,
1651,GO:0032688,1,0.795813072902997,0,2,negative regulation of interferon-beta production,BP,
1654,GO:0032729,1,0.718490506941261,0,2,positive regulation of interferon-gamma production,BP,
1655,GO:0032731,1,0.943785593081157,0,1,positive regulation of interleukin-1 beta production,BP,
1656,GO:0032732,1,0.943785593081157,0,1,positive regulation of interleukin-1 production,BP,
1657,GO:0032733,1,0.943785593081157,0,1,positive regulation of interleukin-10 production,BP,
1659,GO:0032757,1,0.718490506941261,0,2,positive regulation of interleukin-8 production,BP,
1661,GO:0032768,1,0.804275223167467,0,2,regulation of monooxygenase activity,BP,
1662,GO:0032769,1,0.856884470493401,0,1,negative regulation of monooxygenase activity,BP,
1664,GO:0032780,1,0.747407444585123,0,1,negative regulation of ATPase activity,BP,
1665,GO:0032781,1,0.747407444585123,0,1,positive regulation of ATPase activity,BP,
1666,GO:0032784,1,0.736460913827081,0,1,regulation of DNA-templated transcription, elongation,BP,
1668,GO:0032813,1,0.55344739271292,0,3,tumor necrosis factor receptor superfamily binding,MF,
1672,GO:0032845,1,0.657928246177915,0,2,negative regulation of homeostatic process,BP,
1676,GO:0032872,1,0.943785593081157,0,1,regulation of stress-activated MAPK cascade,BP,
1677,GO:0032874,1,0.943785593081157,0,1,positive regulation of stress-activated MAPK cascade,BP,
1680,GO:0032934,1,0.48368524984853,0,2,sterol binding,MF,
1685,GO:0032956,1,0.826321000735877,0,2,regulation of actin cytoskeleton organization,BP,
1686,GO:0032963,1,0.753245494607556,0,1,collagen metabolic process,BP,
1687,GO:0032970,1,0.826321000735877,0,2,regulation of actin filament-based process,BP,
1688,GO:0032984,1,0.75549102206036,0,3,macromolecular complex disassembly,BP,
1690,GO:0032990,1,0.475473553676654,0,3,cell part morphogenesis,BP,
1692,GO:0032994,1,0.980476126491385,0,1,protein-lipid complex,CC,
1693,GO:0033002,1,0.87680015774621,0,2,muscle cell proliferation,BP,
1696,GO:0033043,1,0.364483949574865,0,5,regulation of organelle organization,BP,
1697,GO:0033076,1,0.751229237583286,0,1,isoquinoline alkaloid metabolic process,BP,
1698,GO:0033077,1,0.761888585522679,0,1,T cell differentiation in thymus,BP,
1700,GO:0033162,1,0.751229237583286,0,1,melanosome membrane,CC,
1701,GO:0033185,1,0.981296617652802,0,1,dolichol-phosphate-mannose synthase complex,CC,
1702,GO:0033209,1,0.640206081154498,0,4,tumor necrosis factor-mediated signaling pathway,BP,
1703,GO:0033218,1,0.647348059193898,0,2,amide binding,MF,
1704,GO:0033238,1,0.932766532291112,0,1,regulation of cellular amine metabolic process,BP,
1705,GO:0033267,1,0.751229237583286,0,1,axon part,CC,
1706,GO:0033293,1,0.898308432523336,0,2,monocarboxylic acid binding,MF,
1707,GO:0033306,1,0.756629123575041,0,1,phytol metabolic process,BP,
1708,GO:0033344,1,0.682570813562739,0,2,cholesterol efflux,BP,
1709,GO:0033365,1,0.864933823131346,0,1,protein localization to organelle,BP,
1713,GO:0033539,1,0.453297080026415,0,3,fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,
1715,GO:0033559,1,0.694297055380902,0,1,unsaturated fatty acid metabolic process,BP,
1716,GO:0033612,1,0.718490506941261,0,2,receptor serine/threonine kinase binding,MF,
1718,GO:0033673,1,0.540160745020479,0,3,negative regulation of kinase activity,BP,
1719,GO:0033674,1,0.539884746004702,0,3,positive regulation of kinase activity,BP,
1720,GO:0033700,1,0.682570813562739,0,2,phospholipid efflux,BP,
1722,GO:0033865,1,0.667127256667468,0,2,nucleoside bisphosphate metabolic process,BP,
1723,GO:0033866,1,0.719058751904449,0,1,nucleoside bisphosphate biosynthetic process,BP,
1724,GO:0033869,1,0.928823333484811,0,1,nucleoside bisphosphate catabolic process,BP,
1725,GO:0033875,1,0.667127256667468,0,2,ribonucleoside bisphosphate metabolic process,BP,
1727,GO:0034030,1,0.719058751904449,0,1,ribonucleoside bisphosphate biosynthetic process,BP,
1728,GO:0034031,1,0.928823333484811,0,1,ribonucleoside bisphosphate catabolic process,BP,
1729,GO:0034032,1,0.667127256667468,0,2,purine nucleoside bisphosphate metabolic process,BP,
1730,GO:0034033,1,0.719058751904449,0,1,purine nucleoside bisphosphate biosynthetic process,BP,
1731,GO:0034034,1,0.928823333484811,0,1,purine nucleoside bisphosphate catabolic process,BP,
1732,GO:0034040,1,0.696563650306504,0,1,lipid-transporting ATPase activity,MF,
1733,GO:0034041,1,0.696563650306504,0,1,sterol-transporting ATPase activity,MF,
1740,GO:0034220,1,0.148159074760572,0,8,ion transmembrane transport,BP,
1742,GO:0034249,1,0.933430464161949,0,1,negative regulation of cellular amide metabolic process,BP,
1744,GO:0034260,1,0.747407444585123,0,1,negative regulation of GTPase activity,BP,
1745,GO:0034284,1,0.522121728666879,0,2,response to monosaccharide,BP,
1746,GO:0034308,1,0.710300140996012,0,2,primary alcohol metabolic process,BP,
1747,GO:0034330,1,0.933430464161949,0,1,cell junction organization,BP,
1748,GO:0034332,1,0.933430464161949,0,1,adherens junction organization,BP,
1750,GO:0034341,1,0.542438398215513,0,3,response to interferon-gamma,BP,
1752,GO:0034358,1,0.980476126491385,0,1,plasma lipoprotein particle,CC,
1753,GO:0034361,1,0.980476126491385,0,1,very-low-density lipoprotein particle,CC,
1754,GO:0034364,1,0.980476126491385,0,1,high-density lipoprotein particle,CC,
1755,GO:0034367,1,0.682570813562739,0,2,macromolecular complex remodeling,BP,
1756,GO:0034368,1,0.682570813562739,0,2,protein-lipid complex remodeling,BP,
1757,GO:0034369,1,0.682570813562739,0,2,plasma lipoprotein particle remodeling,BP,
1758,GO:0034374,1,0.696563650306504,0,1,low-density lipoprotein particle remodeling,BP,
1759,GO:0034375,1,0.682570813562739,0,2,high-density lipoprotein particle remodeling,BP,
1760,GO:0034377,1,0.980476126491385,0,1,plasma lipoprotein particle assembly,BP,
1761,GO:0034379,1,0.980476126491385,0,1,very-low-density lipoprotein particle assembly,BP,
1762,GO:0034381,1,0.980476126491385,0,1,plasma lipoprotein particle clearance,BP,
1763,GO:0034382,1,0.980476126491385,0,1,chylomicron remnant clearance,BP,
1764,GO:0034385,1,0.980476126491385,0,1,triglyceride-rich plasma lipoprotein particle,CC,
1765,GO:0034394,1,0.953041941460832,0,1,protein localization to cell surface,BP,
1768,GO:0034433,1,0.682570813562739,0,2,steroid esterification,BP,
1769,GO:0034434,1,0.682570813562739,0,2,sterol esterification,BP,
1770,GO:0034435,1,0.682570813562739,0,2,cholesterol esterification,BP,
1771,GO:0034436,1,0.696563650306504,0,1,glycoprotein transport,BP,
1772,GO:0034437,1,0.696563650306504,0,1,glycoprotein transporter activity,MF,
1774,GO:0034447,1,0.980476126491385,0,1,very-low-density lipoprotein particle clearance,BP,
1776,GO:0034504,1,0.864933823131346,0,1,protein localization to nucleus,BP,
1777,GO:0034599,1,0.645356071201875,0,2,cellular response to oxidative stress,BP,
1778,GO:0034612,1,0.640206081154498,0,4,response to tumor necrosis factor,BP,
1780,GO:0034614,1,0.747407444585123,0,1,cellular response to reactive oxygen species,BP,
1781,GO:0034617,1,0.751229237583286,0,1,tetrahydrobiopterin binding,MF,
1782,GO:0034620,1,0.708832017662095,0,1,cellular response to unfolded protein,BP,
1783,GO:0034622,1,0.665441773097044,0,4,cellular macromolecular complex assembly,BP,
1784,GO:0034632,1,0.939570220896901,0,1,retinol transporter activity,MF,
1785,GO:0034633,1,0.939570220896901,0,1,retinol transport,BP,
1786,GO:0034638,1,0.980476126491385,0,1,phosphatidylcholine catabolic process,BP,
1792,GO:0034698,1,0.697654729170719,0,1,response to gonadotropin,BP,
1793,GO:0034699,1,0.697654729170719,0,1,response to luteinizing hormone,BP,
1794,GO:0034702,1,0.469496936600561,0,3,ion channel complex,CC,
1795,GO:0034703,1,0.481617645613711,0,2,cation channel complex,CC,
1796,GO:0034707,1,0.976084701408914,0,1,chloride channel complex,CC,
1798,GO:0034762,1,0.565566921198172,0,3,regulation of transmembrane transport,BP,
1799,GO:0034764,1,0.729159739479172,0,2,positive regulation of transmembrane transport,BP,
1800,GO:0034765,1,0.565566921198172,0,3,regulation of ion transmembrane transport,BP,
1801,GO:0034767,1,0.729159739479172,0,2,positive regulation of ion transmembrane transport,BP,
1804,GO:0035004,1,0.836616111386651,0,1,phosphatidylinositol 3-kinase activity,MF,
1806,GO:0035094,1,0.522121728666879,0,2,response to nicotine,BP,
1807,GO:0035112,1,0.939570220896901,0,1,genitalia morphogenesis,BP,
1808,GO:0035176,1,0.751229237583286,0,1,social behavior,BP,
1809,GO:0035235,1,0.694072074177941,0,1,ionotropic glutamate receptor signaling pathway,BP,
1810,GO:0035240,1,0.751229237583286,0,1,dopamine binding,MF,
1811,GO:0035251,1,0.904259787207722,0,1,UDP-glucosyltransferase activity,MF,
1813,GO:0035265,1,0.939570220896901,0,1,organ growth,BP,
1814,GO:0035268,1,0.981296617652802,0,1,protein mannosylation,BP,
1815,GO:0035269,1,0.981296617652802,0,1,protein O-linked mannosylation,BP,
1817,GO:0035303,1,0.747407444585123,0,1,regulation of dephosphorylation,BP,
1818,GO:0035304,1,0.747407444585123,0,1,regulation of protein dephosphorylation,BP,
1819,GO:0035305,1,0.747407444585123,0,1,negative regulation of dephosphorylation,BP,
1820,GO:0035306,1,0.747407444585123,0,1,positive regulation of dephosphorylation,BP,
1821,GO:0035308,1,0.747407444585123,0,1,negative regulation of protein dephosphorylation,BP,
1822,GO:0035335,1,0.964984050020043,0,1,peptidyl-tyrosine dephosphorylation,BP,
1828,GO:0035434,1,0.778136964138319,0,1,copper ion transmembrane transport,BP,
1829,GO:0035455,1,0.697654729170719,0,1,response to interferon-alpha,BP,
1830,GO:0035457,1,0.697654729170719,0,1,cellular response to interferon-alpha,BP,
1832,GO:0035567,1,0.932766532291112,0,1,non-canonical Wnt signaling pathway,BP,
1834,GO:0035586,1,0.698431002476331,0,1,purinergic receptor activity,MF,
1835,GO:0035587,1,0.698431002476331,0,1,purinergic receptor signaling pathway,BP,
1836,GO:0035588,1,0.698431002476331,0,1,G-protein coupled purinergic receptor signaling pathway,BP,
1837,GO:0035589,1,0.698431002476331,0,1,G-protein coupled purinergic nucleotide receptor signaling pathway,BP,
1838,GO:0035590,1,0.698431002476331,0,1,purinergic nucleotide receptor signaling pathway,BP,
1839,GO:0035601,1,0.753988517867515,0,1,protein deacylation,BP,
1840,GO:0035623,1,0.695903409309486,0,1,renal glucose absorption,BP,
1841,GO:0035637,1,0.976084701408914,0,1,multicellular organismal signaling,BP,
1844,GO:0035690,1,0.751229237583286,0,1,cellular response to drug,BP,
1845,GO:0035697,1,0.761888585522679,0,1,CD8-positive, alpha-beta T cell extravasation,BP,
1846,GO:0035698,1,0.761888585522679,0,1,CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
1847,GO:0035725,1,0.976084701408914,0,1,sodium ion transmembrane transport,BP,
1848,GO:0035766,1,0.836616111386651,0,1,cell chemotaxis to fibroblast growth factor,BP,
1849,GO:0035767,1,0.836616111386651,0,1,endothelial cell chemotaxis,BP,
1850,GO:0035768,1,0.836616111386651,0,1,endothelial cell chemotaxis to fibroblast growth factor,BP,
1851,GO:0035770,1,0.694332314327877,0,1,ribonucleoprotein granule,CC,
1852,GO:0035794,1,0.745600768235738,0,1,positive regulation of mitochondrial membrane permeability,BP,
1853,GO:0035795,1,0.64378764821232,0,2,negative regulation of mitochondrial membrane permeability,BP,
1854,GO:0035877,1,0.657928246177915,0,2,death effector domain binding,MF,
1855,GO:0035900,1,0.751229237583286,0,1,response to isolation stress,BP,
1856,GO:0035902,1,0.751229237583286,0,1,response to immobilization stress,BP,
1857,GO:0035914,1,0.910467635192227,0,1,skeletal muscle cell differentiation,BP,
1858,GO:0035962,1,0.694832717893905,0,1,response to interleukin-13,BP,
1859,GO:0035963,1,0.694832717893905,0,1,cellular response to interleukin-13,BP,
1860,GO:0035966,1,0.708832017662095,0,1,response to topologically incorrect protein,BP,
1861,GO:0035967,1,0.708832017662095,0,1,cellular response to topologically incorrect protein,BP,
1862,GO:0036041,1,0.916336727632546,0,1,long-chain fatty acid binding,MF,
1863,GO:0036072,1,0.836616111386651,0,1,direct ossification,BP,
1864,GO:0036075,1,0.836616111386651,0,1,replacement ossification,BP,
1865,GO:0036092,1,0.836616111386651,0,1,phosphatidylinositol-3-phosphate biosynthetic process,BP,
1867,GO:0036109,1,0.694297055380902,0,1,alpha-linolenic acid metabolic process,BP,
1868,GO:0036149,1,0.891636723651273,0,1,phosphatidylinositol acyl-chain remodeling,BP,
1869,GO:0036150,1,0.891636723651273,0,1,phosphatidylserine acyl-chain remodeling,BP,
1870,GO:0036151,1,0.891636723651273,0,1,phosphatidylcholine acyl-chain remodeling,BP,
1871,GO:0036152,1,0.891636723651273,0,1,phosphatidylethanolamine acyl-chain remodeling,BP,
1874,GO:0036293,1,0.378077335569273,0,6,response to decreased oxygen levels,BP,
1875,GO:0036294,1,0.631598129129074,0,3,cellular response to decreased oxygen levels,BP,
1876,GO:0036376,1,0.976084701408914,0,1,sodium ion export from cell,BP,
1877,GO:0036379,1,0.875900879520659,0,1,myofilament,CC,
1878,GO:0036462,1,0.761888585522679,0,1,TRAIL-activated apoptotic signaling pathway,BP,
1879,GO:0036464,1,0.694332314327877,0,1,cytoplasmic ribonucleoprotein granule,CC,
1880,GO:0036473,1,0.864933823131346,0,1,cell death in response to oxidative stress,BP,
1881,GO:0036477,1,0.155032198059504,0,7,somatodendritic compartment,CC,
1882,GO:0036498,1,0.708832017662095,0,1,IRE1-mediated unfolded protein response,BP,
1883,GO:0038023,1,0.29947561182879,0,4,signaling receptor activity,MF,
1884,GO:0038034,1,0.761888585522679,0,1,signal transduction in absence of ligand,BP,
1885,GO:0038061,1,0.932766532291112,0,1,NIK/NF-kappaB signaling,BP,
1886,GO:0038093,1,0.932766532291112,0,1,Fc receptor signaling pathway,BP,
1887,GO:0038095,1,0.932766532291112,0,1,Fc-epsilon receptor signaling pathway,BP,
1888,GO:0038127,1,0.754361961097869,0,1,ERBB signaling pathway,BP,
1890,GO:0040008,1,0.651657972044878,0,2,regulation of growth,BP,
1892,GO:0040012,1,0.306007309814281,0,5,regulation of locomotion,BP,
1893,GO:0040013,1,0.747407444585123,0,1,negative regulation of locomotion,BP,
1894,GO:0040014,1,0.694332314327877,0,1,regulation of multicellular organism growth,BP,
1895,GO:0040017,1,0.41352449583698,0,4,positive regulation of locomotion,BP,
1896,GO:0040018,1,0.694332314327877,0,1,positive regulation of multicellular organism growth,BP,
1899,GO:0042036,1,0.843648241871817,0,1,negative regulation of cytokine biosynthetic process,BP,
1900,GO:0042058,1,0.754361961097869,0,1,regulation of epidermal growth factor receptor signaling pathway,BP,
1901,GO:0042060,1,0.482943756904327,0,2,wound healing,BP,
1907,GO:0042104,1,0.718490506941261,0,2,positive regulation of activated T cell proliferation,BP,
1916,GO:0042133,1,0.751229237583286,0,1,neurotransmitter metabolic process,BP,
1917,GO:0042136,1,0.751229237583286,0,1,neurotransmitter biosynthetic process,BP,
1918,GO:0042147,1,0.598670005301796,0,2,retrograde transport, endosome to Golgi,BP,
1919,GO:0042157,1,0.502352230097894,0,4,lipoprotein metabolic process,BP,
1920,GO:0042158,1,0.981296617652802,0,1,lipoprotein biosynthetic process,BP,
1921,GO:0042159,1,0.753988517867515,0,1,lipoprotein catabolic process,BP,
1924,GO:0042176,1,0.696487978099319,0,2,regulation of protein catabolic process,BP,
1927,GO:0042214,1,0.751229237583286,0,1,terpene metabolic process,BP,
1928,GO:0042219,1,0.69574435000495,0,1,cellular modified amino acid catabolic process,BP,
1929,GO:0042220,1,0.761888585522679,0,1,response to cocaine,BP,
1932,GO:0042277,1,0.647348059193898,0,2,peptide binding,MF,
1935,GO:0042303,1,0.843648241871817,0,1,molting cycle,BP,
1937,GO:0042306,1,0.864933823131346,0,1,regulation of protein import into nucleus,BP,
1938,GO:0042325,1,0.287163776535355,0,6,regulation of phosphorylation,BP,
1939,GO:0042326,1,0.540160745020479,0,3,negative regulation of phosphorylation,BP,
1940,GO:0042327,1,0.508589373990247,0,4,positive regulation of phosphorylation,BP,
1941,GO:0042330,1,0.629865537308081,0,2,taxis,BP,
1944,GO:0042345,1,0.864933823131346,0,1,regulation of NF-kappaB import into nucleus,BP,
1945,GO:0042348,1,0.864933823131346,0,1,NF-kappaB import into nucleus,BP,
1947,GO:0042364,1,0.747407444585123,0,1,water-soluble vitamin biosynthetic process,BP,
1948,GO:0042379,1,0.969995247214235,0,1,chemokine receptor binding,MF,
1949,GO:0042383,1,0.976084701408914,0,1,sarcolemma,CC,
1950,GO:0042391,1,0.677042443569163,0,2,regulation of membrane potential,BP,
1951,GO:0042398,1,0.954268878312379,0,1,cellular modified amino acid biosynthetic process,BP,
1952,GO:0042402,1,0.69574435000495,0,1,cellular biogenic amine catabolic process,BP,
1953,GO:0042414,1,0.751229237583286,0,1,epinephrine metabolic process,BP,
1954,GO:0042415,1,0.751229237583286,0,1,norepinephrine metabolic process,BP,
1955,GO:0042416,1,0.751229237583286,0,1,dopamine biosynthetic process,BP,
1956,GO:0042417,1,0.751229237583286,0,1,dopamine metabolic process,BP,
1957,GO:0042418,1,0.751229237583286,0,1,epinephrine biosynthetic process,BP,
1958,GO:0042421,1,0.751229237583286,0,1,norepinephrine biosynthetic process,BP,
1959,GO:0042423,1,0.751229237583286,0,1,catecholamine biosynthetic process,BP,
1960,GO:0042426,1,0.69574435000495,0,1,choline catabolic process,BP,
1965,GO:0042448,1,0.757779355427395,0,1,progesterone metabolic process,BP,
1967,GO:0042461,1,0.751229237583286,0,1,photoreceptor cell development,BP,
1968,GO:0042462,1,0.751229237583286,0,1,eye photoreceptor cell development,BP,
1969,GO:0042470,1,0.751229237583286,0,1,melanosome,CC,
1971,GO:0042503,1,0.694332314327877,0,1,tyrosine phosphorylation of Stat3 protein,BP,
1972,GO:0042506,1,0.694332314327877,0,1,tyrosine phosphorylation of Stat5 protein,BP,
1973,GO:0042509,1,0.694332314327877,0,1,regulation of tyrosine phosphorylation of STAT protein,BP,
1974,GO:0042516,1,0.694332314327877,0,1,regulation of tyrosine phosphorylation of Stat3 protein,BP,
1975,GO:0042517,1,0.694332314327877,0,1,positive regulation of tyrosine phosphorylation of Stat3 protein,BP,
1976,GO:0042522,1,0.694332314327877,0,1,regulation of tyrosine phosphorylation of Stat5 protein,BP,
1977,GO:0042523,1,0.694332314327877,0,1,positive regulation of tyrosine phosphorylation of Stat5 protein,BP,
1978,GO:0042531,1,0.694332314327877,0,1,positive regulation of tyrosine phosphorylation of STAT protein,BP,
1979,GO:0042537,1,0.522121728666879,0,2,benzene-containing compound metabolic process,BP,
1980,GO:0042542,1,0.697654729170719,0,1,response to hydrogen peroxide,BP,
1982,GO:0042558,1,0.872778904713787,0,2,pteridine-containing compound metabolic process,BP,
1983,GO:0042559,1,0.872778904713787,0,2,pteridine-containing compound biosynthetic process,BP,
1984,GO:0042562,1,0.694332314327877,0,1,hormone binding,MF,
1985,GO:0042572,1,0.939570220896901,0,1,retinol metabolic process,BP,
1986,GO:0042578,1,0.792160037434877,0,2,phosphoric ester hydrolase activity,MF,
1987,GO:0042579,1,0.159297746449074,0,8,microbody,CC,
1989,GO:0042590,1,0.863091121236512,0,2,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,
1993,GO:0042623,1,0.696563650306504,0,1,ATPase activity, coupled,MF,
1994,GO:0042626,1,0.696563650306504,0,1,ATPase activity, coupled to transmembrane movement of substances,MF,
1995,GO:0042627,1,0.980476126491385,0,1,chylomicron,CC,
1996,GO:0042632,1,0.63739977840031,0,2,cholesterol homeostasis,BP,
1997,GO:0042633,1,0.843648241871817,0,1,hair cycle,BP,
1998,GO:0042634,1,0.843648241871817,0,1,regulation of hair cycle,BP,
1999,GO:0042635,1,0.843648241871817,0,1,positive regulation of hair cycle,BP,
2000,GO:0042645,1,0.708832017662095,0,1,mitochondrial nucleoid,CC,
2001,GO:0042698,1,0.933430464161949,0,1,ovulation cycle,BP,
2002,GO:0042726,1,0.821260517451259,0,1,flavin-containing compound metabolic process,BP,
2003,GO:0042742,1,0.943785593081157,0,1,defense response to bacterium,BP,
2004,GO:0042745,1,0.522121728666879,0,2,circadian sleep/wake cycle,BP,
2005,GO:0042747,1,0.697654729170719,0,1,circadian sleep/wake cycle, REM sleep,BP,
2006,GO:0042755,1,0.751229237583286,0,1,eating behavior,BP,
2007,GO:0042759,1,0.695794073033159,0,1,long-chain fatty acid biosynthetic process,BP,
2008,GO:0042761,1,0.695794073033159,0,1,very long-chain fatty acid biosynthetic process,BP,
2010,GO:0042771,1,0.943785593081157,0,1,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
2011,GO:0042787,1,0.932766532291112,0,1,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
2016,GO:0042940,1,0.695099127173731,0,1,D-amino acid transport,BP,
2017,GO:0042976,1,0.694332314327877,0,1,activation of Janus kinase activity,BP,
2018,GO:0042977,1,0.694332314327877,0,1,activation of JAK2 kinase activity,BP,
2020,GO:0042982,1,0.696563650306504,0,1,amyloid precursor protein metabolic process,BP,
2021,GO:0042987,1,0.696563650306504,0,1,amyloid precursor protein catabolic process,BP,
2022,GO:0042990,1,0.864933823131346,0,1,regulation of transcription factor import into nucleus,BP,
2023,GO:0042991,1,0.864933823131346,0,1,transcription factor import into nucleus,BP,
2025,GO:0043005,1,0.128318598258133,0,7,neuron projection,CC,
2026,GO:0043009,1,0.939570220896901,0,1,chordate embryonic development,BP,
2027,GO:0043010,1,0.705216484249791,0,2,camera-type eye development,BP,
2028,GO:0043014,1,0.694689250747339,0,1,alpha-tubulin binding,MF,
2030,GO:0043025,1,0.226943492723792,0,6,neuronal cell body,CC,
2031,GO:0043027,1,0.864933823131346,0,1,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,
2032,GO:0043028,1,0.815946865122908,0,2,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,
2033,GO:0043029,1,0.761888585522679,0,1,T cell homeostasis,BP,
2034,GO:0043030,1,0.694832717893905,0,1,regulation of macrophage activation,BP,
2042,GO:0043086,1,0.248755298440576,0,8,negative regulation of catalytic activity,BP,
2043,GO:0043087,1,0.430353211909635,0,3,regulation of GTPase activity,BP,
2044,GO:0043090,1,0.695099127173731,0,1,amino acid import,BP,
2045,GO:0043092,1,0.695099127173731,0,1,L-amino acid import,BP,
2051,GO:0043124,1,0.943785593081157,0,1,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,
2052,GO:0043154,1,0.864933823131346,0,1,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,
2053,GO:0043161,1,0.932766532291112,0,1,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,
2058,GO:0043177,1,0.37095136201529,0,5,organic acid binding,MF,
2059,GO:0043178,1,0.453456104151792,0,3,alcohol binding,MF,
2060,GO:0043195,1,0.751229237583286,0,1,terminal bouton,CC,
2062,GO:0043204,1,0.751229237583286,0,1,perikaryon,CC,
2064,GO:0043209,1,0.886207777244638,0,1,myelin sheath,CC,
2074,GO:0043235,1,0.277348307817373,0,4,receptor complex,CC,
2075,GO:0043241,1,0.75549102206036,0,3,protein complex disassembly,BP,
2076,GO:0043242,1,0.875900879520659,0,1,negative regulation of protein complex disassembly,BP,
2077,GO:0043244,1,0.875900879520659,0,1,regulation of protein complex disassembly,BP,
2078,GO:0043254,1,0.573321270273932,0,3,regulation of protein complex assembly,BP,
2079,GO:0043269,1,0.565566921198172,0,3,regulation of ion transport,BP,
2080,GO:0043270,1,0.729159739479172,0,2,positive regulation of ion transport,BP,
2082,GO:0043278,1,0.761888585522679,0,1,response to morphine,BP,
2083,GO:0043279,1,0.395181542268129,0,3,response to alkaloid,BP,
2086,GO:0043292,1,0.875900879520659,0,1,contractile fiber,CC,
2092,GO:0043405,1,0.579433012529212,0,2,regulation of MAP kinase activity,BP,
2093,GO:0043406,1,0.579433012529212,0,2,positive regulation of MAP kinase activity,BP,
2094,GO:0043408,1,0.545986672761227,0,3,regulation of MAPK cascade,BP,
2095,GO:0043410,1,0.545986672761227,0,3,positive regulation of MAPK cascade,BP,
2097,GO:0043413,1,0.614948783441457,0,3,macromolecule glycosylation,BP,
2098,GO:0043414,1,0.856456321962168,0,2,macromolecule methylation,BP,
2099,GO:0043433,1,0.943785593081157,0,1,negative regulation of sequence-specific DNA binding transcription factor activity,BP,
2102,GO:0043462,1,0.747407444585123,0,1,regulation of ATPase activity,BP,
2103,GO:0043473,1,0.751229237583286,0,1,pigmentation,BP,
2106,GO:0043491,1,0.694689250747339,0,1,protein kinase B signaling,BP,
2107,GO:0043492,1,0.696563650306504,0,1,ATPase activity, coupled to movement of substances,MF,
2109,GO:0043500,1,0.864933823131346,0,1,muscle adaptation,BP,
2110,GO:0043502,1,0.864933823131346,0,1,regulation of muscle adaptation,BP,
2111,GO:0043523,1,0.697654729170719,0,1,regulation of neuron apoptotic process,BP,
2112,GO:0043524,1,0.697654729170719,0,1,negative regulation of neuron apoptotic process,BP,
2113,GO:0043531,1,0.696563650306504,0,1,ADP binding,MF,
2114,GO:0043542,1,0.836616111386651,0,1,endothelial cell migration,BP,
2116,GO:0043547,1,0.430353211909635,0,3,positive regulation of GTPase activity,BP,
2117,GO:0043549,1,0.287163776535355,0,6,regulation of kinase activity,BP,
2118,GO:0043565,1,0.695903409309486,0,1,sequence-specific DNA binding,MF,
2119,GO:0043588,1,0.605058501875226,0,2,skin development,BP,
2123,GO:0043618,1,0.932766532291112,0,1,regulation of transcription from RNA polymerase II promoter in response to stress,BP,
2124,GO:0043620,1,0.932766532291112,0,1,regulation of DNA-templated transcription in response to stress,BP,
2125,GO:0043623,1,0.770761955450571,0,3,cellular protein complex assembly,BP,
2126,GO:0043624,1,0.75549102206036,0,3,cellular protein complex disassembly,BP,
2127,GO:0043627,1,0.697654729170719,0,1,response to estrogen,BP,
2128,GO:0043632,1,0.932766532291112,0,1,modification-dependent macromolecule catabolic process,BP,
2129,GO:0043648,1,0.118300906690125,0,7,dicarboxylic acid metabolic process,BP,
2130,GO:0043650,1,0.695099127173731,0,1,dicarboxylic acid biosynthetic process,BP,
2131,GO:0043651,1,0.694297055380902,0,1,linoleic acid metabolic process,BP,
2132,GO:0043666,1,0.747407444585123,0,1,regulation of phosphoprotein phosphatase activity,BP,
2133,GO:0043679,1,0.751229237583286,0,1,axon terminus,CC,
2134,GO:0043691,1,0.696563650306504,0,1,reverse cholesterol transport,BP,
2135,GO:0043783,1,0.704322975564546,0,1,oxidoreductase activity, oxidizing metal ions with flavin as acceptor,MF,
2139,GO:0043933,1,0.0668424877059159,0,15,macromolecular complex subunit organization,BP,
2140,GO:0044057,1,0.632667418781892,0,3,regulation of system process,BP,
2142,GO:0044087,1,0.270787542318267,0,5,regulation of cellular component biogenesis,BP,
2143,GO:0044088,1,0.694113237147052,0,1,regulation of vacuole organization,BP,
2144,GO:0044089,1,0.656102479742112,0,2,positive regulation of cellular component biogenesis,BP,
2145,GO:0044092,1,0.248755298440576,0,8,negative regulation of molecular function,BP,
2147,GO:0044106,1,0.6482016152171,0,2,cellular amine metabolic process,BP,
2148,GO:0044212,1,0.695903409309486,0,1,transcription regulatory region DNA binding,MF,
2149,GO:0044236,1,0.521022615577674,0,2,multicellular organism metabolic process,BP,
2153,GO:0044243,1,0.753245494607556,0,1,multicellular organismal catabolic process,BP,
2157,GO:0044257,1,0.696487978099319,0,2,cellular protein catabolic process,BP,
2158,GO:0044259,1,0.753245494607556,0,1,multicellular organismal macromolecule metabolic process,BP,
2161,GO:0044265,1,0.696487978099319,0,2,cellular macromolecule catabolic process,BP,
2171,GO:0044306,1,0.751229237583286,0,1,neuron projection terminus,CC,
2172,GO:0044321,1,0.697654729170719,0,1,response to leptin,BP,
2173,GO:0044325,1,0.976084701408914,0,1,ion channel binding,MF,
2174,GO:0044344,1,0.582223569304847,0,2,cellular response to fibroblast growth factor stimulus,BP,
2175,GO:0044351,1,0.943785593081157,0,1,macropinocytosis,BP,
2177,GO:0044391,1,0.863382075063917,0,2,ribosomal subunit,CC,
2180,GO:0044420,1,0.933430464161949,0,1,extracellular matrix component,CC,
2187,GO:0044430,1,0.313698263823861,0,4,cytoskeletal part,CC,
2188,GO:0044431,1,0.696563650306504,0,1,Golgi apparatus part,CC,
2192,GO:0044438,1,0.159297746449074,0,8,microbody part,CC,
2193,GO:0044439,1,0.159297746449074,0,8,peroxisomal part,CC,
2198,GO:0044449,1,0.875900879520659,0,1,contractile fiber part,CC,
2201,GO:0044455,1,0.489138900799433,0,2,mitochondrial membrane part,CC,
2202,GO:0044456,1,0.519414252612948,0,2,synapse part,CC,
2203,GO:0044459,1,0.0466682244348023,0,11,plasma membrane part,CC,
2204,GO:0044463,1,0.700563524748289,0,2,cell projection part,CC,
2206,GO:0044539,1,0.916336727632546,0,1,long-chain fatty acid import,BP,
2207,GO:0044548,1,0.910467635192227,0,1,S100 protein binding,MF,
2215,GO:0044708,1,0.245662730099537,0,5,single-organism behavior,BP,
2221,GO:0044744,1,0.864933823131346,0,1,protein targeting to nucleus,BP,
2226,GO:0044770,1,0.932766532291112,0,1,cell cycle phase transition,BP,
2227,GO:0044772,1,0.932766532291112,0,1,mitotic cell cycle phase transition,BP,
2228,GO:0044801,1,0.694113237147052,0,1,single-organism membrane fusion,BP,
2229,GO:0044802,1,0.444155466948372,0,3,single-organism membrane organization,BP,
2230,GO:0044839,1,0.932766532291112,0,1,cell cycle G2/M phase transition,BP,
2232,GO:0045009,1,0.751229237583286,0,1,chitosome,CC,
2233,GO:0045017,1,0.521222092001996,0,5,glycerolipid biosynthetic process,BP,
2234,GO:0045019,1,0.639291005791314,0,2,negative regulation of nitric oxide biosynthetic process,BP,
2235,GO:0045028,1,0.698431002476331,0,1,G-protein coupled purinergic nucleotide receptor activity,MF,
2236,GO:0045029,1,0.698431002476331,0,1,UDP-activated nucleotide receptor activity,MF,
2245,GO:0045111,1,0.718768411418121,0,1,intermediate filament cytoskeleton,CC,
2246,GO:0045121,1,0.641588149434177,0,2,membrane raft,CC,
2247,GO:0045123,1,0.761888585522679,0,1,cellular extravasation,BP,
2249,GO:0045137,1,0.456148756607111,0,3,development of primary sexual characteristics,BP,
2252,GO:0045211,1,0.694072074177941,0,1,postsynaptic membrane,CC,
2253,GO:0045216,1,0.933430464161949,0,1,cell-cell junction organization,BP,
2254,GO:0045251,1,0.704322975564546,0,1,electron transfer flavoprotein complex,CC,
2255,GO:0045296,1,0.705287574490218,0,1,cadherin binding,MF,
2257,GO:0045333,1,0.398045575476899,0,4,cellular respiration,BP,
2258,GO:0045349,1,0.843648241871817,0,1,interferon-alpha biosynthetic process,BP,
2261,GO:0045354,1,0.843648241871817,0,1,regulation of interferon-alpha biosynthetic process,BP,
2262,GO:0045355,1,0.843648241871817,0,1,negative regulation of interferon-alpha biosynthetic process,BP,
2264,GO:0045358,1,0.843648241871817,0,1,negative regulation of interferon-beta biosynthetic process,BP,
2270,GO:0045471,1,0.489598298314474,0,3,response to ethanol,BP,
2271,GO:0045472,1,0.751229237583286,0,1,response to ether,BP,
2272,GO:0045485,1,0.694297055380902,0,1,omega-6 fatty acid desaturase activity,MF,
2274,GO:0045542,1,0.696563650306504,0,1,positive regulation of cholesterol biosynthetic process,BP,
2278,GO:0045596,1,0.404253678307373,0,4,negative regulation of cell differentiation,BP,
2282,GO:0045637,1,0.761888585522679,0,1,regulation of myeloid cell differentiation,BP,
2283,GO:0045639,1,0.761888585522679,0,1,positive regulation of myeloid cell differentiation,BP,
2284,GO:0045649,1,0.761888585522679,0,1,regulation of macrophage differentiation,BP,
2285,GO:0045651,1,0.761888585522679,0,1,positive regulation of macrophage differentiation,BP,
2286,GO:0045664,1,0.696728333256898,0,1,regulation of neuron differentiation,BP,
2287,GO:0045665,1,0.696728333256898,0,1,negative regulation of neuron differentiation,BP,
2288,GO:0045682,1,0.843648241871817,0,1,regulation of epidermis development,BP,
2289,GO:0045684,1,0.843648241871817,0,1,positive regulation of epidermis development,BP,
2290,GO:0045717,1,0.694611389729427,0,2,negative regulation of fatty acid biosynthetic process,BP,
2291,GO:0045723,1,0.747407444585123,0,1,positive regulation of fatty acid biosynthetic process,BP,
2293,GO:0045732,1,0.696487978099319,0,2,positive regulation of protein catabolic process,BP,
2294,GO:0045742,1,0.754361961097869,0,1,positive regulation of epidermal growth factor receptor signaling pathway,BP,
2295,GO:0045744,1,0.698348976994063,0,1,negative regulation of G-protein coupled receptor protein signaling pathway,BP,
2297,GO:0045786,1,0.831341880353266,0,2,negative regulation of cell cycle,BP,
2298,GO:0045792,1,0.769211113770212,0,1,negative regulation of cell size,BP,
2299,GO:0045806,1,0.980476126491385,0,1,negative regulation of endocytosis,BP,
2300,GO:0045807,1,0.943785593081157,0,1,positive regulation of endocytosis,BP,
2301,GO:0045824,1,0.843648241871817,0,1,negative regulation of innate immune response,BP,
2302,GO:0045833,1,0.694611389729427,0,2,negative regulation of lipid metabolic process,BP,
2303,GO:0045834,1,0.320392933154883,0,5,positive regulation of lipid metabolic process,BP,
2304,GO:0045843,1,0.85516985302707,0,2,negative regulation of striated muscle tissue development,BP,
2305,GO:0045859,1,0.287163776535355,0,6,regulation of protein kinase activity,BP,
2306,GO:0045860,1,0.539884746004702,0,3,positive regulation of protein kinase activity,BP,
2307,GO:0045861,1,0.603434602546963,0,2,negative regulation of proteolysis,BP,
2311,GO:0045913,1,0.747407444585123,0,1,positive regulation of carbohydrate metabolic process,BP,
2312,GO:0045922,1,0.694611389729427,0,2,negative regulation of fatty acid metabolic process,BP,
2313,GO:0045923,1,0.747407444585123,0,1,positive regulation of fatty acid metabolic process,BP,
2314,GO:0045926,1,0.939570220896901,0,1,negative regulation of growth,BP,
2315,GO:0045927,1,0.694332314327877,0,1,positive regulation of growth,BP,
2316,GO:0045930,1,0.932766532291112,0,1,negative regulation of mitotic cell cycle,BP,
2319,GO:0045936,1,0.52907235125553,0,4,negative regulation of phosphate metabolic process,BP,
2320,GO:0045937,1,0.32707290878946,0,7,positive regulation of phosphate metabolic process,BP,
2321,GO:0045940,1,0.473688969393836,0,3,positive regulation of steroid metabolic process,BP,
2323,GO:0045981,1,0.953041941460832,0,1,positive regulation of nucleotide metabolic process,BP,
2324,GO:0046006,1,0.718490506941261,0,2,regulation of activated T cell proliferation,BP,
2325,GO:0046058,1,0.953041941460832,0,1,cAMP metabolic process,BP,
2329,GO:0046121,1,0.788063762325555,0,1,deoxyribonucleoside catabolic process,BP,
2332,GO:0046146,1,0.872778904713787,0,2,tetrahydrobiopterin metabolic process,BP,
2334,GO:0046189,1,0.751229237583286,0,1,phenol-containing compound biosynthetic process,BP,
2337,GO:0046322,1,0.708832017662095,0,1,negative regulation of fatty acid oxidation,BP,
2341,GO:0046328,1,0.943785593081157,0,1,regulation of JNK cascade,BP,
2342,GO:0046330,1,0.943785593081157,0,1,positive regulation of JNK cascade,BP,
2343,GO:0046339,1,0.933430464161949,0,1,diacylglycerol metabolic process,BP,
2344,GO:0046356,1,0.667127256667468,0,2,acetyl-CoA catabolic process,BP,
2345,GO:0046364,1,0.620611724240103,0,3,monosaccharide biosynthetic process,BP,
2346,GO:0046365,1,0.873547569641283,0,1,monosaccharide catabolic process,BP,
2347,GO:0046386,1,0.788063762325555,0,1,deoxyribose phosphate catabolic process,BP,
2348,GO:0046390,1,0.684717250127041,0,2,ribose phosphate biosynthetic process,BP,
2352,GO:0046425,1,0.694332314327877,0,1,regulation of JAK-STAT cascade,BP,
2353,GO:0046427,1,0.694332314327877,0,1,positive regulation of JAK-STAT cascade,BP,
2355,GO:0046449,1,0.694332314327877,0,1,creatinine metabolic process,BP,
2356,GO:0046456,1,0.661943602419084,0,2,icosanoid biosynthetic process,BP,
2357,GO:0046460,1,0.696988626234454,0,2,neutral lipid biosynthetic process,BP,
2358,GO:0046461,1,0.916336727632546,0,1,neutral lipid catabolic process,BP,
2359,GO:0046463,1,0.696988626234454,0,2,acylglycerol biosynthetic process,BP,
2360,GO:0046464,1,0.916336727632546,0,1,acylglycerol catabolic process,BP,
2362,GO:0046467,1,0.981296617652802,0,1,membrane lipid biosynthetic process,BP,
2363,GO:0046470,1,0.80040738895253,0,3,phosphatidylcholine metabolic process,BP,
2364,GO:0046474,1,0.751403243019573,0,3,glycerophospholipid biosynthetic process,BP,
2365,GO:0046475,1,0.980476126491385,0,1,glycerophospholipid catabolic process,BP,
2366,GO:0046477,1,0.856884470493401,0,1,glycosylceramide catabolic process,BP,
2369,GO:0046485,1,0.891636723651273,0,1,ether lipid metabolic process,BP,
2370,GO:0046486,1,0.389825755698931,0,8,glycerolipid metabolic process,BP,
2371,GO:0046487,1,0.705287574490218,0,1,glyoxylate metabolic process,BP,
2372,GO:0046488,1,0.630471590953432,0,4,phosphatidylinositol metabolic process,BP,
2375,GO:0046503,1,0.898308432523336,0,2,glycerolipid catabolic process,BP,
2378,GO:0046527,1,0.904259787207722,0,1,glucosyltransferase activity,MF,
2379,GO:0046530,1,0.751229237583286,0,1,photoreceptor cell differentiation,BP,
2380,GO:0046545,1,0.657593481630454,0,2,development of primary female sexual characteristics,BP,
2381,GO:0046546,1,0.697654729170719,0,1,development of primary male sexual characteristics,BP,
2383,GO:0046620,1,0.939570220896901,0,1,regulation of organ growth,BP,
2384,GO:0046621,1,0.939570220896901,0,1,negative regulation of organ growth,BP,
2393,GO:0046660,1,0.617040705527271,0,3,female sex differentiation,BP,
2395,GO:0046677,1,0.482655987602978,0,2,response to antibiotic,BP,
2396,GO:0046683,1,0.697654729170719,0,1,response to organophosphorus,BP,
2397,GO:0046684,1,0.751229237583286,0,1,response to pyrethroid,BP,
2398,GO:0046686,1,0.663590176861012,0,2,response to cadmium ion,BP,
2400,GO:0046717,1,0.695099127173731,0,1,acid secretion,BP,
2403,GO:0046834,1,0.722310216701496,0,2,lipid phosphorylation,BP,
2406,GO:0046854,1,0.722310216701496,0,2,phosphatidylinositol phosphorylation,BP,
2407,GO:0046864,1,0.939570220896901,0,1,isoprenoid transport,BP,
2408,GO:0046865,1,0.939570220896901,0,1,terpenoid transport,BP,
2410,GO:0046873,1,0.539054077007326,0,2,metal ion transmembrane transporter activity,MF,
2411,GO:0046879,1,0.939570220896901,0,1,hormone secretion,BP,
2412,GO:0046883,1,0.939570220896901,0,1,regulation of hormone secretion,BP,
2413,GO:0046887,1,0.939570220896901,0,1,positive regulation of hormone secretion,BP,
2414,GO:0046889,1,0.327376299987108,0,4,positive regulation of lipid biosynthetic process,BP,
2416,GO:0046902,1,0.64378764821232,0,2,regulation of mitochondrial membrane permeability,BP,
2421,GO:0046915,1,0.778136964138319,0,1,transition metal ion transmembrane transporter activity,MF,
2422,GO:0046916,1,0.778136964138319,0,1,cellular transition metal ion homeostasis,BP,
2423,GO:0046934,1,0.836616111386651,0,1,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,
2424,GO:0046942,1,0.440141535995694,0,3,carboxylic acid transport,BP,
2425,GO:0046943,1,0.695099127173731,0,1,carboxylic acid transmembrane transporter activity,MF,
2429,GO:0046952,1,0.719058751904449,0,1,ketone body catabolic process,BP,
2432,GO:0046997,1,0.69574435000495,0,1,oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor,MF,
2433,GO:0047015,1,0.936872137023806,0,1,3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,MF,
2436,GO:0047442,1,0.757779355427395,0,1,17-alpha-hydroxyprogesterone aldolase activity,MF,
2438,GO:0047750,1,0.9068568801805,0,1,cholestenol delta-isomerase activity,MF,
2439,GO:0047760,1,0.701667730772414,0,1,butyrate-CoA ligase activity,MF,
2440,GO:0047860,1,0.886207777244638,0,1,diiodophenylpyruvate reductase activity,MF,
2441,GO:0048002,1,0.814156852656112,0,3,antigen processing and presentation of peptide antigen,BP,
2442,GO:0048009,1,0.694332314327877,0,1,insulin-like growth factor receptor signaling pathway,BP,
2443,GO:0048010,1,0.836616111386651,0,1,vascular endothelial growth factor receptor signaling pathway,BP,
2444,GO:0048015,1,0.836616111386651,0,1,phosphatidylinositol-mediated signaling,BP,
2445,GO:0048017,1,0.836616111386651,0,1,inositol lipid-mediated signaling,BP,
2446,GO:0048020,1,0.969995247214235,0,1,CCR chemokine receptor binding,MF,
2447,GO:0048029,1,0.80215306869843,0,1,monosaccharide binding,MF,
2449,GO:0048038,1,0.704322975564546,0,1,quinone binding,MF,
2450,GO:0048039,1,0.704322975564546,0,1,ubiquinone binding,MF,
2451,GO:0048048,1,0.751229237583286,0,1,embryonic eye morphogenesis,BP,
2452,GO:0048144,1,0.925582526412575,0,1,fibroblast proliferation,BP,
2453,GO:0048145,1,0.925582526412575,0,1,regulation of fibroblast proliferation,BP,
2454,GO:0048147,1,0.925582526412575,0,1,negative regulation of fibroblast proliferation,BP,
2455,GO:0048148,1,0.761888585522679,0,1,behavioral response to cocaine,BP,
2456,GO:0048156,1,0.910467635192227,0,1,tau protein binding,MF,
2457,GO:0048167,1,0.634263927979616,0,2,regulation of synaptic plasticity,BP,
2458,GO:0048168,1,0.634263927979616,0,2,regulation of neuronal synaptic plasticity,BP,
2459,GO:0048193,1,0.672807452786215,0,2,Golgi vesicle transport,BP,
2460,GO:0048232,1,0.747407444585123,0,1,male gamete generation,BP,
2461,GO:0048244,1,0.80215306869843,0,1,phytanoyl-CoA dioxygenase activity,MF,
2462,GO:0048259,1,0.980476126491385,0,1,regulation of receptor-mediated endocytosis,BP,
2463,GO:0048261,1,0.980476126491385,0,1,negative regulation of receptor-mediated endocytosis,BP,
2464,GO:0048284,1,0.694113237147052,0,1,organelle fusion,BP,
2465,GO:0048305,1,0.939570220896901,0,1,immunoglobulin secretion,BP,
2466,GO:0048306,1,0.910467635192227,0,1,calcium-dependent protein binding,MF,
2468,GO:0048469,1,0.933430464161949,0,1,cell maturation,BP,
2469,GO:0048471,1,0.610520869863268,0,3,perinuclear region of cytoplasm,CC,
2471,GO:0048511,1,0.486328946159398,0,3,rhythmic process,BP,
2472,GO:0048512,1,0.522121728666879,0,2,circadian behavior,BP,
2474,GO:0048514,1,0.780448033435557,0,2,blood vessel morphogenesis,BP,
2481,GO:0048535,1,0.761888585522679,0,1,lymph node development,BP,
2482,GO:0048536,1,0.761888585522679,0,1,spleen development,BP,
2483,GO:0048538,1,0.761888585522679,0,1,thymus development,BP,
2484,GO:0048545,1,0.331119553230742,0,4,response to steroid hormone,BP,
2485,GO:0048562,1,0.705216484249791,0,2,embryonic organ morphogenesis,BP,
2486,GO:0048568,1,0.705216484249791,0,2,embryonic organ development,BP,
2491,GO:0048592,1,0.705216484249791,0,2,eye morphogenesis,BP,
2492,GO:0048593,1,0.705216484249791,0,2,camera-type eye morphogenesis,BP,
2493,GO:0048596,1,0.751229237583286,0,1,embryonic camera-type eye morphogenesis,BP,
2494,GO:0048598,1,0.705216484249791,0,2,embryonic morphogenesis,BP,
2495,GO:0048599,1,0.933430464161949,0,1,oocyte development,BP,
2498,GO:0048634,1,0.85516985302707,0,2,regulation of muscle organ development,BP,
2499,GO:0048635,1,0.85516985302707,0,2,negative regulation of muscle organ development,BP,
2500,GO:0048638,1,0.651657972044878,0,2,regulation of developmental growth,BP,
2501,GO:0048639,1,0.694332314327877,0,1,positive regulation of developmental growth,BP,
2502,GO:0048640,1,0.939570220896901,0,1,negative regulation of developmental growth,BP,
2503,GO:0048641,1,0.910467635192227,0,1,regulation of skeletal muscle tissue development,BP,
2504,GO:0048642,1,0.910467635192227,0,1,negative regulation of skeletal muscle tissue development,BP,
2505,GO:0048646,1,0.73267893679549,0,3,anatomical structure formation involved in morphogenesis,BP,
2506,GO:0048659,1,0.933430464161949,0,1,smooth muscle cell proliferation,BP,
2507,GO:0048660,1,0.933430464161949,0,1,regulation of smooth muscle cell proliferation,BP,
2508,GO:0048662,1,0.933430464161949,0,1,negative regulation of smooth muscle cell proliferation,BP,
2509,GO:0048666,1,0.242807174822077,0,5,neuron development,BP,
2510,GO:0048667,1,0.327164991205054,0,4,cell morphogenesis involved in neuron differentiation,BP,
2511,GO:0048699,1,0.166185975239268,0,6,generation of neurons,BP,
2512,GO:0048705,1,0.836616111386651,0,1,skeletal system morphogenesis,BP,
2513,GO:0048706,1,0.939570220896901,0,1,embryonic skeletal system development,BP,
2514,GO:0048708,1,0.910467635192227,0,1,astrocyte differentiation,BP,
2515,GO:0048729,1,0.932766532291112,0,1,tissue morphogenesis,BP,
2517,GO:0048732,1,0.405427824849557,0,3,gland development,BP,
2518,GO:0048738,1,0.939570220896901,0,1,cardiac muscle tissue development,BP,
2519,GO:0048770,1,0.751229237583286,0,1,pigment granule,CC,
2522,GO:0048807,1,0.939570220896901,0,1,female genitalia morphogenesis,BP,
2523,GO:0048812,1,0.475473553676654,0,3,neuron projection morphogenesis,BP,
2525,GO:0048858,1,0.475473553676654,0,3,cell projection morphogenesis,BP,
2529,GO:0048872,1,0.761888585522679,0,1,homeostasis of number of cells,BP,
2531,GO:0050277,1,0.694832717893905,0,1,sedoheptulokinase activity,MF,
2532,GO:0050508,1,0.694623670811036,0,1,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
2533,GO:0050543,1,0.916336727632546,0,1,icosatetraenoic acid binding,MF,
2542,GO:0050673,1,0.696988626234454,0,2,epithelial cell proliferation,BP,
2543,GO:0050678,1,0.696988626234454,0,2,regulation of epithelial cell proliferation,BP,
2544,GO:0050679,1,0.933430464161949,0,1,positive regulation of epithelial cell proliferation,BP,
2545,GO:0050680,1,0.747407444585123,0,1,negative regulation of epithelial cell proliferation,BP,
2546,GO:0050699,1,0.905354196087773,0,1,WW domain binding,MF,
2547,GO:0050701,1,0.943785593081157,0,1,interleukin-1 secretion,BP,
2548,GO:0050702,1,0.943785593081157,0,1,interleukin-1 beta secretion,BP,
2549,GO:0050704,1,0.943785593081157,0,1,regulation of interleukin-1 secretion,BP,
2550,GO:0050706,1,0.943785593081157,0,1,regulation of interleukin-1 beta secretion,BP,
2551,GO:0050707,1,0.943785593081157,0,1,regulation of cytokine secretion,BP,
2552,GO:0050708,1,0.575716379805678,0,4,regulation of protein secretion,BP,
2553,GO:0050714,1,0.575716379805678,0,4,positive regulation of protein secretion,BP,
2554,GO:0050715,1,0.943785593081157,0,1,positive regulation of cytokine secretion,BP,
2555,GO:0050716,1,0.943785593081157,0,1,positive regulation of interleukin-1 secretion,BP,
2556,GO:0050718,1,0.943785593081157,0,1,positive regulation of interleukin-1 beta secretion,BP,
2558,GO:0050730,1,0.694332314327877,0,1,regulation of peptidyl-tyrosine phosphorylation,BP,
2559,GO:0050731,1,0.694332314327877,0,1,positive regulation of peptidyl-tyrosine phosphorylation,BP,
2561,GO:0050764,1,0.943785593081157,0,1,regulation of phagocytosis,BP,
2562,GO:0050766,1,0.943785593081157,0,1,positive regulation of phagocytosis,BP,
2563,GO:0050767,1,0.483800990093764,0,2,regulation of neurogenesis,BP,
2564,GO:0050768,1,0.696728333256898,0,1,negative regulation of neurogenesis,BP,
2565,GO:0050769,1,0.697654729170719,0,1,positive regulation of neurogenesis,BP,
2566,GO:0050770,1,0.696728333256898,0,1,regulation of axonogenesis,BP,
2567,GO:0050771,1,0.696728333256898,0,1,negative regulation of axonogenesis,BP,
2569,GO:0050777,1,0.843648241871817,0,1,negative regulation of immune response,BP,
2571,GO:0050786,1,0.910467635192227,0,1,RAGE receptor binding,MF,
2577,GO:0050796,1,0.939570220896901,0,1,regulation of insulin secretion,BP,
2578,GO:0050798,1,0.718490506941261,0,2,activated T cell proliferation,BP,
2580,GO:0050802,1,0.697654729170719,0,1,circadian sleep/wake cycle, sleep,BP,
2581,GO:0050804,1,0.316859283953709,0,4,modulation of synaptic transmission,BP,
2582,GO:0050806,1,0.631931652730808,0,2,positive regulation of synaptic transmission,BP,
2585,GO:0050817,1,0.482943756904327,0,2,coagulation,BP,
2586,GO:0050818,1,0.694060852856155,0,1,regulation of coagulation,BP,
2587,GO:0050821,1,0.925582526412575,0,1,protein stabilization,BP,
2588,GO:0050829,1,0.943785593081157,0,1,defense response to Gram-negative bacterium,BP,
2589,GO:0050839,1,0.705287574490218,0,1,cell adhesion molecule binding,MF,
2590,GO:0050848,1,0.747407444585123,0,1,regulation of calcium-mediated signaling,BP,
2591,GO:0050851,1,0.932766532291112,0,1,antigen receptor-mediated signaling pathway,BP,
2592,GO:0050852,1,0.932766532291112,0,1,T cell receptor signaling pathway,BP,
2599,GO:0050873,1,0.885010007692516,0,2,brown fat cell differentiation,BP,
2601,GO:0050878,1,0.482943756904327,0,2,regulation of body fluid levels,BP,
2603,GO:0050890,1,0.683163917658201,0,2,cognition,BP,
2605,GO:0050900,1,0.718490506941261,0,2,leukocyte migration,BP,
2607,GO:0050920,1,0.836616111386651,0,1,regulation of chemotaxis,BP,
2608,GO:0050921,1,0.836616111386651,0,1,positive regulation of chemotaxis,BP,
2609,GO:0050953,1,0.705216484249791,0,2,sensory perception of light stimulus,BP,
2611,GO:0050994,1,0.691132724011711,0,2,regulation of lipid catabolic process,BP,
2612,GO:0050995,1,0.980476126491385,0,1,negative regulation of lipid catabolic process,BP,
2613,GO:0050997,1,0.980476126491385,0,1,quaternary ammonium group binding,MF,
2614,GO:0050999,1,0.804275223167467,0,2,regulation of nitric-oxide synthase activity,BP,
2615,GO:0051001,1,0.856884470493401,0,1,negative regulation of nitric-oxide synthase activity,BP,
2616,GO:0051004,1,0.980476126491385,0,1,regulation of lipoprotein lipase activity,BP,
2617,GO:0051005,1,0.980476126491385,0,1,negative regulation of lipoprotein lipase activity,BP,
2618,GO:0051015,1,0.875900879520659,0,1,actin filament binding,MF,
2619,GO:0051020,1,0.482448624128952,0,2,GTPase binding,MF,
2620,GO:0051023,1,0.939570220896901,0,1,regulation of immunoglobulin secretion,BP,
2621,GO:0051024,1,0.939570220896901,0,1,positive regulation of immunoglobulin secretion,BP,
2622,GO:0051046,1,0.575716379805678,0,4,regulation of secretion,BP,
2623,GO:0051047,1,0.575716379805678,0,4,positive regulation of secretion,BP,
2626,GO:0051051,1,0.73069935911704,0,2,negative regulation of transport,BP,
2627,GO:0051052,1,0.747407444585123,0,1,regulation of DNA metabolic process,BP,
2628,GO:0051053,1,0.747407444585123,0,1,negative regulation of DNA metabolic process,BP,
2629,GO:0051055,1,0.694611389729427,0,2,negative regulation of lipid biosynthetic process,BP,
2633,GO:0051093,1,0.279929610509318,0,6,negative regulation of developmental process,BP,
2638,GO:0051129,1,0.380593998314487,0,5,negative regulation of cellular component organization,BP,
2639,GO:0051130,1,0.656102479742112,0,2,positive regulation of cellular component organization,BP,
2640,GO:0051156,1,0.545804209021376,0,2,glucose 6-phosphate metabolic process,BP,
2643,GO:0051170,1,0.864933823131346,0,1,nuclear import,BP,
2649,GO:0051183,1,0.939570220896901,0,1,vitamin transporter activity,MF,
2651,GO:0051187,1,0.667127256667468,0,2,cofactor catabolic process,BP,
2655,GO:0051208,1,0.864933823131346,0,1,sequestering of calcium ion,BP,
2656,GO:0051209,1,0.864933823131346,0,1,release of sequestered calcium ion into cytosol,BP,
2657,GO:0051213,1,0.80215306869843,0,1,dioxygenase activity,MF,
2658,GO:0051216,1,0.836616111386651,0,1,cartilage development,BP,
2659,GO:0051222,1,0.575716379805678,0,4,positive regulation of protein transport,BP,
2663,GO:0051238,1,0.864933823131346,0,1,sequestering of metal ion,BP,
2666,GO:0051241,1,0.26956383519659,0,9,negative regulation of multicellular organismal process,BP,
2669,GO:0051248,1,0.232424625519293,0,8,negative regulation of protein metabolic process,BP,
2675,GO:0051258,1,0.770761955450571,0,3,protein polymerization,BP,
2676,GO:0051259,1,0.309939700550609,0,6,protein oligomerization,BP,
2677,GO:0051260,1,0.59250060219485,0,3,protein homooligomerization,BP,
2678,GO:0051261,1,0.875900879520659,0,1,protein depolymerization,BP,
2679,GO:0051262,1,0.82625471552652,0,2,protein tetramerization,BP,
2680,GO:0051270,1,0.306007309814281,0,5,regulation of cellular component movement,BP,
2681,GO:0051271,1,0.747407444585123,0,1,negative regulation of cellular component movement,BP,
2682,GO:0051272,1,0.41352449583698,0,4,positive regulation of cellular component movement,BP,
2683,GO:0051282,1,0.864933823131346,0,1,regulation of sequestering of calcium ion,BP,
2684,GO:0051283,1,0.864933823131346,0,1,negative regulation of sequestering of calcium ion,BP,
2686,GO:0051289,1,0.82625471552652,0,2,protein homotetramerization,BP,
2687,GO:0051291,1,0.783822915803807,0,2,protein heterooligomerization,BP,
2689,GO:0051338,1,0.266690924556791,0,7,regulation of transferase activity,BP,
2690,GO:0051340,1,0.747407444585123,0,1,regulation of ligase activity,BP,
2691,GO:0051341,1,0.599496907951174,0,3,regulation of oxidoreductase activity,BP,
2692,GO:0051342,1,0.747407444585123,0,1,regulation of cyclic-nucleotide phosphodiesterase activity,BP,
2693,GO:0051344,1,0.747407444585123,0,1,negative regulation of cyclic-nucleotide phosphodiesterase activity,BP,
2695,GO:0051346,1,0.439171094099141,0,4,negative regulation of hydrolase activity,BP,
2696,GO:0051347,1,0.502522376061228,0,4,positive regulation of transferase activity,BP,
2697,GO:0051348,1,0.50278007658501,0,4,negative regulation of transferase activity,BP,
2698,GO:0051352,1,0.747407444585123,0,1,negative regulation of ligase activity,BP,
2699,GO:0051353,1,0.747407444585123,0,1,positive regulation of oxidoreductase activity,BP,
2700,GO:0051354,1,0.856884470493401,0,1,negative regulation of oxidoreductase activity,BP,
2701,GO:0051384,1,0.474105566544681,0,3,response to glucocorticoid,BP,
2702,GO:0051385,1,0.522121728666879,0,2,response to mineralocorticoid,BP,
2703,GO:0051402,1,0.52962041920403,0,2,neuron apoptotic process,BP,
2704,GO:0051403,1,0.943785593081157,0,1,stress-activated MAPK cascade,BP,
2705,GO:0051412,1,0.522121728666879,0,2,response to corticosterone,BP,
2706,GO:0051436,1,0.932766532291112,0,1,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,BP,
2707,GO:0051437,1,0.932766532291112,0,1,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,BP,
2708,GO:0051438,1,0.932766532291112,0,1,regulation of ubiquitin-protein transferase activity,BP,
2709,GO:0051439,1,0.932766532291112,0,1,regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,BP,
2710,GO:0051443,1,0.932766532291112,0,1,positive regulation of ubiquitin-protein transferase activity,BP,
2711,GO:0051444,1,0.932766532291112,0,1,negative regulation of ubiquitin-protein transferase activity,BP,
2712,GO:0051480,1,0.864933823131346,0,1,regulation of cytosolic calcium ion concentration,BP,
2713,GO:0051493,1,0.826321000735877,0,2,regulation of cytoskeleton organization,BP,
2714,GO:0051494,1,0.875900879520659,0,1,negative regulation of cytoskeleton organization,BP,
2715,GO:0051495,1,0.943785593081157,0,1,positive regulation of cytoskeleton organization,BP,
2718,GO:0051539,1,0.704322975564546,0,1,4 iron, 4 sulfur cluster binding,MF,
2720,GO:0051591,1,0.697654729170719,0,1,response to cAMP,BP,
2721,GO:0051597,1,0.910467635192227,0,1,response to methylmercury,BP,
2722,GO:0051602,1,0.751229237583286,0,1,response to electrical stimulus,BP,
2723,GO:0051603,1,0.696487978099319,0,2,proteolysis involved in cellular protein catabolic process,BP,
2724,GO:0051604,1,0.456525045822019,0,3,protein maturation,BP,
2725,GO:0051606,1,0.696563650306504,0,1,detection of stimulus,BP,
2730,GO:0051693,1,0.875900879520659,0,1,actin filament capping,BP,
2731,GO:0051694,1,0.875900879520659,0,1,pointed-end actin filament capping,BP,
2732,GO:0051703,1,0.751229237583286,0,1,intraspecies interaction between organisms,BP,
2734,GO:0051705,1,0.751229237583286,0,1,multi-organism behavior,BP,
2737,GO:0051726,1,0.831341880353266,0,2,regulation of cell cycle,BP,
2738,GO:0051797,1,0.843648241871817,0,1,regulation of hair follicle development,BP,
2739,GO:0051798,1,0.843648241871817,0,1,positive regulation of hair follicle development,BP,
2740,GO:0051896,1,0.694689250747339,0,1,regulation of protein kinase B signaling,BP,
2741,GO:0051897,1,0.694689250747339,0,1,positive regulation of protein kinase B signaling,BP,
2742,GO:0051924,1,0.747407444585123,0,1,regulation of calcium ion transport,BP,
2743,GO:0051928,1,0.747407444585123,0,1,positive regulation of calcium ion transport,BP,
2744,GO:0051938,1,0.695099127173731,0,1,L-glutamate import,BP,
2745,GO:0051960,1,0.483800990093764,0,2,regulation of nervous system development,BP,
2746,GO:0051961,1,0.696728333256898,0,1,negative regulation of nervous system development,BP,
2747,GO:0051962,1,0.697654729170719,0,1,positive regulation of nervous system development,BP,
2748,GO:0051990,1,0.705287574490218,0,1,(R)-2-hydroxyglutarate dehydrogenase activity,MF,
2749,GO:0052314,1,0.751229237583286,0,1,phytoalexin metabolic process,BP,
2752,GO:0052652,1,0.953041941460832,0,1,cyclic purine nucleotide metabolic process,BP,
2754,GO:0052692,1,0.856884470493401,0,1,raffinose alpha-galactosidase activity,MF,
2755,GO:0052739,1,0.891636723651273,0,1,phosphatidylserine 1-acylhydrolase activity,MF,
2756,GO:0052740,1,0.891636723651273,0,1,1-acyl-2-lysophosphatidylserine acylhydrolase activity,MF,
2757,GO:0052742,1,0.836616111386651,0,1,phosphatidylinositol kinase activity,MF,
2758,GO:0052813,1,0.836616111386651,0,1,phosphatidylinositol bisphosphate kinase activity,MF,
2759,GO:0055017,1,0.939570220896901,0,1,cardiac muscle tissue growth,BP,
2760,GO:0055021,1,0.939570220896901,0,1,regulation of cardiac muscle tissue growth,BP,
2761,GO:0055022,1,0.939570220896901,0,1,negative regulation of cardiac muscle tissue growth,BP,
2762,GO:0055024,1,0.939570220896901,0,1,regulation of cardiac muscle tissue development,BP,
2763,GO:0055026,1,0.939570220896901,0,1,negative regulation of cardiac muscle tissue development,BP,
2764,GO:0055037,1,0.371882284981258,0,3,recycling endosome,CC,
2767,GO:0055070,1,0.778136964138319,0,1,copper ion homeostasis,BP,
2772,GO:0055081,1,0.63739977840031,0,2,anion homeostasis,BP,
2776,GO:0055088,1,0.63739977840031,0,2,lipid homeostasis,BP,
2777,GO:0055091,1,0.63739977840031,0,2,phospholipid homeostasis,BP,
2778,GO:0055092,1,0.63739977840031,0,2,sterol homeostasis,BP,
2779,GO:0055094,1,0.696563650306504,0,1,response to lipoprotein particle,BP,
2780,GO:0055099,1,0.696563650306504,0,1,response to high density lipoprotein particle,BP,
2781,GO:0055102,1,0.980476126491385,0,1,lipase inhibitor activity,MF,
2783,GO:0060038,1,0.939570220896901,0,1,cardiac muscle cell proliferation,BP,
2784,GO:0060041,1,0.939570220896901,0,1,retina development in camera-type eye,BP,
2785,GO:0060042,1,0.939570220896901,0,1,retina morphogenesis in camera-type eye,BP,
2786,GO:0060043,1,0.939570220896901,0,1,regulation of cardiac muscle cell proliferation,BP,
2787,GO:0060044,1,0.939570220896901,0,1,negative regulation of cardiac muscle cell proliferation,BP,
2788,GO:0060047,1,0.732894496640572,0,2,heart contraction,BP,
2789,GO:0060059,1,0.939570220896901,0,1,embryonic retina morphogenesis in camera-type eye,BP,
2790,GO:0060065,1,0.939570220896901,0,1,uterus development,BP,
2791,GO:0060068,1,0.939570220896901,0,1,vagina development,BP,
2792,GO:0060070,1,0.932766532291112,0,1,canonical Wnt signaling pathway,BP,
2793,GO:0060071,1,0.932766532291112,0,1,Wnt signaling pathway, planar cell polarity pathway,BP,
2794,GO:0060078,1,0.694072074177941,0,1,regulation of postsynaptic membrane potential,BP,
2795,GO:0060079,1,0.694072074177941,0,1,excitatory postsynaptic potential,BP,
2796,GO:0060089,1,0.29947561182879,0,4,molecular transducer activity,MF,
2797,GO:0060090,1,0.843648241871817,0,1,binding, bridging,MF,
2798,GO:0060157,1,0.939570220896901,0,1,urinary bladder development,BP,
2800,GO:0060191,1,0.915091954504307,0,2,regulation of lipase activity,BP,
2801,GO:0060192,1,0.980476126491385,0,1,negative regulation of lipase activity,BP,
2802,GO:0060193,1,0.933430464161949,0,1,positive regulation of lipase activity,BP,
2804,GO:0060228,1,0.980476126491385,0,1,phosphatidylcholine-sterol O-acyltransferase activator activity,MF,
2807,GO:0060260,1,0.695903409309486,0,1,regulation of transcription initiation from RNA polymerase II promoter,BP,
2808,GO:0060261,1,0.695903409309486,0,1,positive regulation of transcription initiation from RNA polymerase II promoter,BP,
2809,GO:0060284,1,0.483800990093764,0,2,regulation of cell development,BP,
2810,GO:0060291,1,0.910467635192227,0,1,long-term synaptic potentiation,BP,
2811,GO:0060322,1,0.372489062350937,0,3,head development,BP,
2812,GO:0060326,1,0.836616111386651,0,1,cell chemotaxis,BP,
2813,GO:0060333,1,0.780370606826261,0,2,interferon-gamma-mediated signaling pathway,BP,
2815,GO:0060338,1,0.761888585522679,0,1,regulation of type I interferon-mediated signaling pathway,BP,
2816,GO:0060340,1,0.761888585522679,0,1,positive regulation of type I interferon-mediated signaling pathway,BP,
2818,GO:0060343,1,0.939570220896901,0,1,trabecula formation,BP,
2819,GO:0060347,1,0.939570220896901,0,1,heart trabecula formation,BP,
2820,GO:0060348,1,0.624021533259666,0,2,bone development,BP,
2821,GO:0060349,1,0.836616111386651,0,1,bone morphogenesis,BP,
2822,GO:0060350,1,0.836616111386651,0,1,endochondral bone morphogenesis,BP,
2823,GO:0060359,1,0.761888585522679,0,1,response to ammonium ion,BP,
2824,GO:0060396,1,0.694332314327877,0,1,growth hormone receptor signaling pathway,BP,
2825,GO:0060397,1,0.694332314327877,0,1,JAK-STAT cascade involved in growth hormone signaling pathway,BP,
2826,GO:0060401,1,0.864933823131346,0,1,cytosolic calcium ion transport,BP,
2827,GO:0060402,1,0.864933823131346,0,1,calcium ion transport into cytosol,BP,
2828,GO:0060416,1,0.482117084077993,0,2,response to growth hormone,BP,
2829,GO:0060419,1,0.939570220896901,0,1,heart growth,BP,
2830,GO:0060420,1,0.939570220896901,0,1,regulation of heart growth,BP,
2832,GO:0060491,1,0.694689250747339,0,1,regulation of cell projection assembly,BP,
2833,GO:0060537,1,0.85516985302707,0,2,muscle tissue development,BP,
2834,GO:0060538,1,0.910467635192227,0,1,skeletal muscle organ development,BP,
2836,GO:0060544,1,0.641588149434177,0,2,regulation of necroptotic process,BP,
2837,GO:0060546,1,0.761888585522679,0,1,negative regulation of necroptotic process,BP,
2838,GO:0060547,1,0.657928246177915,0,2,negative regulation of necrotic cell death,BP,
2840,GO:0060589,1,0.694113237147052,0,1,nucleoside-triphosphatase regulator activity,MF,
2841,GO:0060612,1,0.640128194135842,0,2,adipose tissue development,BP,
2842,GO:0060627,1,0.444924524539578,0,4,regulation of vesicle-mediated transport,BP,
2843,GO:0060696,1,0.691132724011711,0,2,regulation of phospholipid catabolic process,BP,
2844,GO:0060759,1,0.521401462268001,0,4,regulation of response to cytokine stimulus,BP,
2845,GO:0060760,1,0.761888585522679,0,1,positive regulation of response to cytokine stimulus,BP,
2846,GO:0060761,1,0.864933823131346,0,1,negative regulation of response to cytokine stimulus,BP,
2847,GO:0060828,1,0.932766532291112,0,1,regulation of canonical Wnt signaling pathway,BP,
2848,GO:0060992,1,0.697654729170719,0,1,response to fungicide,BP,
2849,GO:0061008,1,0.535530861444646,0,2,hepaticobiliary system development,BP,
2850,GO:0061024,1,0.444155466948372,0,3,membrane organization,BP,
2851,GO:0061025,1,0.694113237147052,0,1,membrane fusion,BP,
2852,GO:0061035,1,0.836616111386651,0,1,regulation of cartilage development,BP,
2853,GO:0061036,1,0.836616111386651,0,1,positive regulation of cartilage development,BP,
2854,GO:0061041,1,0.694060852856155,0,1,regulation of wound healing,BP,
2855,GO:0061061,1,0.85516985302707,0,2,muscle structure development,BP,
2856,GO:0061117,1,0.939570220896901,0,1,negative regulation of heart growth,BP,
2857,GO:0061134,1,0.568665996735784,0,3,peptidase regulator activity,MF,
2858,GO:0061135,1,0.603434602546963,0,2,endopeptidase regulator activity,MF,
2859,GO:0061326,1,0.719058751904449,0,1,renal tubule development,BP,
2860,GO:0061337,1,0.976084701408914,0,1,cardiac conduction,BP,
2862,GO:0061383,1,0.939570220896901,0,1,trabecula morphogenesis,BP,
2863,GO:0061384,1,0.939570220896901,0,1,heart trabecula morphogenesis,BP,
2864,GO:0061418,1,0.932766532291112,0,1,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
2865,GO:0061448,1,0.53382462635194,0,3,connective tissue development,BP,
2867,GO:0061564,1,0.475473553676654,0,3,axon development,BP,
2868,GO:0061695,1,0.943785593081157,0,1,transferase complex, transferring phosphorus-containing groups,CC,
2870,GO:0065003,1,0.116949152154945,0,12,macromolecular complex assembly,BP,
2871,GO:0065005,1,0.980476126491385,0,1,protein-lipid complex assembly,BP,
2875,GO:0070003,1,0.932766532291112,0,1,threonine-type peptidase activity,MF,
2880,GO:0070064,1,0.694332314327877,0,1,proline-rich region binding,MF,
2881,GO:0070085,1,0.614948783441457,0,3,glycosylation,BP,
2882,GO:0070125,1,0.634514931652741,0,3,mitochondrial translational elongation,BP,
2883,GO:0070126,1,0.863382075063917,0,2,mitochondrial translational termination,BP,
2884,GO:0070129,1,0.736460913827081,0,1,regulation of mitochondrial translation,BP,
2885,GO:0070161,1,0.864322510360387,0,1,anchoring junction,CC,
2886,GO:0070195,1,0.694332314327877,0,1,growth hormone receptor complex,CC,
2888,GO:0070227,1,0.761888585522679,0,1,lymphocyte apoptotic process,BP,
2889,GO:0070228,1,0.761888585522679,0,1,regulation of lymphocyte apoptotic process,BP,
2890,GO:0070229,1,0.761888585522679,0,1,negative regulation of lymphocyte apoptotic process,BP,
2891,GO:0070231,1,0.761888585522679,0,1,T cell apoptotic process,BP,
2892,GO:0070232,1,0.761888585522679,0,1,regulation of T cell apoptotic process,BP,
2893,GO:0070233,1,0.761888585522679,0,1,negative regulation of T cell apoptotic process,BP,
2894,GO:0070235,1,0.761888585522679,0,1,regulation of activation-induced cell death of T cells,BP,
2895,GO:0070236,1,0.761888585522679,0,1,negative regulation of activation-induced cell death of T cells,BP,
2898,GO:0070268,1,0.718768411418121,0,1,cornification,BP,
2899,GO:0070271,1,0.119736598725994,0,11,protein complex biogenesis,BP,
2901,GO:0070293,1,0.695903409309486,0,1,renal absorption,BP,
2902,GO:0070296,1,0.864933823131346,0,1,sarcoplasmic reticulum calcium ion transport,BP,
2903,GO:0070302,1,0.943785593081157,0,1,regulation of stress-activated protein kinase signaling cascade,BP,
2904,GO:0070304,1,0.943785593081157,0,1,positive regulation of stress-activated protein kinase signaling cascade,BP,
2905,GO:0070371,1,0.789161757057777,0,2,ERK1 and ERK2 cascade,BP,
2906,GO:0070372,1,0.789161757057777,0,2,regulation of ERK1 and ERK2 cascade,BP,
2907,GO:0070374,1,0.789161757057777,0,2,positive regulation of ERK1 and ERK2 cascade,BP,
2908,GO:0070382,1,0.751229237583286,0,1,exocytic vesicle,CC,
2909,GO:0070402,1,0.889170363159422,0,1,NADPH binding,MF,
2910,GO:0070405,1,0.736223863714798,0,2,ammonium ion binding,MF,
2911,GO:0070482,1,0.378077335569273,0,6,response to oxygen levels,BP,
2912,GO:0070509,1,0.864933823131346,0,1,calcium ion import,BP,
2913,GO:0070513,1,0.843648241871817,0,1,death domain binding,MF,
2914,GO:0070525,1,0.75055146595722,0,2,tRNA threonylcarbamoyladenosine metabolic process,BP,
2915,GO:0070538,1,0.916336727632546,0,1,oleic acid binding,MF,
2917,GO:0070555,1,0.659133660650735,0,2,response to interleukin-1,BP,
2918,GO:0070569,1,0.873547569641283,0,1,uridylyltransferase activity,MF,
2919,GO:0070588,1,0.645356071201875,0,2,calcium ion transmembrane transport,BP,
2920,GO:0070613,1,0.602356552550822,0,2,regulation of protein processing,BP,
2923,GO:0070646,1,0.932766532291112,0,1,protein modification by small protein removal,BP,
2928,GO:0070670,1,0.694832717893905,0,1,response to interleukin-4,BP,
2929,GO:0070696,1,0.943785593081157,0,1,transmembrane receptor protein serine/threonine kinase binding,MF,
2930,GO:0070700,1,0.943785593081157,0,1,BMP receptor binding,MF,
2931,GO:0070704,1,0.694297055380902,0,1,sterol desaturase activity,MF,
2933,GO:0070742,1,0.694066116802129,0,1,C2H2 zinc finger domain binding,MF,
2934,GO:0070777,1,0.695099127173731,0,1,D-aspartate transport,BP,
2935,GO:0070779,1,0.695099127173731,0,1,D-aspartate import,BP,
2936,GO:0070820,1,0.705287574490218,0,1,tertiary granule,CC,
2937,GO:0070838,1,0.645356071201875,0,2,divalent metal ion transport,BP,
2938,GO:0070848,1,0.434838821463239,0,3,response to growth factor,BP,
2939,GO:0070851,1,0.547888160684683,0,3,growth factor receptor binding,MF,
2940,GO:0070857,1,0.697654729170719,0,1,regulation of bile acid biosynthetic process,BP,
2941,GO:0070859,1,0.697654729170719,0,1,positive regulation of bile acid biosynthetic process,BP,
2943,GO:0070900,1,0.75055146595722,0,2,mitochondrial tRNA modification,BP,
2944,GO:0070901,1,0.936872137023806,0,1,mitochondrial tRNA methylation,BP,
2945,GO:0070902,1,0.801693816427004,0,1,mitochondrial tRNA pseudouridine synthesis,BP,
2946,GO:0070925,1,0.694113237147052,0,1,organelle assembly,BP,
2947,GO:0070936,1,0.843648241871817,0,1,protein K48-linked ubiquitination,BP,
2949,GO:0070996,1,0.953041941460832,0,1,type 1 melanocortin receptor binding,MF,
2950,GO:0070997,1,0.52962041920403,0,2,neuron death,BP,
2951,GO:0071071,1,0.645411884078384,0,2,regulation of phospholipid biosynthetic process,BP,
2952,GO:0071073,1,0.916336727632546,0,1,positive regulation of phospholipid biosynthetic process,BP,
2953,GO:0071214,1,0.761888585522679,0,1,cellular response to abiotic stimulus,BP,
2958,GO:0071236,1,0.697654729170719,0,1,cellular response to antibiotic,BP,
2959,GO:0071241,1,0.522121728666879,0,2,cellular response to inorganic substance,BP,
2960,GO:0071248,1,0.522121728666879,0,2,cellular response to metal ion,BP,
2961,GO:0071260,1,0.761888585522679,0,1,cellular response to mechanical stimulus,BP,
2964,GO:0071276,1,0.697654729170719,0,1,cellular response to cadmium ion,BP,
2965,GO:0071287,1,0.751229237583286,0,1,cellular response to manganese ion,BP,
2967,GO:0071312,1,0.522121728666879,0,2,cellular response to alkaloid,BP,
2968,GO:0071316,1,0.751229237583286,0,1,cellular response to nicotine,BP,
2969,GO:0071320,1,0.697654729170719,0,1,cellular response to cAMP,BP,
2970,GO:0071322,1,0.522121728666879,0,2,cellular response to carbohydrate stimulus,BP,
2971,GO:0071326,1,0.522121728666879,0,2,cellular response to monosaccharide stimulus,BP,
2972,GO:0071331,1,0.522121728666879,0,2,cellular response to hexose stimulus,BP,
2973,GO:0071333,1,0.522121728666879,0,2,cellular response to glucose stimulus,BP,
2975,GO:0071346,1,0.542438398215513,0,3,cellular response to interferon-gamma,BP,
2976,GO:0071347,1,0.659133660650735,0,2,cellular response to interleukin-1,BP,
2977,GO:0071353,1,0.694832717893905,0,1,cellular response to interleukin-4,BP,
2978,GO:0071356,1,0.640206081154498,0,4,cellular response to tumor necrosis factor,BP,
2980,GO:0071363,1,0.434838821463239,0,3,cellular response to growth factor stimulus,BP,
2981,GO:0071371,1,0.697654729170719,0,1,cellular response to gonadotropin stimulus,BP,
2982,GO:0071372,1,0.697654729170719,0,1,cellular response to follicle-stimulating hormone stimulus,BP,
2983,GO:0071373,1,0.697654729170719,0,1,cellular response to luteinizing hormone stimulus,BP,
2985,GO:0071378,1,0.482117084077993,0,2,cellular response to growth hormone stimulus,BP,
2986,GO:0071383,1,0.697654729170719,0,1,cellular response to steroid hormone stimulus,BP,
2987,GO:0071384,1,0.697654729170719,0,1,cellular response to corticosteroid stimulus,BP,
2988,GO:0071385,1,0.697654729170719,0,1,cellular response to glucocorticoid stimulus,BP,
2991,GO:0071407,1,0.522121728666879,0,2,cellular response to organic cyclic compound,BP,
2993,GO:0071436,1,0.976084701408914,0,1,sodium ion export,BP,
2994,GO:0071450,1,0.747407444585123,0,1,cellular response to oxygen radical,BP,
2995,GO:0071451,1,0.747407444585123,0,1,cellular response to superoxide,BP,
2996,GO:0071453,1,0.631598129129074,0,3,cellular response to oxygen levels,BP,
2997,GO:0071456,1,0.631598129129074,0,3,cellular response to hypoxia,BP,
3001,GO:0071548,1,0.697654729170719,0,1,response to dexamethasone,BP,
3002,GO:0071549,1,0.697654729170719,0,1,cellular response to dexamethasone stimulus,BP,
3003,GO:0071550,1,0.641588149434177,0,2,death-inducing signaling complex assembly,BP,
3004,GO:0071553,1,0.698431002476331,0,1,G-protein coupled pyrimidinergic nucleotide receptor activity,MF,
3005,GO:0071559,1,0.697654729170719,0,1,response to transforming growth factor beta,BP,
3006,GO:0071560,1,0.697654729170719,0,1,cellular response to transforming growth factor beta stimulus,BP,
3012,GO:0071774,1,0.582223569304847,0,2,response to fibroblast growth factor,BP,
3014,GO:0071825,1,0.682570813562739,0,2,protein-lipid complex subunit organization,BP,
3015,GO:0071826,1,0.864933823131346,0,1,ribonucleoprotein complex subunit organization,BP,
3016,GO:0071827,1,0.682570813562739,0,2,plasma lipoprotein particle organization,BP,
3017,GO:0071830,1,0.980476126491385,0,1,triglyceride-rich lipoprotein particle clearance,BP,
3019,GO:0071855,1,0.953041941460832,0,1,neuropeptide receptor binding,MF,
3020,GO:0071867,1,0.697654729170719,0,1,response to monoamine,BP,
3021,GO:0071868,1,0.697654729170719,0,1,cellular response to monoamine stimulus,BP,
3022,GO:0071869,1,0.697654729170719,0,1,response to catecholamine,BP,
3023,GO:0071870,1,0.697654729170719,0,1,cellular response to catecholamine stimulus,BP,
3024,GO:0071871,1,0.697654729170719,0,1,response to epinephrine,BP,
3025,GO:0071872,1,0.697654729170719,0,1,cellular response to epinephrine stimulus,BP,
3026,GO:0071887,1,0.761888585522679,0,1,leukocyte apoptotic process,BP,
3027,GO:0071897,1,0.747407444585123,0,1,DNA biosynthetic process,BP,
3028,GO:0071900,1,0.545986672761227,0,3,regulation of protein serine/threonine kinase activity,BP,
3029,GO:0071901,1,0.943785593081157,0,1,negative regulation of protein serine/threonine kinase activity,BP,
3030,GO:0071902,1,0.579433012529212,0,2,positive regulation of protein serine/threonine kinase activity,BP,
3032,GO:0071955,1,0.694113237147052,0,1,recycling endosome to Golgi transport,BP,
3033,GO:0072001,1,0.502208845297894,0,3,renal system development,BP,
3034,GO:0072006,1,0.719058751904449,0,1,nephron development,BP,
3035,GO:0072009,1,0.719058751904449,0,1,nephron epithelium development,BP,
3036,GO:0072014,1,0.719058751904449,0,1,proximal tubule development,BP,
3037,GO:0072019,1,0.719058751904449,0,1,proximal convoluted tubule development,BP,
3038,GO:0072073,1,0.719058751904449,0,1,kidney epithelium development,BP,
3039,GO:0072080,1,0.719058751904449,0,1,nephron tubule development,BP,
3040,GO:0072170,1,0.719058751904449,0,1,metanephric tubule development,BP,
3041,GO:0072207,1,0.719058751904449,0,1,metanephric epithelium development,BP,
3042,GO:0072229,1,0.719058751904449,0,1,metanephric proximal convoluted tubule development,BP,
3043,GO:0072234,1,0.719058751904449,0,1,metanephric nephron tubule development,BP,
3044,GO:0072237,1,0.719058751904449,0,1,metanephric proximal tubule development,BP,
3045,GO:0072243,1,0.719058751904449,0,1,metanephric nephron epithelium development,BP,
3048,GO:0072331,1,0.943785593081157,0,1,signal transduction by p53 class mediator,BP,
3049,GO:0072332,1,0.943785593081157,0,1,intrinsic apoptotic signaling pathway by p53 class mediator,BP,
3050,GO:0072338,1,0.694332314327877,0,1,cellular lactam metabolic process,BP,
3051,GO:0072350,1,0.43043938235757,0,3,tricarboxylic acid metabolic process,BP,
3054,GO:0072376,1,0.485624529381451,0,2,protein activation cascade,BP,
3055,GO:0072378,1,0.699109736897407,0,1,blood coagulation, fibrin clot formation,BP,
3058,GO:0072511,1,0.645356071201875,0,2,divalent inorganic cation transport,BP,
3066,GO:0072558,1,0.943785593081157,0,1,NLRP1 inflammasome complex,CC,
3068,GO:0072562,1,0.697867488744479,0,1,blood microparticle,CC,
3070,GO:0072594,1,0.864933823131346,0,1,establishment of protein localization to organelle,BP,
3071,GO:0072604,1,0.943785593081157,0,1,interleukin-6 secretion,BP,
3072,GO:0072606,1,0.943785593081157,0,1,interleukin-8 secretion,BP,
3073,GO:0072608,1,0.943785593081157,0,1,interleukin-10 secretion,BP,
3074,GO:0072676,1,0.718490506941261,0,2,lymphocyte migration,BP,
3075,GO:0072678,1,0.718490506941261,0,2,T cell migration,BP,
3076,GO:0072683,1,0.761888585522679,0,1,T cell extravasation,BP,
3079,GO:0080135,1,0.608283774403835,0,3,regulation of cellular response to stress,BP,
3081,GO:0086036,1,0.976084701408914,0,1,regulation of cardiac muscle cell membrane potential,BP,
3082,GO:0089711,1,0.695099127173731,0,1,L-glutamate transmembrane transport,BP,
3083,GO:0089720,1,0.657928246177915,0,2,caspase binding,MF,
3084,GO:0090066,1,0.634209419079781,0,3,regulation of anatomical structure size,BP,
3085,GO:0090077,1,0.696563650306504,0,1,foam cell differentiation,BP,
3087,GO:0090090,1,0.932766532291112,0,1,negative regulation of canonical Wnt signaling pathway,BP,
3088,GO:0090130,1,0.836616111386651,0,1,tissue migration,BP,
3089,GO:0090132,1,0.836616111386651,0,1,epithelium migration,BP,
3090,GO:0090174,1,0.694113237147052,0,1,organelle membrane fusion,BP,
3091,GO:0090175,1,0.932766532291112,0,1,regulation of establishment of planar polarity,BP,
3093,GO:0090195,1,0.943785593081157,0,1,chemokine secretion,BP,
3094,GO:0090196,1,0.943785593081157,0,1,regulation of chemokine secretion,BP,
3095,GO:0090197,1,0.943785593081157,0,1,positive regulation of chemokine secretion,BP,
3096,GO:0090199,1,0.815946865122908,0,2,regulation of release of cytochrome c from mitochondria,BP,
3097,GO:0090200,1,0.943785593081157,0,1,positive regulation of release of cytochrome c from mitochondria,BP,
3098,GO:0090201,1,0.864933823131346,0,1,negative regulation of release of cytochrome c from mitochondria,BP,
3099,GO:0090205,1,0.696563650306504,0,1,positive regulation of cholesterol metabolic process,BP,
3100,GO:0090207,1,0.747407444585123,0,1,regulation of triglyceride metabolic process,BP,
3101,GO:0090208,1,0.747407444585123,0,1,positive regulation of triglyceride metabolic process,BP,
3102,GO:0090257,1,0.864933823131346,0,1,regulation of muscle system process,BP,
3103,GO:0090263,1,0.932766532291112,0,1,positive regulation of canonical Wnt signaling pathway,BP,
3104,GO:0090276,1,0.939570220896901,0,1,regulation of peptide hormone secretion,BP,
3105,GO:0090277,1,0.939570220896901,0,1,positive regulation of peptide hormone secretion,BP,
3106,GO:0090287,1,0.836616111386651,0,1,regulation of cellular response to growth factor stimulus,BP,
3109,GO:0090322,1,0.747407444585123,0,1,regulation of superoxide metabolic process,BP,
3111,GO:0090484,1,0.9068568801805,0,1,drug transporter activity,MF,
3114,GO:0090533,1,0.976084701408914,0,1,cation-transporting ATPase complex,CC,
3115,GO:0090559,1,0.64378764821232,0,2,regulation of membrane permeability,BP,
3116,GO:0090596,1,0.705216484249791,0,2,sensory organ morphogenesis,BP,
3117,GO:0090630,1,0.694113237147052,0,1,activation of GTPase activity,BP,
3118,GO:0090646,1,0.75055146595722,0,2,mitochondrial tRNA processing,BP,
3119,GO:0097006,1,0.682570813562739,0,2,regulation of plasma lipoprotein particle levels,BP,
3120,GO:0097028,1,0.924720397590426,0,1,dendritic cell differentiation,BP,
3121,GO:0097049,1,0.761888585522679,0,1,motor neuron apoptotic process,BP,
3122,GO:0097060,1,0.694072074177941,0,1,synaptic membrane,CC,
3123,GO:0097089,1,0.80215306869843,0,1,methyl-branched fatty acid metabolic process,BP,
3126,GO:0097164,1,0.285004690653476,0,6,ammonium ion metabolic process,BP,
3129,GO:0097191,1,0.371558341975535,0,6,extrinsic apoptotic signaling pathway,BP,
3130,GO:0097192,1,0.761888585522679,0,1,extrinsic apoptotic signaling pathway in absence of ligand,BP,
3134,GO:0097202,1,0.761888585522679,0,1,activation of cysteine-type endopeptidase activity,BP,
3136,GO:0097296,1,0.641588149434177,0,2,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
3138,GO:0097305,1,0.489598298314474,0,3,response to alcohol,BP,
3139,GO:0097340,1,0.864933823131346,0,1,inhibition of cysteine-type endopeptidase activity,BP,
3140,GO:0097341,1,0.864933823131346,0,1,zymogen inhibition,BP,
3142,GO:0097345,1,0.745600768235738,0,1,mitochondrial outer membrane permeabilization,BP,
3144,GO:0097421,1,0.747407444585123,0,1,liver regeneration,BP,
3146,GO:0097435,1,0.770761955450571,0,3,supramolecular fiber organization,BP,
3147,GO:0097458,1,0.115807251896061,0,8,neuron part,CC,
3148,GO:0097485,1,0.754361961097869,0,1,neuron projection guidance,BP,
3149,GO:0097502,1,0.981296617652802,0,1,mannosylation,BP,
3150,GO:0097527,1,0.761888585522679,0,1,necroptotic signaling pathway,BP,
3151,GO:0097553,1,0.864933823131346,0,1,calcium ion transmembrane import into cytosol,BP,
3153,GO:0097696,1,0.584363043782668,0,2,STAT cascade,BP,
3155,GO:0097722,1,0.747407444585123,0,1,sperm motility,BP,
3156,GO:0098533,1,0.976084701408914,0,1,ATPase dependent transmembrane transport complex,CC,
3158,GO:0098552,1,0.521297166970198,0,2,side of membrane,CC,
3159,GO:0098562,1,0.751229237583286,0,1,cytoplasmic side of membrane,CC,
3160,GO:0098573,1,0.704322975564546,0,1,intrinsic component of mitochondrial membrane,CC,
3162,GO:0098589,1,0.641588149434177,0,2,membrane region,CC,
3163,GO:0098590,1,0.694072074177941,0,1,plasma membrane region,CC,
3164,GO:0098599,1,0.753988517867515,0,1,palmitoyl hydrolase activity,MF,
3167,GO:0098655,1,0.463171829320582,0,5,cation transmembrane transport,BP,
3168,GO:0098656,1,0.469565321437016,0,3,anion transmembrane transport,BP,
3169,GO:0098657,1,0.695099127173731,0,1,import into cell,BP,
3170,GO:0098660,1,0.463171829320582,0,5,inorganic ion transmembrane transport,BP,
3171,GO:0098661,1,0.976084701408914,0,1,inorganic anion transmembrane transport,BP,
3172,GO:0098662,1,0.463171829320582,0,5,inorganic cation transmembrane transport,BP,
3173,GO:0098700,1,0.751229237583286,0,1,neurotransmitter loading into synaptic vesicle,BP,
3174,GO:0098732,1,0.753988517867515,0,1,macromolecule deacylation,BP,
3175,GO:0098734,1,0.753988517867515,0,1,macromolecule depalmitoylation,BP,
3176,GO:0098754,1,0.712703872478519,0,2,detoxification,BP,
3178,GO:0098772,1,0.217290307191638,0,9,molecular function regulator,MF,
3179,GO:0098773,1,0.605058501875226,0,2,skin epidermis development,BP,
3180,GO:0098781,1,0.933430464161949,0,1,ncRNA transcription,BP,
3181,GO:0098793,1,0.751229237583286,0,1,presynapse,CC,
3182,GO:0098794,1,0.694072074177941,0,1,postsynapse,CC,
3183,GO:0098796,1,0.641588149434177,0,2,membrane protein complex,CC,
3184,GO:0098797,1,0.641588149434177,0,2,plasma membrane protein complex,CC,
3185,GO:0098798,1,0.704322975564546,0,1,mitochondrial protein complex,CC,
3186,GO:0098802,1,0.481617645613711,0,2,plasma membrane receptor complex,CC,
3188,GO:0098857,1,0.641588149434177,0,2,membrane microdomain,CC,
3189,GO:0098869,1,0.712703872478519,0,2,cellular oxidant detoxification,BP,
3190,GO:0098878,1,0.481617645613711,0,2,neurotransmitter receptor complex,CC,
3191,GO:0098916,1,0.159966161023842,0,6,anterograde trans-synaptic signaling,BP,
3192,GO:0099080,1,0.433811879704888,0,3,supramolecular complex,CC,
3193,GO:0099081,1,0.433811879704888,0,3,supramolecular polymer,CC,
3194,GO:0099094,1,0.694072074177941,0,1,ligand-gated cation channel activity,MF,
3196,GO:0099504,1,0.751229237583286,0,1,synaptic vesicle cycle,BP,
3197,GO:0099512,1,0.433811879704888,0,3,supramolecular fiber,CC,
3198,GO:0099513,1,0.497147746069682,0,2,polymeric cytoskeletal fiber,CC,
3199,GO:0099536,1,0.159966161023842,0,6,synaptic signaling,BP,
3200,GO:0099537,1,0.159966161023842,0,6,trans-synaptic signaling,BP,
3201,GO:0099565,1,0.694072074177941,0,1,chemical synaptic transmission, postsynaptic,BP,
3202,GO:0099568,1,0.694689250747339,0,1,cytoplasmic region,CC,
3203,GO:0099600,1,0.29947561182879,0,4,transmembrane receptor activity,MF,
3206,GO:0102009,1,0.753245494607556,0,1,proline dipeptidase activity,MF,
3207,GO:0102336,1,0.695794073033159,0,1,3-oxo-arachidoyl-CoA synthase activity,MF,
3208,GO:0102337,1,0.695794073033159,0,1,3-oxo-cerotoyl-CoA synthase activity,MF,
3209,GO:0102338,1,0.695794073033159,0,1,3-oxo-lignoceronyl-CoA synthase activity,MF,
3210,GO:0120025,1,0.115807251896061,0,8,plasma membrane bounded cell projection,CC,
3211,GO:0198738,1,0.932766532291112,0,1,cell-cell signaling by wnt,BP,
3212,GO:1900046,1,0.694060852856155,0,1,regulation of hemostasis,BP,
3215,GO:1900180,1,0.864933823131346,0,1,regulation of protein localization to nucleus,BP,
3216,GO:1900274,1,0.933430464161949,0,1,regulation of phospholipase C activity,BP,
3217,GO:1900371,1,0.953041941460832,0,1,regulation of purine nucleotide biosynthetic process,BP,
3218,GO:1900373,1,0.953041941460832,0,1,positive regulation of purine nucleotide biosynthetic process,BP,
3219,GO:1900407,1,0.645356071201875,0,2,regulation of cellular response to oxidative stress,BP,
3220,GO:1900408,1,0.864933823131346,0,1,negative regulation of cellular response to oxidative stress,BP,
3221,GO:1900409,1,0.747407444585123,0,1,positive regulation of cellular response to oxidative stress,BP,
3222,GO:1900542,1,0.953041941460832,0,1,regulation of purine nucleotide metabolic process,BP,
3223,GO:1900544,1,0.953041941460832,0,1,positive regulation of purine nucleotide metabolic process,BP,
3224,GO:1900864,1,0.75055146595722,0,2,mitochondrial RNA modification,BP,
3225,GO:1901019,1,0.747407444585123,0,1,regulation of calcium ion transmembrane transporter activity,BP,
3226,GO:1901021,1,0.747407444585123,0,1,positive regulation of calcium ion transmembrane transporter activity,BP,
3227,GO:1901028,1,0.745600768235738,0,1,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
3228,GO:1901029,1,0.745600768235738,0,1,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
3229,GO:1901031,1,0.747407444585123,0,1,regulation of response to reactive oxygen species,BP,
3230,GO:1901033,1,0.747407444585123,0,1,positive regulation of response to reactive oxygen species,BP,
3231,GO:1901052,1,0.69574435000495,0,1,sarcosine metabolic process,BP,
3232,GO:1901053,1,0.69574435000495,0,1,sarcosine catabolic process,BP,
3235,GO:1901137,1,0.417823128257956,0,5,carbohydrate derivative biosynthetic process,BP,
3236,GO:1901184,1,0.754361961097869,0,1,regulation of ERBB signaling pathway,BP,
3237,GO:1901186,1,0.754361961097869,0,1,positive regulation of ERBB signaling pathway,BP,
3238,GO:1901214,1,0.697654729170719,0,1,regulation of neuron death,BP,
3239,GO:1901215,1,0.697654729170719,0,1,negative regulation of neuron death,BP,
3240,GO:1901264,1,0.696563650306504,0,1,carbohydrate derivative transport,BP,
3244,GO:1901317,1,0.747407444585123,0,1,regulation of flagellated sperm motility,BP,
3245,GO:1901318,1,0.747407444585123,0,1,negative regulation of flagellated sperm motility,BP,
3246,GO:1901338,1,0.751229237583286,0,1,catecholamine binding,MF,
3251,GO:1901505,1,0.696563650306504,0,1,carbohydrate derivative transporter activity,MF,
3256,GO:1901570,1,0.661943602419084,0,2,fatty acid derivative biosynthetic process,BP,
3260,GO:1901606,1,0.461978736125673,0,3,alpha-amino acid catabolic process,BP,
3264,GO:1901618,1,0.696563650306504,0,1,organic hydroxy compound transmembrane transporter activity,MF,
3267,GO:1901654,1,0.522121728666879,0,2,response to ketone,BP,
3268,GO:1901655,1,0.697654729170719,0,1,cellular response to ketone,BP,
3271,GO:1901668,1,0.747407444585123,0,1,regulation of superoxide dismutase activity,BP,
3272,GO:1901671,1,0.747407444585123,0,1,positive regulation of superoxide dismutase activity,BP,
3273,GO:1901681,1,0.681092136522107,0,2,sulfur compound binding,MF,
3274,GO:1901685,1,0.954268878312379,0,1,glutathione derivative metabolic process,BP,
3275,GO:1901687,1,0.954268878312379,0,1,glutathione derivative biosynthetic process,BP,
3280,GO:1901861,1,0.85516985302707,0,2,regulation of muscle tissue development,BP,
3281,GO:1901862,1,0.85516985302707,0,2,negative regulation of muscle tissue development,BP,
3282,GO:1901879,1,0.875900879520659,0,1,regulation of protein depolymerization,BP,
3283,GO:1901880,1,0.875900879520659,0,1,negative regulation of protein depolymerization,BP,
3284,GO:1901894,1,0.747407444585123,0,1,regulation of calcium-transporting ATPase activity,BP,
3285,GO:1901896,1,0.747407444585123,0,1,positive regulation of calcium-transporting ATPase activity,BP,
3287,GO:1901987,1,0.932766532291112,0,1,regulation of cell cycle phase transition,BP,
3288,GO:1901988,1,0.932766532291112,0,1,negative regulation of cell cycle phase transition,BP,
3289,GO:1901990,1,0.932766532291112,0,1,regulation of mitotic cell cycle phase transition,BP,
3290,GO:1901991,1,0.932766532291112,0,1,negative regulation of mitotic cell cycle phase transition,BP,
3291,GO:1901998,1,0.696563650306504,0,1,toxin transport,BP,
3292,GO:1902001,1,0.696271990189966,0,1,fatty acid transmembrane transport,BP,
3293,GO:1902041,1,0.641588149434177,0,2,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,
3294,GO:1902042,1,0.641588149434177,0,2,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,
3295,GO:1902043,1,0.761888585522679,0,1,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,
3297,GO:1902106,1,0.924720397590426,0,1,negative regulation of leukocyte differentiation,BP,
3299,GO:1902108,1,0.64378764821232,0,2,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
3300,GO:1902109,1,0.64378764821232,0,2,negative regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
3301,GO:1902110,1,0.745600768235738,0,1,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
3302,GO:1902115,1,0.694113237147052,0,1,regulation of organelle assembly,BP,
3303,GO:1902175,1,0.864933823131346,0,1,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
3304,GO:1902176,1,0.864933823131346,0,1,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
3305,GO:1902221,1,0.92965217786867,0,1,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,BP,
3306,GO:1902222,1,0.92965217786867,0,1,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,BP,
3308,GO:1902305,1,0.976084701408914,0,1,regulation of sodium ion transmembrane transport,BP,
3309,GO:1902307,1,0.976084701408914,0,1,positive regulation of sodium ion transmembrane transport,BP,
3310,GO:1902311,1,0.778136964138319,0,1,regulation of copper ion transmembrane transport,BP,
3311,GO:1902475,1,0.695099127173731,0,1,L-alpha-amino acid transmembrane transport,BP,
3312,GO:1902476,1,0.976084701408914,0,1,chloride transmembrane transport,BP,
3314,GO:1902495,1,0.469496936600561,0,3,transmembrane transporter complex,CC,
3315,GO:1902524,1,0.843648241871817,0,1,positive regulation of protein K48-linked ubiquitination,BP,
3317,GO:1902532,1,0.62617573279093,0,3,negative regulation of intracellular signal transduction,BP,
3319,GO:1902554,1,0.943785593081157,0,1,serine/threonine protein kinase complex,CC,
3320,GO:1902555,1,0.936872137023806,0,1,endoribonuclease complex,CC,
3322,GO:1902580,1,0.286677525750181,0,4,single-organism cellular localization,BP,
3323,GO:1902582,1,0.286677525750181,0,4,single-organism intracellular transport,BP,
3324,GO:1902589,1,0.339035586014499,0,6,single-organism organelle organization,BP,
3325,GO:1902593,1,0.864933823131346,0,1,single-organism nuclear import,BP,
3326,GO:1902600,1,0.952054095564578,0,1,hydrogen ion transmembrane transport,BP,
3329,GO:1902656,1,0.864933823131346,0,1,calcium ion import into cytosol,BP,
3332,GO:1902686,1,0.745600768235738,0,1,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,
3333,GO:1902749,1,0.932766532291112,0,1,regulation of cell cycle G2/M phase transition,BP,
3334,GO:1902750,1,0.932766532291112,0,1,negative regulation of cell cycle G2/M phase transition,BP,
3335,GO:1902858,1,0.719058751904449,0,1,propionyl-CoA metabolic process,BP,
3336,GO:1902860,1,0.719058751904449,0,1,propionyl-CoA biosynthetic process,BP,
3337,GO:1902882,1,0.645356071201875,0,2,regulation of response to oxidative stress,BP,
3338,GO:1902883,1,0.864933823131346,0,1,negative regulation of response to oxidative stress,BP,
3339,GO:1902884,1,0.747407444585123,0,1,positive regulation of response to oxidative stress,BP,
3340,GO:1902903,1,0.826321000735877,0,2,regulation of supramolecular fiber organization,BP,
3341,GO:1902904,1,0.875900879520659,0,1,negative regulation of supramolecular fiber organization,BP,
3342,GO:1902905,1,0.943785593081157,0,1,positive regulation of supramolecular fiber organization,BP,
3343,GO:1902911,1,0.943785593081157,0,1,protein kinase complex,CC,
3344,GO:1902914,1,0.843648241871817,0,1,regulation of protein polyubiquitination,BP,
3345,GO:1902916,1,0.843648241871817,0,1,positive regulation of protein polyubiquitination,BP,
3347,GO:1902932,1,0.696563650306504,0,1,positive regulation of alcohol biosynthetic process,BP,
3349,GO:1903010,1,0.747407444585123,0,1,regulation of bone development,BP,
3350,GO:1903011,1,0.747407444585123,0,1,negative regulation of bone development,BP,
3351,GO:1903034,1,0.694060852856155,0,1,regulation of response to wounding,BP,
3354,GO:1903047,1,0.932766532291112,0,1,mitotic cell cycle process,BP,
3355,GO:1903050,1,0.696487978099319,0,2,regulation of proteolysis involved in cellular protein catabolic process,BP,
3356,GO:1903052,1,0.696487978099319,0,2,positive regulation of proteolysis involved in cellular protein catabolic process,BP,
3357,GO:1903169,1,0.747407444585123,0,1,regulation of calcium ion transmembrane transport,BP,
3358,GO:1903173,1,0.756629123575041,0,1,fatty alcohol metabolic process,BP,
3359,GO:1903201,1,0.864933823131346,0,1,regulation of oxidative stress-induced cell death,BP,
3360,GO:1903202,1,0.864933823131346,0,1,negative regulation of oxidative stress-induced cell death,BP,
3361,GO:1903273,1,0.976084701408914,0,1,regulation of sodium ion export,BP,
3362,GO:1903275,1,0.976084701408914,0,1,positive regulation of sodium ion export,BP,
3363,GO:1903276,1,0.976084701408914,0,1,regulation of sodium ion export from cell,BP,
3364,GO:1903278,1,0.976084701408914,0,1,positive regulation of sodium ion export from cell,BP,
3365,GO:1903305,1,0.698348976994063,0,1,regulation of regulated secretory pathway,BP,
3366,GO:1903317,1,0.602356552550822,0,2,regulation of protein maturation,BP,
3367,GO:1903318,1,0.864933823131346,0,1,negative regulation of protein maturation,BP,
3369,GO:1903321,1,0.932766532291112,0,1,negative regulation of protein modification by small protein conjugation or removal,BP,
3371,GO:1903362,1,0.696487978099319,0,2,regulation of cellular protein catabolic process,BP,
3372,GO:1903364,1,0.696487978099319,0,2,positive regulation of cellular protein catabolic process,BP,
3375,GO:1903427,1,0.639291005791314,0,2,negative regulation of reactive oxygen species biosynthetic process,BP,
3382,GO:1903514,1,0.864933823131346,0,1,calcium ion transport from endoplasmic reticulum to cytosol,BP,
3383,GO:1903522,1,0.732894496640572,0,2,regulation of blood circulation,BP,
3384,GO:1903530,1,0.575716379805678,0,4,regulation of secretion by cell,BP,
3385,GO:1903532,1,0.575716379805678,0,4,positive regulation of secretion by cell,BP,
3386,GO:1903533,1,0.864933823131346,0,1,regulation of protein targeting,BP,
3390,GO:1903610,1,0.747407444585123,0,1,regulation of calcium-dependent ATPase activity,BP,
3391,GO:1903611,1,0.747407444585123,0,1,negative regulation of calcium-dependent ATPase activity,BP,
3392,GO:1903624,1,0.747407444585123,0,1,regulation of DNA catabolic process,BP,
3393,GO:1903625,1,0.747407444585123,0,1,negative regulation of DNA catabolic process,BP,
3394,GO:1903627,1,0.747407444585123,0,1,regulation of dUTP diphosphatase activity,BP,
3395,GO:1903629,1,0.747407444585123,0,1,positive regulation of dUTP diphosphatase activity,BP,
3396,GO:1903630,1,0.747407444585123,0,1,regulation of aminoacyl-tRNA ligase activity,BP,
3397,GO:1903631,1,0.747407444585123,0,1,negative regulation of aminoacyl-tRNA ligase activity,BP,
3398,GO:1903633,1,0.747407444585123,0,1,regulation of leucine-tRNA ligase activity,BP,
3399,GO:1903634,1,0.747407444585123,0,1,negative regulation of leucine-tRNA ligase activity,BP,
3401,GO:1903707,1,0.924720397590426,0,1,negative regulation of hemopoiesis,BP,
3403,GO:1903725,1,0.632356061795054,0,3,regulation of phospholipid metabolic process,BP,
3404,GO:1903726,1,0.980476126491385,0,1,negative regulation of phospholipid metabolic process,BP,
3405,GO:1903727,1,0.916336727632546,0,1,positive regulation of phospholipid metabolic process,BP,
3406,GO:1903779,1,0.976084701408914,0,1,regulation of cardiac conduction,BP,
3407,GO:1903825,1,0.481687677578068,0,2,organic acid transmembrane transport,BP,
3411,GO:1904062,1,0.565566921198172,0,3,regulation of cation transmembrane transport,BP,
3412,GO:1904064,1,0.729159739479172,0,2,positive regulation of cation transmembrane transport,BP,
3413,GO:1904177,1,0.891636723651273,0,1,regulation of adipose tissue development,BP,
3414,GO:1904251,1,0.697654729170719,0,1,regulation of bile acid metabolic process,BP,
3415,GO:1904253,1,0.697654729170719,0,1,positive regulation of bile acid metabolic process,BP,
3416,GO:1904406,1,0.639291005791314,0,2,negative regulation of nitric oxide metabolic process,BP,
3418,GO:1904427,1,0.747407444585123,0,1,positive regulation of calcium ion transmembrane transport,BP,
3419,GO:1904589,1,0.864933823131346,0,1,regulation of protein import,BP,
3422,GO:1904666,1,0.932766532291112,0,1,regulation of ubiquitin protein ligase activity,BP,
3423,GO:1904667,1,0.932766532291112,0,1,negative regulation of ubiquitin protein ligase activity,BP,
3424,GO:1904668,1,0.932766532291112,0,1,positive regulation of ubiquitin protein ligase activity,BP,
3425,GO:1904724,1,0.705287574490218,0,1,tertiary granule lumen,CC,
3427,GO:1904833,1,0.747407444585123,0,1,positive regulation of removal of superoxide radicals,BP,
3428,GO:1904847,1,0.836616111386651,0,1,regulation of cell chemotaxis to fibroblast growth factor,BP,
3429,GO:1904849,1,0.836616111386651,0,1,positive regulation of cell chemotaxis to fibroblast growth factor,BP,
3430,GO:1904892,1,0.694332314327877,0,1,regulation of STAT cascade,BP,
3431,GO:1904894,1,0.694332314327877,0,1,positive regulation of STAT cascade,BP,
3432,GO:1904949,1,0.976084701408914,0,1,ATPase complex,CC,
3433,GO:1904951,1,0.575716379805678,0,4,positive regulation of establishment of protein localization,BP,
3434,GO:1905037,1,0.694113237147052,0,1,autophagosome organization,BP,
3435,GO:1905039,1,0.481687677578068,0,2,carboxylic acid transmembrane transport,BP,
3436,GO:1905114,1,0.646638817826929,0,2,cell surface receptor signaling pathway involved in cell-cell signaling,BP,
3437,GO:1905330,1,0.932766532291112,0,1,regulation of morphogenesis of an epithelium,BP,
3438,GO:1905348,1,0.936872137023806,0,1,endonuclease complex,CC,
3439,GO:1905368,1,0.932766532291112,0,1,peptidase complex,CC,
3440,GO:1905369,1,0.932766532291112,0,1,endopeptidase complex,CC,
3441,GO:1905709,1,0.64378764821232,0,2,negative regulation of membrane permeability,BP,
3442,GO:1905710,1,0.745600768235738,0,1,positive regulation of membrane permeability,BP,
3443,GO:1905952,1,0.682570813562739,0,2,regulation of lipid localization,BP,
3444,GO:1905953,1,0.682570813562739,0,2,negative regulation of lipid localization,BP,
3445,GO:1905954,1,0.696563650306504,0,1,positive regulation of lipid localization,BP,
3446,GO:1990001,1,0.864933823131346,0,1,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,BP,
3447,GO:1990111,1,0.932766532291112,0,1,spermatoproteasome complex,CC,
3448,GO:1990234,1,0.926035774146092,0,2,transferase complex,CC,
3449,GO:1990351,1,0.469496936600561,0,3,transporter complex,CC,
3450,GO:1990481,1,0.801693816427004,0,1,mRNA pseudouridine synthesis,BP,
3451,GO:1990542,1,0.696271990189966,0,1,mitochondrial transmembrane transport,BP,
3452,GO:1990748,1,0.712703872478519,0,2,cellular detoxification,BP,
3453,GO:1990777,1,0.980476126491385,0,1,lipoprotein particle,CC,
3454,GO:1990837,1,0.695903409309486,0,1,sequence-specific double-stranded DNA binding,MF,
3455,GO:1990904,1,0.559282423818243,0,4,ribonucleoprotein complex,CC,
3456,GO:2000021,1,0.864933823131346,0,1,regulation of ion homeostasis,BP,
3458,GO:2000027,1,0.932766532291112,0,1,regulation of organ morphogenesis,BP,
3459,GO:2000058,1,0.932766532291112,0,1,regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
3460,GO:2000060,1,0.932766532291112,0,1,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
3461,GO:2000106,1,0.761888585522679,0,1,regulation of leukocyte apoptotic process,BP,
3462,GO:2000107,1,0.761888585522679,0,1,negative regulation of leukocyte apoptotic process,BP,
3466,GO:2000117,1,0.864933823131346,0,1,negative regulation of cysteine-type endopeptidase activity,BP,
3467,GO:2000121,1,0.747407444585123,0,1,regulation of removal of superoxide radicals,BP,
3468,GO:2000142,1,0.695903409309486,0,1,regulation of DNA-templated transcription, initiation,BP,
3469,GO:2000144,1,0.695903409309486,0,1,positive regulation of DNA-templated transcription, initiation,BP,
3470,GO:2000145,1,0.306007309814281,0,5,regulation of cell motility,BP,
3471,GO:2000146,1,0.747407444585123,0,1,negative regulation of cell motility,BP,
3472,GO:2000147,1,0.41352449583698,0,4,positive regulation of cell motility,BP,
3474,GO:2000257,1,0.697867488744479,0,1,regulation of protein activation cascade,BP,
3475,GO:2000278,1,0.747407444585123,0,1,regulation of DNA biosynthetic process,BP,
3476,GO:2000279,1,0.747407444585123,0,1,negative regulation of DNA biosynthetic process,BP,
3478,GO:2000378,1,0.639291005791314,0,2,negative regulation of reactive oxygen species metabolic process,BP,
3480,GO:2000401,1,0.718490506941261,0,2,regulation of lymphocyte migration,BP,
3481,GO:2000403,1,0.718490506941261,0,2,positive regulation of lymphocyte migration,BP,
3482,GO:2000404,1,0.718490506941261,0,2,regulation of T cell migration,BP,
3483,GO:2000406,1,0.718490506941261,0,2,positive regulation of T cell migration,BP,
3484,GO:2000407,1,0.761888585522679,0,1,regulation of T cell extravasation,BP,
3485,GO:2000409,1,0.761888585522679,0,1,positive regulation of T cell extravasation,BP,
3486,GO:2000449,1,0.761888585522679,0,1,regulation of CD8-positive, alpha-beta T cell extravasation,BP,
3487,GO:2000451,1,0.761888585522679,0,1,positive regulation of CD8-positive, alpha-beta T cell extravasation,BP,
3488,GO:2000452,1,0.761888585522679,0,1,regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
3489,GO:2000454,1,0.761888585522679,0,1,positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
3490,GO:2000482,1,0.943785593081157,0,1,regulation of interleukin-8 secretion,BP,
3491,GO:2000484,1,0.943785593081157,0,1,positive regulation of interleukin-8 secretion,BP,
3492,GO:2000544,1,0.836616111386651,0,1,regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
3493,GO:2000546,1,0.836616111386651,0,1,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
3494,GO:2000649,1,0.976084701408914,0,1,regulation of sodium ion transmembrane transporter activity,BP,
3495,GO:2000778,1,0.943785593081157,0,1,positive regulation of interleukin-6 secretion,BP,
3496,GO:2000785,1,0.694113237147052,0,1,regulation of autophagosome assembly,BP,
3498,GO:2001014,1,0.910467635192227,0,1,regulation of skeletal muscle cell differentiation,BP,
3499,GO:2001015,1,0.910467635192227,0,1,negative regulation of skeletal muscle cell differentiation,BP,
3500,GO:2001026,1,0.836616111386651,0,1,regulation of endothelial cell chemotaxis,BP,
3501,GO:2001028,1,0.836616111386651,0,1,positive regulation of endothelial cell chemotaxis,BP,
3505,GO:2001179,1,0.943785593081157,0,1,regulation of interleukin-10 secretion,BP,
3506,GO:2001181,1,0.943785593081157,0,1,positive regulation of interleukin-10 secretion,BP,
3507,GO:2001198,1,0.924720397590426,0,1,regulation of dendritic cell differentiation,BP,
3508,GO:2001199,1,0.924720397590426,0,1,negative regulation of dendritic cell differentiation,BP,
3509,GO:2001233,1,0.273799191489371,0,7,regulation of apoptotic signaling pathway,BP,
3510,GO:2001234,1,0.409863805037036,0,4,negative regulation of apoptotic signaling pathway,BP,
3511,GO:2001235,1,0.564926158713702,0,4,positive regulation of apoptotic signaling pathway,BP,
3512,GO:2001236,1,0.371558341975535,0,6,regulation of extrinsic apoptotic signaling pathway,BP,
3513,GO:2001237,1,0.55344739271292,0,3,negative regulation of extrinsic apoptotic signaling pathway,BP,
3514,GO:2001238,1,0.671602351328508,0,3,positive regulation of extrinsic apoptotic signaling pathway,BP,
3515,GO:2001242,1,0.815946865122908,0,2,regulation of intrinsic apoptotic signaling pathway,BP,
3516,GO:2001243,1,0.864933823131346,0,1,negative regulation of intrinsic apoptotic signaling pathway,BP,
3517,GO:2001245,1,0.916336727632546,0,1,regulation of phosphatidylcholine biosynthetic process,BP,
3518,GO:2001267,1,0.641588149434177,0,2,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
3519,GO:2001269,1,0.641588149434177,0,2,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
1182,GO:0016747,1,0.0968703120468404,0,7,transferase activity, transferring acyl groups other than amino-acyl groups,MF,
1344,GO:0022607,1,0.0526397619042907,0,14,cellular component assembly,BP,
3013,GO:0071822,1,0.1017237400802,0,13,protein complex subunit organization,BP,
